Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-27T07:15:57.541Z Has data issue: false hasContentIssue false

Part III - Non-regulated Jurisdictions

Published online by Cambridge University Press:  02 February 2023

Daisy Cheung
Affiliation:
The University of Hong Kong
Michael Dunn
Affiliation:
National University of Singapore

Summary

Type
Chapter
Information
Advance Directives Across Asia
A Comparative Socio-legal Analysis
, pp. 223 - 336
Publisher: Cambridge University Press
Print publication year: 2023
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This content is Open Access and distributed under the terms of the Creative Commons Attribution licence CC-BY-NC-ND 4.0 https://creativecommons.org/cclicenses/

12 Advance Directives in China’s Mainland: An Emerging Framework?

Bo Chen
12.1 Introduction

China’s mainland is rapidly becoming an ageing society. In 2010 there were 168 million Chinese people aged 60 years of age or above – and the elderly population is projected to increase to 402 million by 2040, representing about 28% of the projected total population of China.Footnote 1 Accordingly, it is expected that there will be increased demands for high-quality healthcare in general, and for greater autonomy in end-of-life care. While they have attracted controversy, Advance directives (ADs) are considered as potentially useful legal instruments to promote patient autonomy at the end of life.Footnote 2

This book defines an AD as a statement in which a competent person makes an advance decision in any number of areas (including healthcare, social welfare and any other personal matters), to be implemented in the event that the person becomes incompetent (loses mental capacity) in the future.Footnote 3 Even by this arguably narrow definition, it should be stated that China’s legal system does not provide a normative framework governing the use of ADs. In recent decades, however, new developments in both law and a professional code of ethics have emerged, and one might reasonably expect these new rules and guidelines will centre patient autonomy, echoing the spirit of ADs.

This chapter explores the emerging normative framework governing the use of ADs in China, which primarily consists of relevant provisions from the Civil CodeFootnote 4 and the Chinese Medical Doctors’ Code of Ethics (CoE).Footnote 5 The chapter argues that where the stakeholders (primarily doctors, and patients’ family members who play a part in medical decision-making) choose to respect a patient’s will (made before they lost mental capacity), this framework provides such a legal and ethical basis. However, the chapter also observes that such a normative framework is rarely applied in legal proceedings, as revealed by a thorough search of the judicial database for courts’ judgments, or in healthcare practice. The chapter will also survey a number of civil society organisations that advocate for the use of ADs in China, before forming a conclusion.

12.2 Making Sense of the Emerging Normative Framework

For the purposes of this chapter, I draw upon a broad definition of ADs to examine the law and professional guidelines in China. The term “advance directive” refers to two types of statements in which the patient may (a) appoint a substitute decision-maker for and by the patient concerned (power of attorney); and/or (b) make specific decisions for future healthcare planning (generally known as a living will). It is the latter meaning of AD that this book adopts, even though recognising its limitations. In this chapter however, given the significance of the adult guardianship system in China, and the general absence of specific laws or regulations on ADs, the norms that apply to both forms of ADs will be considered. This section first explores the relevant provisions of the adult guardianship system as provided in the Civil Code, and which I suggest could potentially provide a legal basis for a Chinese version of power of attorney. It then examines the provisions of the CoE that direct Chinese doctors to respect the living wills made by mentally competent patients.

12.2.1 Adult Voluntary Guardianship: Chinese Version of Power of Attorney

The enforcement of China’s Civil Code which adopted provisions on adult guardianship law began on 1 January 2021. The code is not entirely new, however, as it was initially introduced in 2017 by another piece of legislation, the General Provisions of Civil Law,Footnote 6 as part of a project preparing for the final Civil Code.

Adult guardianship authorises a third party (i.e. the guardian) to make legally binding decisions on behalf of another person under their guardianship. The legitimacy of adult guardianship and other forms of substitute decision-making arrangements have been the subject of considerable debates and controversies since the adoption of the United Nations Convention on the Rights of Persons with Disabilities (UNCRPD)Footnote 7 and the first General Comment No.1 on article 12 – Equal recognition before the law.Footnote 8 China has been a State Party to the UNCRPD since 2008, and the reform of the law regarding adult guardianship is arguably a step towards maximising the autonomy of persons with disabilities, who are often made subjects of adult guardianship.Footnote 9 Although the chapter focuses on the current applicable law, it acknowledges the visible gap between domestic law and the relevant requirements made by the UNCRPD.

Before embarking on a closer examination of the adult voluntary guardianship system, it should be noted that the role played by guardians on behalf of those they are responsible for goes beyond mere decision-making. Guardianship in the Chinese context includes the extension of a combination of both rights (or powers) over the person under guardianship, in addition to having a duty of care to ensure the protection of personal rights, property rights and other rightful interests of the person.Footnote 10 In practice, guardians also have a duty of responsibility for many aspects of the life of the person under guardianship, such as caring for the person on a daily basis. A guardian may also be liable for the actions of the person under guardianship, for instance, if the person under guardianship causes injury to a third party or their property, and the guardian is deemed not to have fulfilled their oversight duty.Footnote 11

In such a context where guardians have a significant responsibility and power over the life of the person under guardianship, the Civil Code allows the person under guardianship to be involved in the process of choosing the individual who will be appointed as guardian, while the person retains the mental capacity to make rational decisions.Footnote 12 Before moving to the specific arrangements of voluntary guardianship, it is equally important to briefly examine the provisions on mental capacity and adult guardianship in general.

The Civil Code adopts the term of “capacity for performing civil juristic acts” that is based on the assessment of whether an adult can “comprehend his own conduct”.Footnote 13 For adults who are considered as going to lose or having already lost full or partial capacity for performing civil juristic acts, guardians could be appointed in three major methods. The first one is appointing guardians by a legal order of close relatives,Footnote 14 where the spouse of the person is the most prioritised candidate of guardian, followed by one’s parents and adult children; if all the candidates are inapplicable or unable to take the responsibility, other close relatives or other willing and approved individuals or organisations would also become eligible.Footnote 15 Guardians may also be appointed by agreement among eligible candidates of guardianship,Footnote 16 and by voluntary or prearranged guardianship.Footnote 17 In circumstances where conflict arises over the choice of guardian, the law states that the local village, neighbourhood committee or local government’s civil affairs department should intervene, or the issue be resolved in a court of law.Footnote 18 As a last resort, in instances where there are no eligible family or others who can take on the responsibility, the local village or neighbourhood committee or local government’s civil affairs department would take on the responsibility of guardianship.Footnote 19 Since guardianship in the Chinese context consists of both decision-making rights as agent and a duty of care, the legal order prescribed in article 28 of the Civil Code serves the purpose of ensuring that the person believed to be in need of such will ultimately be assigned a guardian.

Given that the state does not generally provide guardians with sufficient financial remuneration or other resources to enable them to carry out their guardianship responsibilities efficiently and effectively, to be appointed as a guardian requires a significant psychological and financial commitment.

Voluntary guardianship, or prearranged guardianship, since guardianship can hardly be genuinely voluntary, was introduced in 2017 by the General Provisions of Civil Law, and it reflected the principle of maximum respect for the autonomy and wills of persons under guardianship.Footnote 20 An official English translation of article 32 of the Civil Code reads:

An adult with full capacity for performing civil juristic acts may, in anticipation of incapacity in the future, consult his close relatives, or other individuals or organisations willing to be his guardian, and appoint in writing a guardian for himself, who shall perform the duties of guardian when the adult loses all or part of the capacity for performing civil juristic acts.Footnote 21

The provision suggests that the appointed guardian will serve the function of a power of attorney, as happens when a competent person appoints a representative to make future healthcare decisions on their behalf, in the event they lose the capacity to do so themselves at some future time. In the context of Chinese civil law, entering a contract of healthcare services with a healthcare service provider, such as a hospital or clinic, deciding on a treatment plan, and, perhaps more controversially, signing on the informed consent documentation are often considered as the so-called civil juristic acts mentioned previously.

It is clear that voluntary guardianship and its terms and conditions must be agreed in writing,Footnote 22 but less transparent are the mechanisms to ensure its enforcement. The Civil Code does not elaborate on which aspects of decision-making capacity should be assessed and how the capacity for performing civil juristic acts should be assessed and declared. In the context of healthcare services, it seems reasonable to assume that relevant medical professionals are best suited to make such an assessment. However, the Civil Procedure Law contains a section detailing the special procedure for declaring full or partial loss of capacity, a decision which must be made by a court.Footnote 23 A careful reading leads one to infer that this procedure applies in assessing capacity, since the Civil Code is silent on this issue. On the other hand, it has been common practice that public notarisation is sufficient to activate voluntary guardianship, in which case, the aforementioned court proceeding is bypassed or simply ignored.Footnote 24 This uncertainty in activating voluntary guardianship might be a factor influencing its utilisation in practice, an issue which will be explored later in the chapter.

Once the guardianship is established, the guardian’s action must be based on the Best Interest Principle of the person under guardianship.Footnote 25 The Civil Code does not elaborate on what actions the guardian is required to fulfil under the Best Interest Principle. One interpretation of this provision given by the Leadership Unit for implementing the Civil Code of the Supreme People’s Court provides an example of this principle:Footnote 26 the guardian may dispose of the property of the person under guardianship only for the express purpose of defending his or her interests, an eventuality that is also provided for in the Civil Code. Interestingly, however, such an interpretation also provides that the essence of the Best Interest Principle is to fully respect the wishes of the adult under guardianship, another principle that governs the guardians’ actions.

Article 35 of the Civil Code obliges guardians to give maximum respect to the true wishes of the person, by supporting the person to undertake matters that are appropriate to their capacity, while refraining from intervention.Footnote 27 The principles of “Best Interest” and “maximum respect for true wishes” have the potential to come into conflict with each other; however, the practice as reflected in judicial proceedings and published medical studies seems inadequate to form a basis on which to examine the actual tension, as will be discussed later. These principles might be admittedly more relevant to the daily decision-making for persons with intellectual disabilities or mental health problems than ADs in end-of-life care or healthcare generally. At the very least, however, the principle of maximum respect for autonomy, as well as other provisions examined previously, demonstrates a clear direction in law that the autonomy of the persons whose mental capacity might be in question should be given serious consideration and respected as far as possible.

12.2.2 Code of Ethics: Respecting for Living Wills at End-of-Life Care

The Chinese Medical Doctor Association, representing 2.3 million members, issued the CoE on 25 June 2014. The association claims that the binding force of the CoE lies between non-binding declaration and formally binding regulation,Footnote 28 the exact implication of which warrants further clarification.

The CoE is comprehensive in content, consisting of 40 articles that are divided into the following sections: basic principles, doctor–patient relationship, the relationship with fellow doctors, doctor–society relationship and doctor–enterprise relationship. Patient autonomy is one of the key themes. Article 1 requires doctors to give adequate respect to their patients,Footnote 29 and article 9 asks medical professionals to listen to the patients and to strive to build relationships of mutual trust.Footnote 30 In doing so, doctors are required to communicate with their patients in a manner that is understandable to the patient.Footnote 31 An example here would be the procedure of obtaining informed consent before a surgical operation; it is expected that a special examination or treatment would not be conducted as a mere box-ticking exercise or an excuse for avoiding possible liability.Footnote 32

It is also evident that the framework is grounded in paternalism. The CoE allows doctors to conceal information considered to be potentially harmful should it become known to the patient.Footnote 33 Guided by arguably competing approaches, some provisions read less clear. For example, article 23 of the CoE requires doctors to respect patients’ “reasonable” requests and choices, including their right to accept or decline any medical recommendation.Footnote 34 Yet there remain the problematic questions of how to assess “reasonableness” in this context as there is no standard measure, or what consequences should follow when patients decline medical recommendations, both of which requires further research.

The most relevant provision relating to ADs is article 20, the first sentence of which requires doctors to take seriously patients’ life-sustaining decisions.Footnote 35 It is followed by the second sentence which states that doctors should also respect any wishes expressed by patients through living wills and substitute decision-making arrangements made while patients lost their mental capacity.Footnote 36 The text is unclear on whether the endorsement of living wills is limited within the scope of maintaining or withdrawing life-sustaining arrangements. Nonetheless, even for patients whose capacity for performing civil juristic acts is in question, their doctors should facilitate their maximum participation in all aspects of medical decision-making.Footnote 37 There does not appear to be any empirical research on how these articles operate in practice, or how doctors have implemented any such living wills (if at all), so it remains unclear whether article 20 has been put into practice and, if so, how this was done, the circumstances, and with what consequences.

12.2.3 Summary

The normative framework governing mental capacity and professional ethics in China represents a mixed package which endorses both paternalistic benevolence and personal autonomy. Maximum respect for autonomy and involvement in healthcare decision-making goes hand in hand with the Best Interest Principle in the Civil Code and the “reasonableness” assessment in the CoE.

That said, it is equally evident from this discussion that both the voluntary guardianship in the Civil Code and the living wills provision in the CoE offer at least a possibility that ADs could become functional in China. From a historical perspective, the current normative framework demonstrates a step towards respecting patients’ autonomy in healthcare decision-making. For all stakeholders who have concerns about ADs, they at least have something to start with, albeit there remains considerable uncertainty. On the other hand, however, the fact that adult guardianship has undergone recent reform may imply that legally binding ADs are not likely to be introduced in the foreseeable future. The adult guardianship system may reinforce the pre-existing practice and culture which prioritises substitute decision-making arrangements over giving consideration to patients’ wishes expressed through living wills. Given these possibilities, the form in which these will ultimately be adopted depends on how this will be practiced on the ground.

12.3 Explanations for Under-implementation

The previous section argued that the current normative framework at least creates the possibility that ADs could be made and respected, both legally and ethically. This section explores the extent to which this theoretical possibility has been realised. It does so firstly by examining the databases of courts’ rulings and medical research, specifically seeking evidence that would suggest real-world use and application of the aforementioned legal and ethical provisions.

Before its introduction in 2017 by the General Provisions of Civil Law, the actual application of voluntary guardianship was long-awaited. However, based on the search results from China Judgments Online, the official publicly accessible database of courts’ rulings, there has yet to be a case where the court has been called upon to decide on the legality of voluntary guardianship.Footnote 38 Moreover, the CoE was mentioned by a plaintiff in only one case, and the court did not address the question of whether the CoE had been breached. The search results suggest rare, if not non-existent, application of the current normative framework of ADs in Chinese courts. Healthcare services appear not to utilise the normative framework either. Extensive and close searching of CNKI.NET, the largest electronic database for academic papers, failed to identify any research studies on the actual application of ADs or the CoE provision. Most of the several dozen relevant papers are either theoretical or seek to promote its regulation by introducing foreign law on ADs. The following sections will explore why implementation has been weak, firstly by presenting the factors in the normative framework, followed by a discussion on attitudinal and cultural underpinnings.

12.3.1 Legal Uncertainty and Practical Unnecessity

In the previous discussion of the normative framework, I briefly touched on the matter of legal uncertainty. The Civil Code does not specify who should be appointed to assess the extent of incapacitation, or the procedure for activating voluntary guardianship. Moreover, the CoE fails to clarify the determination of the concept of reasonableness in patients’ wills, or whether the respect for living wills applies only in end-of-life decisions. Even though awareness of ADs has been growing, it would be reasonable to assume these uncertainties do not encourage patients or doctors to invest their time and energy in these matters. This would be particularly the case when they are unsure of the legal or practical consequences that will follow.

Risks exist in the application of ADs in light of other relevant rules. For example, faced with a living will that outlines a refusal of life-sustaining treatment, the doctor will be placed in a dilemma: on one hand, the CoE imposes an ethical duty on the doctor to respect the living will, if they are convinced that the patient’s refusal of treatment is “reasonable” and all other conditions are met.Footnote 39 On the other hand, the doctor has a legal obligation to save lives, and, moreover, the law does not appear to allow exceptions, even where living wills specify the patients’ refusal of life-saving treatment. For example, the Law on Practicing Doctors (LPD) explicitly requires doctors in China to adopt emergency treatment measures, and stipulates that doctors cannot refuse to give emergency treatment.Footnote 40 The penalties for non-compliance range from suspension for 6–12 months, to having their medical license revoked, to facing even criminal prosecution if their (in)actions result in delays in the rescue and treatment of patients in emergency and critical condition, and serious consequences due to negligence.Footnote 41 Similar provisions are also to be found in lower-ranking regulations, such as the Administrative Regulations on Medical Institution in 1994Footnote 42 and The Guiding Opinions on the Establishment of an Emergency Relief System for Diseases in 2013.Footnote 43

It could be argued that respecting the refusal of life-sustaining treatment through a living will does not violate these general rules. Front-line practitioners, however, appear to feel assured when they are explicitly guided by clear rules that support their legal and ethical obligations to comply with the living will.Footnote 44

In addition to these legal uncertainties in the rules and their legal consequences, substitute decision-making by formal voluntary guardianship may be seen to be unnecessary in practice. It has been widely acknowledged that the procedural requirement established by the Civil Procedure Law for declaring the capacity for performing civil juristic acts, the precondition for validating adult guardianship in theory, is facing significant practical difficulties.Footnote 45 More importantly, family members are granted considerable rights to information and decision-making in healthcare services.Footnote 46 Since in most cases, it is family members who serve as the substitute decision-makers, proceedings before the court would not be regarded as necessary.Footnote 47

12.3.2 Attitudinal and Cultural Factors

In addition to the previous analysis, there also exists a body of literature that explores attitudinal and cultural factors that drive the slow translation of ADs into practice. For example, the low awareness-rate of ADs among all stakeholders (including the persons themselves, their family members, and doctors and nurses), the tradition of avoiding discussions about death, and the parent–child relationship under Confucianism are widely believed to be the main social and cultural factors relevant to the promotion of ADs.Footnote 48 This proposition appears to be supported by empirical studies conducted in China in recent years.

Although there are no available national studies, some medical research papers have explored stakeholders’ attitudes towards ADs with relatively small samples or at the local level. For example, a study on the acceptance of ADs consisting of 280 senior patient-participants with chronic disease living in the community suggests that educational level and attitudes to death have the most significant influence on acceptance level.Footnote 49 Those patients with higher educational levels indicated a higher acceptance level towards ADs in their responses. Participants who indicated that they had a higher level of acceptance of death as a natural consequence of life also had a higher level of acceptance of the use of ADs (mainly being more open to the idea of and use of ADs).Footnote 50

Another study of 249 family members of stroke patients investigated their attitudes towards setting up ADs.Footnote 51 Only 40% of participating family members agreed with the idea of setting up ADs; a quarter of participants explicitly disagreed and the remaining 35% preferred not to answer for a variety of reasons. The reasons for family members’ disapproval of ADs included the following: “the patients’ choice is not necessarily reasonable” (33.3%), “family members cannot accept that their relatives would be left to die” (25.2%), “our family cannot afford a free choice among different types of cares” (14.3%), “the medical decision should be made by me (or other family members)” (12.9%) and “family members concern that doctors would not actively rescue the patients with ADs” (13.6%). Interestingly, the study also asked whether participating family members would themselves have ADs. Of 128 family members who answered “no”, 67 respondents believed doctors and family members were capable of making wise decisions on their behalf, while 60 respondents stated that they did not have adequate information to make ADs. In addition to the low awareness, it also reflects an evident attitudinal and cultural preference that favours substitute decision-making arrangements over respect for patients’ autonomy by ADs. Such a cultural preference likely also stems from what has been described as the family-based decision-making model prevalent in Confucian Chinese societies, where the family, rather than the individual patient, is seen as the primary unit of medical decision-making.Footnote 52

A study in 2020 explored attitudes of 530 healthcare professionals towards ADs.Footnote 53 Its findings revealed that awareness of ADs among healthcare professionals is still low; only 44.5% of the participants knew about ADs. That study adopted a broader definition of ADs, including both types of living wills and powers-of-attorney. Of the participating professionals, 84% and 70.4% approved of living wills and powers-of-attorney respectively. Regarding living wills, the reasons for approval include respect for patients’ right to choose (98.2%), reducing unnecessary suffering (91.7%) and over-treatment (77.3%), avoiding conflict of opinions among family members in resuscitation (74.4%), reducing family members’ financial (74.4%), psychological/ethical (73.7%), and caring (72.6%) burden and improving patients’ quality of life (73%).

Similar considerations shaped reasons for approving of powers of attorney, but, interestingly, some other reasons were also mentioned, for example, “avoiding the difficulties among different choices faced by doctors” and “saving time for treatment”. Among those who disapprove of ADs (16% for living wills and 29.6% for powers of attorney), legal uncertainty represented the shared reason, 68.2% and 66.2% respectively. Regarding living wills, other major reasons for disapproval include losing opportunities for resuscitation, depriving the patient’s right to life, conflicts of opinions between patients and family members, violating professional ethics, being uncomfortable discussing the topic with patients, hindering technological progress and lack of time for doctor–patient communication. Among those who disapproved of powers of attorney, there were concerns that “the patients’ decision to refuse treatment could be changed by their agents” and “the patient might lose autonomy if the power-of-attorney is signed under pressure”. A particularly potent reason was that “family members would become the agent in decision-making automatically”, meaning powers of attorney are unnecessary.

While further empirical research is needed, particularly at the national level, existing studies provide a glimpse into the role that ADs may be able to play in China. Although resistance from family members to the idea of ADs is likely to pose a challenge to the uptake of ADs, healthcare practitioners appear surprisingly supportive of living wills in particular, which may be a positive factor in facilitating further awareness and support of ADs in China over time.

12.4 Ongoing Projects Promoting Advance Directives in China

Nonetheless, the attitudinal and cultural factors discussed here are subject to change. As well as a critical review of the literature explaining the status quo, the chapter also considers some pilot projects that promote ADs and were initiated by civil society organisations. These projects are still in their early stages, and their scope is largely limited to urban areas and particular social groups. But they are potential change-makers through their active engagement with social discussions and practice.

12.4.1 Promotion by Beijing Living Will Promotion Association

Beijing Living Will Promotion Association (BLWPA) was established in 2013 as a non-governmental organisation with the ultimate goal being to promote the idea of “die with dignity” and living wills.Footnote 54 In addition to distributing information booklets and public advocacy through mass media, one of its key works is supporting more people in thinking about their end-of-life decisions and making their living wills.

BLWPA’s official website (www.lwpa.org.cn) provides a tool by which people can complete a form indicating their wills and preferences regarding their end-of-life decisions. Informed by “My Five Wishes” in the United States, BLWPA guides its users to consider their wishes for wanting (a) certain elements involved in medical treatments (such as “I do not want any treatment or examination that would increase pain even when doctors and nurses believe it to be beneficial” and “I do want to keep my body clear all the time”); (b) life-sustaining treatment (including applying Cardiopulmonary Resuscitation, feeding tube, or expensive antibiotics); (c) how other people will treat me (such as “I want to die at home if possible” and “I do not want to be disturbed by volunteers”); (d) what I want my family members and friends to know (such as “I want my family to know I love them” and “I do not want any memorial service”); and (e) who will help me (appointing a substitute decision-maker to ensure these wishes would be respected as much as possible). Users need to register with BLWPA’s website to access the form, which requires that the contact information of relevant family members or friends be provided. The default setting is that the wills are activated only when two medical professionals believe the person concerned has become incompetent. BLWPA also recommends its users to notarise their wills, the purpose of which is most likely to enhance the wills’ legal status, so that doctors are more likely to follow the directives set out within the wills. That said, BLWPA acknowledges that the wills are not legally binding, as China has not enacted any law that clarifies the doctors’ roles and responsibilities in acceding to the directions stipulated within the wills.

It remains unknown how many people have used BLWPA’s service. However, arguably due to BLWPA’s advocacy, directly or indirectly, the Chinese Government initiated a pilot project on palliative care in 76 cities or districts nationwide in 2019.Footnote 55 Legal recognition of living wills is not mentioned in the policy document of the pilot project. Nonetheless, the development of such services would be expected to have an impact on the social attitudes towards end-of-life care and surrounding legal arrangements.

12.4.2 Active Use of Voluntary Guardianship by the LGBT Community in China

The process of civil law reform in China has provoked deep concerns from among interest groups and stakeholders, among these groups being China’s lesbian, gay, bisexual, and transgender (LGBT) community. In the final text of the Civil Code, neither same-sex marriage nor civil partnership is legalised. Thus, there exists the need for other legal tools or formal arrangements that would help to ensure a legal bond between homosexual couples in China. Voluntary guardianship, therefore, has become a heated topic within the community and has raised some scholarly concerns.Footnote 56

Yanhui Peng, a community leader from the group LGBT Rights Advocacy China, shared in an online panel in 2020 that they are exploring whether voluntary guardianship could be helpful in gaining control in a variety of issues faced by the LGBT community in China. By setting up voluntary guardianship, community members seek to make their partners legitimate agents or decision-makers on medical treatment, living arrangements as they become older, property and litigation.Footnote 57

Facing the legal uncertainty discussed here, Peng also recommends notarising the voluntary guardianship documents. To promote voluntary guardianship among the community members and to advocate for equal rights of the LGBT community, LGBT Rights Advocacy China actively works with notary agencies in different areas. Through their active engagement, Nanjing Public Notary Office has publicly promoted their services in setting up voluntary guardianships for medical decision-making to the LBGT community in their social media accounts.Footnote 58

How these voluntary guardianship arrangements function in practice, especially in the healthcare setting, requires further observation. The efforts from the community, nevertheless, are creating or expanding the possibility that the normative framework of ADs could be activated, thereby changing social attitudes and awareness of ADs.

12.5 Conclusion

This chapter has drawn on related practice and scholarly literature to examine the current semi-normative framework for ADs in China, including related practice and scholarly discussion. Without specific legislation that acknowledges and gives binding force to ADs, China’s new Civil Code nevertheless sets out legal criteria by which a person may be assessed as lacking in decision-making capacity, and guidance on the appointment of substitute decision-makers for such people. The CoE requires Chinese medical practitioners to respect patients’ expressed wills made at a time when the patient was of mental capacity and able to make rational decisions, and to ensure patients’ maximum participation in the decision-making process, even when the patients are considered to be beyond capacity. The chapter presents a discussion of such a framework of norms that may potentially have a positive impact on practices related to advance healthcare directives.

Existing evidence derived from judicial proceedings and medical research literature suggests it is rare, if not non-existent, that the framework has actually been translated into medical practice. The chapter considers the legal, attitudinal and cultural factors that hinder the implementation of ADs. In addition, it has also surveyed two leading examples of civil society-led pilot projects that promote ADs in China, presenting a wider landscape of the relevant practice. With only a vaguely promising prospect that the social attitudes of stakeholders will become more friendly to broader implementation of the power of attorney and living wills in their current form, it is argued that the current legal, policy and economic-social context in China appears unready for the legislation of legally binding ADs.

13 Guideline-Based Approach to End-of-Life Care Decisions in Japan: Practice, Regulation and the Place of Advance Directives

Reina Ozeki-Hayashi , Futoshi Iwata , Satoshi Kodama & Miho Tanaka
13.1 Introduction

End-of-life decision-making has become an increasingly important issue in Japan, where the super-ageing of the population is progressing. To date, no legislation that specifically addresses medical considerations related to end-of-life care (e.g. advance directives [ADs]), forgoing life-sustaining treatment) has been enacted. End-of-life decision-making on care and medical treatment continues to be dealt with primarily according to the Ministry of Health, Labour and Welfare guidelines, which make no mention of ADs, although they are based on the ideas of ADs and advance care planning (ACP).

Despite the lack of formal AD regulation by way of laws or guidelines, and therefore uncertainty about their place in the end-of-life care context and the potential legal implications of AD implementation, empirical data suggest that ADs are in fact discussed and used in Japanese practice. How these data should be interpreted, however, is far from straightforward. There is evidence, for example, that whilst attitudes towards ADs have become more positive over time, there is still a large discrepancy between such attitudes and AD practice. In light of all this, how do ADs fit into the Japanese legal and sociocultural context, and the end-of-life process in particular? This is one of the questions we consider in this chapter, which begins with an examination of issues related to the withdrawal of life-sustaining treatment through court cases and incidents in the past few decades. We then discuss the process guidelines on end-of-life decision-making, national attitude surveys on end-of-life issues and sociocultural factors that have a potential impact on ADs and ACP in Japan.

13.2 A Brief History of Court Cases Dealing with End-of-Life Decisions

The past 30 years have seen some of the most important issues concerning decision-making on end-of-life care raised in Japan. There is no specific statute that recognises the legally binding nature of end-of-life decisions about ADs and do not attempt resuscitation (DNAR) orders and no legal definition of ADs, and only a few court cases have interpreted the basic murder provisions of the substantive criminal law (Penal Code s. 199)Footnote 1 and the general negligence provision (Civil Code s. 709)Footnote 2 that governs end-of-life discussions. Furthermore, no official entity (e.g. public advocate, ombudsperson, public guardian) is tasked with protecting the rights of the elderly and the validity of the medical decision-making process.Footnote 3 The illegality of active euthanasia has been established in a few cases.Footnote 4 One of the most important developments in this area was the creation by the Ministry in 2007 of so-called process guidelines (see Section 13.3), which are formulated around end-of-life care and treatment more broadly.Footnote 5 Several medical colleges also subsequently created guidelines based on the process guidelines. However, because these guidelines are not legally binding,Footnote 6 it may remain difficult in practice for a patient/family to align a medical care team’s strategy with the patient’s decision and to obtain judicial relief if the team intentionally or negligently ignores the patient’s wishes,Footnote 7 although relief may be provided by the courts by taking into consideration whether the conduct concerned fell below the standard of care in tort cases or can be excused or justified in murder cases. In this sense, the Ministry’s process guidelines and medical colleges’ guidelines offer a regulatory tool to aid the courts in interpreting relevant laws. There have been calls for enactment of a Natural Death Act (known as the AD Bill) by the Japan Society for Dying with Dignity and non-partisan Diet members, although such legislation has yet to be realised by the Japanese government, and is unlikely to be so in the near future.Footnote 8

Most developed countries, including the United States and Australia, have a similar medico-legal framework to that of Japan, and treatment without patient consent is considered unlawful under civil and, in rarer situations, criminal law. In other words, patients have the right to refuse treatment at any time, especially before treatment is initiated, which is basically the same as what the informed consent theory requires, although courts in Japan typically do not use the expression “informed consent”. However, it is debatable whether the right of patients to refuse treatment automatically guarantees the withdrawal – upon patient request – of life-sustaining treatments to which they themselves consented. The Japanese courts view the withholding and withdrawal of treatment to impose different duties on medical professionals;Footnote 9 that is, once they start treatment, it is their duty to continue it to preserve the patient’s life. Many doctors believe that a patient with amyotrophic lateral sclerosis (ALS), for example, can legally refuse ventilator support; however, once the patient is placed on ventilator support, doctors are legally bound to continue using the ventilator even if the patient asks them to remove it unless the patient’s condition becomes terminal (the courts use the expression “imminence of death”). Whilst there is no case law or legislation that definitively resolves this matter, it could be argued that an answer, at least to some extent, can be found in the Ministry’s process guidelines, an argument we make in this chapter.

Several provisions in Japanese criminal law address the protection of human life, such as prohibiting homicide (Penal Code s. 199) and aiding suicide (Penal Code s. 202), although suicide itself is not punishable by law. These two provisions are generally understood as making it clear that terminating one’s life cannot be justified simply as an autonomous decision because the Penal Code prohibits assisting death, even if it is the victim’s autonomous wish. In light of these provisions, the most important question for our purposes is how much leeway is allowed, or to what extent the withholding or withdrawal of treatment should be considered permissible.

Two criminal cases, the 1998 case of Kawasaki Kyodo Hospital and the 2000 case involving Imizu Municipal Hospital, were the major drivers of the development of the Ministry’s process guidelines, which embody the concept of patient autonomy, with the medical care team taking on a facilitating role. Uncertainty over whether medical professionals would face legal consequences as a result of withdrawing medical treatment was a central focus of both cases, pushing the Ministry to address end-of-life care more extensively by creating the process guidelines.Footnote 10

The most important judgment concerning the withdrawal of treatment and active euthanasia in Japan is the 2009 Supreme Court ruling in the Kawasaki Kyodo Hospital case. In that case, an attending physician had removed an endotracheal tube from a patient who was in a comatose state owing to bronchial asthma with the consent of the patient’s family. The physician had then administered intravenous muscle relaxants to ease the patient’s death.Footnote 11 The physician was charged with and convicted of murder by the court in 2005. In 2007, the Tokyo High Court reduced the sentence in half, to one year in prison, suspended for three years, a sentence affirmed by the Supreme Court in 2009. This was the first Supreme Court case concerning the issue of end-of-life decisions. The court decided that it was premature to consider whether the physician’s conduct (i.e. withdrawing the tube and injecting lethal drugs) was justifiable or excusable as an exception to murder. According to the court, only after objective criteria have been met can the issue be considered (e.g. the “imminence of death” condition was not clearly established in this case). More specifically, because no brain death test had been conducted, and no consultation with the hospital president or peer physicians had been sought, the court maintained that it did not need to discuss the validity of withdrawing treatment as an exception to the murder provision. Even assuming that the removal of the endotracheal tube had been done with the family’s consent, the physician’s explanation was considered legally insufficient and inaccurate, that is, not a valid basis for consent, because the physician was not herself aware of the patient’s medical diagnosis and prognosis.

In its ruling in the case, the Tokyo High Court (one of eight appellate courts) included the following frank statement: “A fundamental solution to the problem of death with dignity in such cases would require the enactment of a Death with Dignity Act, or alternatively, a set of guidelines”. (“Namely, the court felt uncomfortable … creat[ing] leeway to allow active euthanasia and/or [the] withholding and withdrawal of treatment through interpretation”, explained Judge Kunio Harada, one of the three judges.Footnote 12) In other words, the issue of death with dignity should be the subject of a broader national consensus, the outcome of which should be a law or set of guidelines rather than something to be decided by the courts amidst their prevalent deference to the legislative and executive branches.

In the Imizu Municipal Hospital case, which occurred in 2000, an attending physician had discontinued the use of a ventilator in seven terminally ill patients at the request of the patients or their families. All of the patients died following the discontinuation of ventilator support.Footnote 13 In response to media reports, the hospital director publicly apologised for the physician’s “unethical” decisions. The police subsequently investigated the patients’ deaths and filed a report with the local prosecutor’s office in 2008 indicating that there was no need for punitive action. The case was dropped in 2009 on the ground that causation could not be established (i.e. the causes of the deaths were unclear).Footnote 14 This case understandably created considerable confusion and uneasiness in the medical field.

In 2007, soon after the Tokyo High Court decision on the Kawasaki case and the reporting of the Imizu case, the Ministry issued process guidelines on the withdrawal of life-sustaining treatment,Footnote 15 followed by the publication of more specific end-of-life care guidelinesFootnote 16 by several professional associations.

13.3 The Process Guidelines

The Ministry’s process guidelines, which came into force in 2007, are not linked to any legislation and have no penalties,Footnote 17 nor are ADs explicitly mentioned therein. Nevertheless, these guidelines are widely regarded as representative of the Ministry’s official position on end-of-life care issues, and are thus the currently most influential document in this arena. The process guidelines consist of two core elements: (1) respect for patients’ wishes, which is stated as the most important principle in the guidelinesFootnote 18 and (2) decision-making led by the healthcare team (i.e. not by the attending physician alone). The guidelines stipulate that the healthcare team shall make healthcare decisions through repeated discussions with the patient and his or her family, with particular emphasis on respect for the patient’s choice. They also specify that if a patient cannot express his or her wishes, then the healthcare team shall decide on the best course of care in light of the family’s wishes. The guidelines further recommend that if it is difficult for the healthcare team to reach consensus with the patient/family, a committee comprising multiple experts should be set up for consultation purposes.Footnote 19 In this manner, the process guidelines place significant emphasis on consensus-building amongst those involved in the patient’s end-of-life care. Notably, it is clearly stated that the issue of active euthanasia is outside the scope of the guidelines, meaning that no change is imposed by the guidelines regarding the illegality of active euthanasia (i.e. administration of lethal drugs).

The process guidelines purposely specify only procedural matters in relation to end-of-life treatments, rather than the substance of those treatments, which is why they are referred to as “process” guidelines. There are two main reasons why the guidelines do not prescribe which treatments can be withheld or withdrawn: (1) it is difficult to prescribe which treatments are permissible/impermissible, as a variety of situations exist depending on patients’ type of illness and prognosis, their wishes and family situation, and their relationships with doctors, nurses and care workers (also, because existing guidelines rarely address these issues, the relevant committee in the Ministry responsible for developing these guidelines felt that it was up to medical and care specialists/societies to develop specific guidelines as appropriate); and, more importantly and (2) to improve the quality of care at the end of life, it is necessary to consider a longer process of dying without limiting the question to whether to start or stop a particular treatment.

The guidelines also call for improvements in palliative care. The Japanese government responded to that call by implementing measures to promote palliative care and ACP. The Cancer Control ActFootnote 20 was enacted at almost the same time as publication of the guidelines. The PEACE (Palliative care programme Emphasizing symptom management and Assessment for Continuous medical Education) Project, an educational programme for basic palliative care, was also subsequently initiated. In 2014, revisions to the medical insurance reimbursement system made it a requirement to calculate the “cancer patient management guidance fee”. The mandatory participation of at least 90 per cent of oncologists at each institution in the PEACE Project workshop led to a rapid increase in the number of programme participants.Footnote 21 With regard to ACP, E-FIELD (Education for Implementing End-of-Life Discussion), an educational programme aimed at facilitating ACP, was launched in 2014. Despite these efforts by the government, there is still an insufficient number of medical practitioners who can implement ACP. In 2018, the Ministry revised the process guidelines to bring the idea of ACP into focus and to broaden the scope of the guidelines to include all care settings, such as nursing homes and home care, emphasising the importance of healthcare proxies. It is interesting to note here that even though the 2018 revisions focus on good practice in ACP, there is still no mention made of ADs, although they are based on the ideas of ADs and ACP.

13.4 Issues with the Process Guidelines

The process guidelines fall short in three respects. First, there is no clear definition of what constitutes the “end of life”, or terminal stage of illness, in the main body of the guidelines, even though their title contains the phrase “end-of-life treatment”. Thus, there is ambiguity over when a patient is considered to be “terminal”, and the judgement of whether a patient is facing the end of his or her life is left to the discretion of the healthcare team members assessing the patient’s condition.Footnote 22 The committee responsible for development of the process guidelines felt it was better to leave the issue to the professional discretion of medical specialists, as end-of-life situations vary depending on illness, age and other factors. For example, in neurological diseases such as ALS, it is difficult to define the end-of-life stage owing to the chronic and incurable nature of the diseases, and whether the concept of “end of life” is applicable in this context is a highly complex question. As this lack of clarity may result in inconsistencies in application, further discussion is needed to address this issue.

Second, there have been discussions regarding the ambiguity of whether healthcare professionals who withhold (or withdraw) life-sustaining treatment according to the guidelines should be held liable under criminal or civil law. The process guidelines are not legally binding because, although issued by the Ministry, they lack supporting statutes. Some scholars, including two of the authors of this chapter (Kodama and Tanaka), believe that legislation is necessary to ensure immunity for healthcare professionals who discontinue life-sustaining treatment.Footnote 23 Indeed, the Guidelines for the Treatment of Amyotrophic Lateral Sclerosis acknowledge that removal of ventilator support is a difficult issue, as it is currently unclear what the legal basis for doing so would be. Further discussion is warranted to reach social consensus on this issue.Footnote 24, Footnote 25 Having said that, however, to the best of our knowledge (although no official statistics are available), there has been no instance of a police investigation or prosecution concerning the withholding or withdrawal of life-sustaining treatments since the establishment of the process guidelines in 2007. Even prior to that year, no case of withheld treatment was subjected to police investigation or prosecution. In fact, no case of withdrawn treatment not categorised as active euthanasia (i.e. use of lethal injection, discontinuation of ventilator support in non-terminal patients) has ever been subjected to criminal prosecution (in the 1996 Kokuho Keihoku Hospital case, the police investigated the use of muscle relaxants on a terminal cancer patient but decided not to prosecute). Moreover, only a few police investigations have been conducted in cases involving the withdrawal of ventilators (i.e. 2004 Hokkaido Haboro Hospital case, 2006 Wakayama Medical University Kikoku Hospital case). There is some anecdotal evidence suggesting that healthcare professionals are unlikely to be held liable, criminally or civilly, as long as they follow the process guidelines and subsequent guidelines.Footnote 26 According to some jurists, including one of the authors of this chapter (Iwata), the process guidelines are broadly interpreted to permit the withdrawal of end-of-life treatment in cases where patients state their clear wishes,Footnote 27 and even in cases where patients do not explicitly express their wishes. Although some areas of ambiguity remain, there is growing recognition that no penalty will be imposed for withdrawing life-sustaining treatment in accordance with the guidelines. Further qualitative and quantitative research covering healthcare professionals, as well as national data on treatment withdrawal, is needed to understand the impact of the guidelines on the practice of healthcare professionals, however.

Third, while the process guidelines are an important, if problematic, development in determining the framework for end-of-life patients, the lack of proper legislation on ADs in Japan remains a concern, as patient-centred decision-making can be difficult to enforce without it. In the specific context of emergency care settings (ambulance transport), for example, there may be significant gaps between the attitudes of, and measures taken by, paramedics and municipal ambulance departments and processes for respecting the wishes of the patient as set forth by the guidelines. For example, a family member in distress in the face of an emergency situation may request ambulance transport against the prior wishes of the patient, with resuscitation being attempted as a result. In other words, ADs may not be utilised in the field of emergency transport. What should be done when a person who does not wish to receive cardiopulmonary resuscitation (CPR) is rushed to hospital with cardiopulmonary arrest? This issue concerning DNAR has been debated since the 2010s.Footnote 28 If a patient with DNAR wishes experiences a sudden physical change, his or her family may call an ambulance, even though doing so runs contrary to the patient’s wishes. In other situations, such as those in elderly care facilities, facility staff may not be fully aware of every resident’s wishes regarding CPR. Once an ambulance arrives, paramedics provide emergency treatments (e.g. life-prolonging treatments) even if the patient has written a living will (LW) or the family has conveyed the patient’s wish not to receive CPR, with the doctor’s confirmation (it is widely and wrongly believed that paramedics are legally required to administer CPR). Studies show that when elderly individuals suffer cardiac arrest, they are unlikely to recover even with aggressive treatment. At best, they become vegetative or comatose. Nonetheless, CPR is still sometimes performed by the paramedics of some ambulance departments, who believe that doing so is a legally binding duty, despite the development of a national policy to respect a person’s wish at the end-of-life stage, including the inclusion of the ACP concept in the revised 2018 process guidelines.

Moreover, the importance of legislation, guidelines and other measures by local medical control councils to educate paramedics on the provision of medical treatment and to review their practices has been highlighted by the Ambulance Department’s committee on this issue. The current prevailing interpretation is that it is “not illegal” to transport a patient without performing CPR, or to not transport him or her at all in accordance with his or her wishes, if those wishes are confirmed by the attending physician.Footnote 29 In the emergency context, procedures vary by locality, and there are no uniform national rules. In the event of an emergency, confirmation of the patient’s intentions should be sought from the attending physician (family doctor), and, if the attending physician cannot be reached, the relevant decision may be made by an online medical control physician.

13.5 Public Attitudes towards Advance Directives

In this section, we discuss the attitudes of the general public and healthcare professionals towards ADs and ACP. It is interesting to note that in some Japanese publications, AD is not used in its conventional sense to refer to something prepared by the individual in question, but rather to an individual’s presumed intentions based on discussions with family members, which makes it difficult to perform cross-study comparisons. Hence, a broader understanding of the concept of ADs may be more appropriate in the Japanese context, especially given the emphasis on the role of the family in patient-centred care, which will be further discussed in Section 13.6.

First, we examine the results of a national attitude survey on end-of-life issues administered by the Ministry in 2018. National attitude surveys are conducted every five years. Although ADs are not legally binding, they were included in the survey because of the efforts of the Japan Society for Dying with Dignity, which has been calling for the discontinuation of futile life-sustaining treatments in Japan since the QuinlanFootnote 30 case in the United States. Furthermore, the Science Council of Japan and other organisations also took up the issue of ADs in the wake of the Tokai University Hospital case. Both the general public and physicians (66 and 77 per cent, respectively) expressed support for ADs in the survey. However, within these groups, only 8 and 6 per cent, respectively, responded that they had completed their own ADs.Footnote 31 The AD completion rate in Japan is quite low compared to that in Western countries (e.g. 36.7 per cent in the United StatesFootnote 32), a phenomenon discussed in further detail later in the chapter. The rate of agreement with AD legislation was almost the same for physicians and the general public, with 20 per cent supporting AD legislation, 40 per cent responding that such legislation was unnecessary and 10 per cent opposing it. With respect to the use of written ADs, almost 50 per cent of healthcare professionals responded that they do not use any specific document, but discuss patients’ wishes regarding end-of-life treatment when patients ask them to do so.Footnote 33 It has been suggested that these results reflect traditional Japanese attitudes; that is, the Japanese consider it more “comfortable” to have things decided in a certain way through family conversations rather than through written ADs.Footnote 34

Second, we consider the attitudes of physicians towards ADs, as demonstrated by various studies over the past two decades. In a study conducted in 2003, nearly 70 per cent of general practitioners responded that they would not change their treatment even if informed of the presence of an LWFootnote 35 for the following reasons: (1) official formats for and the regulation of LWs are lacking; (2) the process for ascertaining the wishes of patients with dementia or interpreting what death with dignity means to individual patients according to their LWs is unclear; (3) the timing for the use of LWs is unclear; and (4) an ethical challenge to following LWs arises when patients and/or their families decline a treatment based on a misunderstanding of its effectiveness.Footnote 36 A 2010 survey of palliative care physicians found the proportion of physicians who “always” or “very often” ask their patients about existing ADs to stand at 46.9 per cent. The proportions who “always” or “very often” recommend that patients designate a healthcare proxy or complete an AD in the event they lose their decision-making capacity were 40.4 and 30.3 per cent, respectively.Footnote 37 The discrepancy in physician attitudes in the two studies is likely explained by the very different study populations: the 2003 study focused on general practitioners, whilst the 2010 study concerned specialised palliative care physicians.

Interestingly, an annual survey of the bereaved families of patients with LWs conducted in 2019 by the Japan Society for Dying with Dignity (which promotes the use of LWs) revealed that 85 per cent of the families had provided the patients’ LWs to their healthcare providers and that 94 per cent of LWs were honoured, although the survey provided no details on what changes had been made to treatments or which wishes were followed by doctors.Footnote 38 Whilst these data demonstrate a high degree of respect for LWs amongst healthcare providers, members of the Japan Society for Dying with Dignity often use a prescribed form of LW that is well recognised by healthcare providers, which makes it much more likely that their LWs will be respected and implemented.

Third, we discuss research conducted in nursing home settings, in which ADs play an important role. A relatively high proportion of ADs are created in nursing homes, presumably because the residents of geriatric healthcare facilities are elderly people, many with declining cognitive function. Prior confirmation is necessary, as such residents are unlikely to be able to express their wishes should a sudden change in their medical condition occur. In one study of nursing home care providers, 28 per cent indicated that they encourage their residents to express their wishes regarding end-of-life care at the time of admission, regardless of whether they are in the final stage of life, and 70 per cent declared that it is their policy to confirm the wishes of residents at the time of admission.Footnote 39 In a recent survey, more than half of nursing homes responded that they have adopted a particular AD format (with some variation). These ADs are basically instructional directives and include documents providing explanations and/or informed consent for end-of-life care in nursing homes.Footnote 40 However, personal choice-type directive formats were more often introduced during admission to the nursing homes that took part in the survey. They require the signature of a family member (68.3 per cent), the resident himself or herself (48 per cent) and/or a staff member (31.0 per cent). Amongst explanation-and-consent directives, which are more common in end-of-life care situations, 97.2 per cent require the signature of a family member.Footnote 41 Therefore, it appears that, unlike ADs in Western countries, ADs in Japanese nursing homes place heavy emphasis on family involvement, and it is debatable whether such ADs can be considered the equivalent of those in Western countries.

In terms of why ADs appear to be more common in the nursing home setting, additional funding for end-of-life care became available in 2006 as an initial step to provide economic support for terminal care in Japanese nursing homes,Footnote 42 and such funding could well have been a catalyst for increasing the number of ADs produced in nursing homes. To be eligible for the funding, nursing homes are required to fulfil five high-level care requirements: employ a registered nurse as the team leader, provide end-of-life care guidelines on admission, operate a 24-hour on-call nursing system, provide staff training in end-of-life care and have private rooms available for residents. Every resident is also required to have a diagnosis of the end-of-life (terminal) stage made by a physician, and informed consent in relation to end-of-life care preferences (e.g. CPR, artificial nutrition) must be obtained from residents or family members. It thus appears that discussions regarding advanced end-of-life care are encouraged in nursing homes to a greater extent than in other settings.Footnote 43

13.6 Sociocultural Factors Related to the Completion Rate of Advance Directives

Finally, we discuss several sociocultural factors that may contribute to the completion and implementation rates of ADs in Japanese medical and care settings.

13.6.1 Family-Centred Decision-Making

In Japan, family-centred decision-making is prioritised because people remain influenced by the family-centric beliefs inspired by Confucianism.Footnote 44 In a study examining the facilitators of and barriers to the completion of ADs from the patient perspective, the participants regarded such completion as a parental responsibility owed to children.Footnote 45 Amongst the views they expressed were that written ADs allow for a death without any futile life-prolongation and free their children from a caregiving burden should they become disabled. These views motivated the participants to complete ADs. However, some participants expressed negative views concerning how ADs function in actual decision-making. They were aware of the decision-making norm in Japanese society whereby family consensus typically overrides patient autonomy. The study’s authors suggested that the participants understood family-centredness to constitute values shared across the generations, as they themselves had fulfilled the responsibilities expected by their families throughout their lives.

Similarly, Nakazawa et al. found that, in addition to concerns over uncertainty and propriety with respect to successful AD implementation, the involvement of cultural preferences in family-centred decision-making near the end of life also influences AD practice by physicians. Whilst the physicians in their study generally expressed positive attitudes towards ADs, their practices with respect to ADs, for example, recommending that patients complete ADs, did not reflect those attitudes.Footnote 46

13.6.2 Character Traits

According to some studies,Footnote 47 there are several character traits in Japanese culture that may contribute to the low AD completion rate in Japan. First, omakase (when someone asks family members, close friends or medical doctors to take responsibility, it is called omakaseFootnote 48) is commonly seen in elderly Japanese patients. These patients feel unburdened by not having to make difficult decisions for themselves even when they are capable of making their own decisions.Footnote 49 This omakase character trait is based on the Japanese psychological factor of amae. Amae in medical practice is manifested in the attitude of patients who do not wish to make any decisions regarding their course of treatment, but instead have someone else decide what is best for them. Patients can thus both avoid making a difficult decision and taking responsibility for it. If patients ask someone else to decide what is best for them, they can live as usual without thinking about their death, and hence they also do not need to think about an AD. In this sense, omakase is a likely cultural factor contributing to the low AD completion rate in Japan.

Second, the “reticence” of many elderly Japanese people, which causes them to hide their real thoughts, may also affect the end-of-life decision-making process. This character trait often interacts with the importance of the family in Japanese culture, as discussed previously. Reticence is often observed in people who, for example, want to avoid overburdening their family members, be it financially, physically or emotionally.Footnote 50 In addition, Japanese people tend to consider it important to have good family relationships at the end of life.Footnote 51 For example, even if elderly patients would prefer to die at home, they often hide their true wishes and agree to a hospital stay recommended by family members or medical providers because they do not want to be a burden or disrupt family harmony. Patients with this character trait are hesitant to write ADs, as the presence of an AD can constrain family decision-making and impose a burden.

13.6.3 Pursuit of a Good Death

The pursuit of a good death is also an important goal in Japanese culture. Interestingly, this goal has both a positive and negative effect on the making and implementation of ADs. On the one hand, Tsuda et al. found that participants regarded ADs primarily as a means to pursue their ideal death. On the other, the “Good Death Study” targeting Japanese people found one of the most common answers to the question “If you were dying, what would be the most desirable or good thing for you to do?” was “not being aware of death”.Footnote 52 As a result, ADs and ACP are considered “bad luck”, and many people avoid writing ADs or talking about the end of life.Footnote 53

13.7 Conclusion

Despite being a familiar concept amongst physicians and patients in the end-of-life context in Japan, as evidenced in practice, ADs do not currently have any formal role in the decision-making process at the end of life in Japan. As explained in this chapter, end-of-life decision-making has been under intense discussion since the late 1990s and facilitated based on guidelines rather than legislation. The development of educational programmes for doctors on palliative care or end-of-life communication and the promotion of ACP to the general public have led to a gradual improvement in the process of end-of-life decision-making in general. However, there are still a number of issues that require further discussion, such as the definition of the end of life, the need for legislation on surrogate decision-makers and ADs, and euthanasia. The lack of any legal force for ADs is particularly problematic because decision-making in Japan tends to be family centred, which can lead to situations in which a patient’s own wishes are not respected. Such situations are in fact contrary to the most important principle of the process guidelines, despite there being no provision for ADs within the guidelines themselves. To protect the rights of patients, it is important to continue the discussion on the issue of ADs and the legal weight they have. However, given that many Japanese do not hold positive views on legislating ADs and prefer traditional family-centred decision-making, and given the various sociocultural factors at play, it may be more realistic and practical to explore a more culturally appropriate approach to decision-making based on ACP.

14 Advance Directives in Macao: Not Legally Recognised, but…

Vera Lúcia Raposo & Man Teng Iong
14.1 Introduction

The Macao Special Administrative Region (SAR) is one of two special regions of the People’s Republic of China (PRC). According to the PRC principle of “one country, two systems”, Macao is vested with its own executive, legislative and judicial powers. Macao law rests on many different legal theories and practices, and is heavily inspired by the Portuguese legal tradition, which differs from that of the PRC. Although the Joint Declaration on the Question of Macao, which was signed into effect on 26 March 1987, provided for the transfer of sovereignty from Portugal to the PRC on 20 December 1999, Macao’s law has remained largely unchanged following the handover of power.Footnote 1 The profound influence of the previous Portuguese administration means that it appears natural that courts in Macao should adopt solutions from Portuguese doctrine and case law to support their judicial decisions. However, new legal trends from the PRC and nearby countries, and the growing influence of Chinese values imposed by a predominantly Chinese community, are being added to this Portuguese tradition. All of these factors have created in Macao a legal framework that blends the West and the East.Footnote 2

Regarding informed consent theory more generally, most of the solutions in place in Portugal are also applicable in Macao. As in Portugal, Macao’s main informed consent solutions reside in its Criminal Code (CC)Footnote 3, specifically in Article 150 (which requires prior patient consent for medical acts) and Article 151 (which requires referred consent to be fully informed). However, they depart in similarity in the domain of advance directives (ADs), which is a branch of the right to informed consent. Although ADs have been legally recognised in Portugal since 2012,Footnote 4 Macao has not followed this legislative step. Even though members of the Ethics Committee for Life Sciences under Macao’s Health Bureau agreed that ADs should be implemented in Macao in 2019,Footnote 5 efforts to legislate ADs have now reached a standstill.

To date, no legal document has dealt with ADs in Macao or with the professional regulation of, or guidance for such directives. However, this does not mean that ADs have no application in this small territory. The present chapter analyses the legal relevance of ADs in the Macanese CC, the applicability of ADs in Macao, the ways in which doctors and family members can affect their applicability, the attitudes of the Macao government and Macanese residents towards the current application of ADs and the possible features of a future legislation.

14.2 The Legal Relevance of Advance Directives in the Macanese Criminal Code

One of the most relevant provisions in the Macanese CC is Article 150, which provides for the crime of “arbitrary medical-chirurgical interventions”.Footnote 6 Number 1 of this norm states that “[t]he people mentioned in Article 144 that in view of the purposes referred to therein, perform effective intervention or treatment without the patient’s consent shall be punished with imprisonment up to 3 years or a fine”.Footnote 7 In contrast with the situations in nearby jurisdictions, such as Hong Kong, the PRC or Taiwan, in Macao, a doctor who does not obtain lawful consent for medical interventions or treatments commits a criminal offence: the crime of arbitrary medical-chirurgical intervention. According to the wording of the norm, the criminal penalty applies even if the patient’s health condition improves, and even if their life is saved by the doctor. In practical terms, however, it is unlikely that the doctor would be condemned; certainly, in Macao, there are no instances of legal suits having been brought against doctors, based on this norm, and the instances of such legal suits in Portugal are few in number.

However, obtaining lawful consent is not an absolute requirement for doctors. Lawmakers have accepted that in certain scenarios it is not possible to obtain the patient’s prior consent, and thus Article 150/2 includes two exceptions. The first refers to a situation in which consent can be obtained, but would require that the medical intervention be postponed, an eventuality that would involve danger to life (simple danger) or serious danger (qualified danger) to body or health. The second involves a situation in which consent has been given for a certain intervention or treatment, but it is later discovered in the course of treatment or surgery that a different procedure must be performed (due either to new information on the patient’s medical situation or to actual changes in the patient’s condition) to avoid danger (simple danger) to life, body or health. However, for the doctor to avoid criminal prosecution, an additional condition is set for both exceptions: the existence of circumstances which lead to the certain conclusion that consent would be refused. Such circumstances include conversations with the patient’s family members, relatives or friends, and the existence or discovery of ADs or similar documents. A hypothetical danger that is not likely to occur is not an adequate basis for medical intervention or treatment; otherwise, it would be acceptable to invoke presumed consent each time a doctor wanted to override a patient’s wishes.Footnote 8 Doctors must be able to safely conclude that the patient would not have rejected the proposed medical interventions or treatments if they were in a condition to express their will.

This requirement – the absence of circumstances leading to the certain conclusion that consent would be refused, provided in Article 150/2 of the CC – is called “presumed consent”. This solution is established in Number 2 of Article 38 of the same code,Footnote 9 which provides the legal regime of consent for most situations, whereas Article 150/2 provides a specific regime that is only applicable to the medical domain.Footnote 10 The relation between these two norms is one of lex generalis/lex specialis. However, there is a difference between the two: Article 38/2 considers the conduct lawful whenever the surrounding circumstances lead to the conclusion that the holder of the legal interests protected (the person whose consent is required to prevent the agent’s criminal liability) would have provided his/her consent, whereas Article 150/2 considers the conduct lawful unless the surrounding circumstances lead to the conclusion that if the interest holder were in a position to express their will, consent would have been refused. Thus, Article 150/2 permits broader scope for some interventions to be made without consent than does Article 38/2.Footnote 11

Presumed consent cannot become an instrument used to override the patient’s refusal of a medical act in favour of the relatives’ wishes or the doctor’s assessment. Article 150/2 of the CC clearly centres on the patient’s true wishes, as demonstrated by a systematic interpretation of the CC and the inclusion of this criminal provision in the chapter regarding self-determination. Accordingly, the legal value protected in Article 150 of the CC is self-determination in health matters – that is, regarding the healthcare that the patient desires to receive (or not).

There are, of course, some situations where the patient’s doctor does not have any knowledge of the patient’s wishes. When there is doubt surrounding the patient’s presumed decision, doctors must intervene and provide the required medical intervention or treatment, in line with the in dubio pro vita principle,Footnote 12 that is, in case of doubt, the doctor should act on decisions that will safeguard the patient’s life.

14.3 The Applicability of Advance Directives

As discussed previously, ADs are not subject to specific legislation in Macao. Moreover, they are seldom studied or mentioned in local doctrine.Footnote 13 There is therefore an absence of explicit legal guidance or provision to direct the outcome if a patient presents an AD, more correctly, something similar to an AD. The absence of a legal concept of AD in Macao prevents a definition of what would be considered an AD in this jurisdiction, and which requirements would have to be fulfilled. In this study, we will consider written ADs because we believe these to be the form most likely to be accepted in Macao, a very conservative jurisdiction in this regard.

Because there is no specific legal standard, the legal value of ADs must be assessed considering other applicable norms, namely those addressing informed consent and presumed informed consent. Under Article 150/2 of the CC, doctors are required to consider any indications given by the patient about the medical care that they would or would not wish to receive. ADs typically contain the patient’s wishes, which doctors must take into consideration. Here, to take “in consideration” merely means to acknowledge its existence, though there is no binding requirement.

The only situation in which doctors may violate the criminal standard occurs when they completely disregard the AD, for instance, where the doctor is alerted to the existence of an AD, but does not read the document. By contrast, if the doctor reads the AD but acts against the wishes expressed within, this is not necessarily interpreted as an act of non-compliance. The doctor can always argue that they were not sufficiently convinced that the wishes contained within the AD were true reflections of the patient’s actual wishes. Thus, even when the doctor has considered the AD, the freedom of assessment granted by law empowers them to disregard its contents and to decide to proceed as they see fit to do. In sum, there is no law that forces doctors to be bound by ADs in MacaoFootnote 14 and moreover, the extant regulations indicate that current documents lack binding force. Consequently, ADs are valid only if doctors believe them to be the authentic expression of the patient’s current and true will, leaving the decision to the doctor’s discretion (and eventually to the court’s assessment in case of litigation).Footnote 15

Another major obstacle to compliance with an AD in light of Article 150/2 of the CC is the requirement that the patient’s consent shall be actual – that is, consent must be given concurrently with the medical act.Footnote 16 This rule excludes consent given years, months or even weeks in advance. By nature, ADs involve advance (often well in advance) consent/refusal, which raises issues regarding the timeliness of the decision. A possible interpretation of this requisite is that all decisions remain up to date – that is, valid – as long as the AD is not changed by the patient. However, this legal interpretation is open to debate. This requirement has been circumvented by some jurisdictions by requiring revalidation of the AD after a certain number of years to ensure that it remains the patient’s will.Footnote 17 This could be a possible solution for a future law on ADs in Macao.

In conclusion, the Macanese legal framework has not determined the legal status of ADs,Footnote 18 but this “omission” does not affect their validity. ADs can be regarded as a legitimate indicator of the patient’s acceptance or rejection of medical care, according to Article 150/2 of the CC. However, they have no binding power over doctors. Besides their non-binding nature, the patient’s wishes as expressed in ADs can be affected by factors that inform their actual decision, and which may actually contradict such wishes, such as information provided by relatives or friends to the doctor.Footnote 19

14.4 The Triumvirate Relationship between Family Members, Doctors and the Patient

In Macao, according to Numbers 2 and 3 of Article 37, consent is always a personal act. Except in the case of minors and incompetent adults – both of whom should have legal representatives empowered to act on their behalf and in their best interest – consent can be given only by the patient.Footnote 20 In theory, then, ADs should represent the exclusive decision of the patient, made freely, and without the influence of others.

In practice, however, the patient’s stated desire as expressed in the AD may be informed by others, especially by the wishes and decisions of family members and doctors. Medical decisions frequently involve a triangular relationship between family members, doctors and the patient. In the majority of cases, the extent to which the patient’s expressed desires (specifically as stated within the AD) may be considered an autonomous decision, or to which their desires will be wholly or partially followed depends on the interventions of family members and/or doctors. In jurisdictions such as Macao, where family members can exercise major influence over their relatives’ medical decisions, we envisage that they will be able to affect the patient’s desires as expressed in their AD.

Familism is a cultural practice which in China facilitates and encourages the family to play a decisive role in the healthcare of family members.Footnote 21 Chinese familism has its philosophic roots in Confucianism (although other more practical factors explain familism in modern Chinese society), and still plays a major role in Chinese communities.Footnote 22 Based on the social and cultural specificities of the territory, it is fair to assume that family wishes continue to be critical actors in the process of actually instigating ADs, in shaping doctors’ perceptions of the content of an AD, and in determining the extent to which the doctor takes the patient’s wishes into account.

Presumed consent must be assessed considering – among other criteria – information regarding the patient taken from their relatives.Footnote 23 When assessing an AD, doctors normally take several elements – including conversations with family members – into consideration in order to determine whether the content of the AD is consistent with the patient’s current and true desire. In this regard, the family’s reaction is often a primary factor shaping doctors’ perceptions. In certain situations, family members may want to keep the patient alive even though their relative’s AD expresses their desire to reject essential medical interventions or treatments. In this case, family members may attempt to influence the doctors’ perception of the veracity of the patient’s wishes as expressed in the AD. The prevalence of familism is such that within Chinese culture, doctors believe that family members possess knowledge of their relative’s true desire and are thus able to confirm whether the desire stated in the AD is true and current.Footnote 24 Moreover, when confronted with an AD that rejects a medical treatment – especially if that intervention is life saving – doctors will probably disregard it, fearing potential litigation by family members, and the likely outcome of a conservative (pro-life) judgment of any court assessing the conflict. Thus, in defending a refusal to comply with the AD, the doctor might argue, for instance, that the patient’s desire expressed in the AD was indeed taken into consideration, but that it did not correspond to the patient’s current or true will. Under Macanese law, relatives are not called upon to make medical decisions for the patient, but in actuality the concept of presumed consent is operationalised in such a way that relatives can influence the way the AD (or any other “sign” to be considered in light of Article 150/2) is understood by the doctor. This is likely to happen in individualist communities (see the case of Portugal, with this very same norm), but the likelihood of this occurring increases in more collectivist communities such as Macao. It can be confidently argued that the triangular relationship in healthcare (patient, doctor, family) enables family members to influence doctors’ interpretation of the ADs.

Given the power of the cultural influence of familism within Chinese healthcare provision, and decision-making, patients’ wishes can be affected by erroneous (and very discretionary) interpretation of ADs by healthcare providers. That ADs must be given binding force is therefore imperative if patients’ autonomy is to be respected and protected. Further legislation to clarify the legal status of ADs and to enforce binding power in Macao is required, considering that Article 150/2 of CC does not provide sufficient mechanisms to protect the patient’s decisions as expressed in the AD.

14.5 Advance Directives and Palliative Care

The Hospice & Palliative Care Centre in Kiang Wu Hospital is Macao’s sole healthcare institution providing hospice and palliative careFootnote 25 for terminal cancer patients.Footnote 26 Local residents (holders of Macao identity card) who receive diagnoses of terminal cancer can receive hospice and palliative care at the centre. Patients who require such care are typically experiencing extreme physical and emotional suffering. The centre provides palliative care which includes painkillers, morphine injections and acupuncture (traditional Chinese medicine), to eliminate or at least relieve pain. On a spiritual level, the centre organises events such as birthday parties and tea gatherings. In addition to patient care, the centre provides psychological counselling for family members.Footnote 27 Care is provided free of charge, as it is paid for by the Macao SAR government.

Before admission to the centre, cancer patients must sign a document called “Consent for the Hospice & Palliative Care Centre”,Footnote 28 which is intended to allow doctors the right to not intervene should the patient’s condition require specific urgent medical action, such as cardiopulmonary resuscitation, electrical cardioversion, tracheal intubation or cardio tonic injection. The literal translation of the document is “Consent for…”, but in practice, it is not a document for patients to authorise the provision or non-provision of medical procedures, but an acceptance of the hospital’s terms and conditions, which include the non-provision of these medical procedures. The decision to sign – or to not sign – the document is usually made by the family, not by the patient, and to withhold a signature is considered a rejection of the centre’s services and conditions, and thus the patient cannot be admitted. Notably, the consent form required by the Hospice & Palliative Care Centre is the closest formally recognised mechanism to an AD in Macao, and it appears that the form has binding force only when used at the Kiang Wu hospital. However, its ambit is narrow: (i) it includes only the rejection of medical interventions, not acceptance and (ii) it covers only medical acts standardised in the document, rather than covering the full range of medical acts.

A further drawback to this document is evident: the signatory to the “Consent in the Hospice & Palliative Care Centre” is not the patient, but a relative (in the presence of a witness).Footnote 29 This document can thus regarded more as a “family AD”, where the AD represents the wishes of the family, rather than those of the individual patient. However, under Article 150/2 of the CC in Macao, third parties cannot give consent to the refusal of medical interventions –particularly life-saving medical interventions – a right reserved solely for the patient, except for some specific cases where a legal representative is assigned by the court. Not only does this document demonstrate profound disregard for the rights and autonomy of patients who are already vulnerable due to their terminal state: there is a glaring contradiction, for the fact that a relative is required to sign this document in order to indicate consent to the refusal of medical interventions for the patient represents an act that is in clear violation of Macao law.

14.6 The Current Position of the Macao Executive on Advance Directives

To date, the Macao ExecutiveFootnote 30 has taken a cautious approach towards ADs, accepting (or tolerating) these instruments, but yet not investing them with binding force. It has been reported that given Macao’s ageing population, and in light of the adoption of AD legislation in over twenty countries including the United States, Australia, Canada and Singapore, the Executive has recognised the need to legislate ADs. Such binding legal instruments will not only help to enhance the quality of life and to protect the dignity of patients at the end of their lives, but will also reduce unnecessary medical expenses.Footnote 31 On 3 December 2019, the Macao Health Bureau, under its sub-entity the Ethics Committee for Life Sciences, introduced “Questions and Future Policy Guidelines for ADs” in Macao and agreed to legitimise ADs.Footnote 32

Despite agreement over the implementation of ADs, the Executive insists that discussions over ADs remain at the preliminary stage. This hesitancy may reflect the bureau’s fear of difficulties and controversies surrounding plans for their implementation.Footnote 33 These barriers to implementation arise from low public awareness regarding the legislation of ADs, the possibility that the patient could change their mind as the end of life approaches, and the willingness of the patient’s family to comply with their relative’s desires. The bureau holds that extensive and in-depth public education in the social, academic and legal fields is needed, and that a law introducing ADs can be implemented only after obtaining consensus from all sectors.Footnote 34

In response, it is possible to argue that the Executive’s position lacks proper justification. First, the kind of consensus invoked to postpone a regulation on ADs is not possible to achieve, given the multiplicity of legal, ethical and even religious views on the matter. Second, even if such a consensus could be achieved, the Executive has not taken steps to encourage or facilitate discussion or awareness among the population.Footnote 35 This was demonstrated in a recent study exploring the willingness of Macao Chinese people to make ADs.Footnote 36 The study found that the lack of information about ADs was the main factor deterring individuals from making ADs. The study also found that 73.6% of the sample (n = 724) were willing to complete an AD if the document had legal recognition. Together with recent media coverage of this issue with voices supporting patients’ choices regarding end-of-life decisions,Footnote 37 these findings suggest that the questions raised by the formal recognition of ADs are clearly of concern to residents. Two grounds for their concern are apparent: first, the patient’s well-being, for in Macao it is common for healthcare delivery to extend until the patient’s death, at the cost of much physical and mental pain for the patient and distress to the family; and second, the financial burden of such futile medical treatment, either for the patient or for the hospital. Notwithstanding these important and prevalent concerns, there remains a great deal of resistance – from certain groups of Macao residents and from the Executive – to the implementation of proper regulations on ADs. One possible reason for this hesitancy is the fear that formally legislating ADs could lead to euthanasia, a practice forbidden in Macao,Footnote 38 even though the two situations are clearly different.Footnote 39

It is imperative that the Executives regulate ADs, namely, to clarify some legal voids, such as the requirements to be met in order for them to be legally operational. The decision on whether ADs should be merely indicative or truly binding is the most controversial feature. The binding nature would clearly be in syntony with patient’s autonomy, the cornerstone of modern healthcare law, and would also be the most adequate solution from a human rights perspective. Moreover, the binding nature of ADs is also the solution most compatible with Article 150/2 of the CC and with the Portuguese legal heritage that still largely shapes the Macanese jurisdiction. In that respect, a regulation such as that stated in Portugal (Law 25/2012, 16 July 2012) could be a viable option. However, the hazards of legal transplants are well known and it is not clear whether binding ADs would indeed be congruent with the general values of a predominantly Chinese community, still very grounded in and attached to familism. Further studies are required to clarify this and other issues, for example, there are no data on the estimated number and implementation of ADs in Macao’s jurisdiction, and there is an urgent need for research studies that explore doctors’ perspectives on ADs.

14.7 Conclusion

Macao represents an interesting case study from legal, ethical and sociological perspectives: the existence and application of predominantly Western (Portuguese-inspired) legislation does not always meet the expectations of a community composed primarily of Chinese peopleFootnote 40 nor of an Executive that aims to implement a “not so Western law”. However, it is unclear whether the Executive’s decision to put a pause on AD legislation actually has the support of the population, especially considering the empirical evidence suggesting that a large percentage of the Macanese population is likely to be willing to complete an AD if legalised, and the growing number of voices in favour of legally binding ADs in the PRC.Footnote 41 While there is currently a mechanism whereby the content of ADs may be taken into consideration, via Article 150/2 of the Macanese CC, there remains some uncertainty as to how effective ADs will be, particularly in light of the fact that doctors are likely to disregard any AD rejecting life-sustaining treatment, as discussed previously.

In Macao, the AD discussion is almost non-existent. Without clear and transparent discussions that include experts and assessments of sound legal arguments, there will be no related legal developments concerning the nature, scope and use of ADs in the near future.

15 Advance Directives in Pakistan: Religious, Cultural and Social Influences

Mohammad Asim Beg , Erfan Hussain , Noshin Khan , Asma Hamid & Muhammad Atif Waqar
15.1 Introduction

The Islamic Republic of Pakistan falls into the category of developing nations. Pakistan is abundant in human resources. According to United Nations (UN) data, it is the fifth most populous country in the world, with a total population of 223,103,549 as of January 2021.Footnote 1 The median age is 22.8 years, and life expectancy is 67.79 years.Footnote 2 With approximately 90 per cent of the population currently under the age of 54, only a very small number of Pakistanis are elderly.Footnote 3 The country’s very high birth rate creates innumerable challenges, as well as compromised living conditions and a poor quality of life. According to the UN’s Human Development Index (HDI) 2020, Pakistan ranks 154th out of a total of 189 countries.Footnote 4 Such a low position on the HDI reflects the condition of the population in terms of health, education and well-being. With its rapidly increasing population, inadequate healthcare facilities, low literacy rates and extreme poverty, Pakistan is in a predicament. Although the country is blessed with the demographic dividend of a large youth population, palliative and end-of-life care cannot be ignored, as terminal illness can strike at any age or stage of life. The relatively short life expectancy and poor health conditions in Pakistan demand better healthcare policies and the ability to delegate responsibility appropriately in the event that a person loses the capacity to make decisions.

Advance directives (ADs) are an important way of specifying the type of treatment a person would like to receive at the end of his or her life. Owing to a range of economic, social, cultural and medical factors, however, no laws or legislation on ADs have thus far been passed in Pakistan. This chapter explores the many influences, perspectives and challenges pertaining to ADs to examine why they have not yet surfaced on the legislative agenda. The remaining sections of chapter are laid out as follows. Section 15.2 describes the governance system, healthcare structure and legislative process in Pakistan. Section 15.3 details the subtleties of the factors creating obstacles on the path to AD legislation, including religious, socioeconomic, cultural and medical factors. Section 15.4 discusses the key issues affecting the feasibility of legislating and implementing ADs in the context of Pakistan, and Section 15.5 concludes.

15.2 Governance, Healthcare Structure and Legislation

Pakistan lags behind other countries in legislating many important issues. Healthcare is a largely neglected sector, and the lack of legislation thereon results in a complex situation. The absence of laws and legislation on such important issues as ADs is due in part to Pakistan’s convoluted governance system and its multi-tiered, mixed public and private healthcare system. To gain insight into the lack of AD legislation, it is important to outline the governance structure, map out the healthcare system and briefly describe the legislation related to individual autonomy in healthcare.

15.2.1 Governance Structure

Healthcare was a federal matter in the 1973 constitution, but the 18th constitutional amendment in 2011 transferred healthcare to provincial health departments.Footnote 5 Accordingly, the four provinces of Balochistan, Punjab, Sindh and Khyber Pakhtunkhwa assumed legislative and executive responsibility for healthcare in their provinces.Footnote 6 The federally administered territory of Islamabad was left to the federal mechanism even though the federal Ministry of Health (MoH) was dissolved.Footnote 7 After dissolution of the federal MoH, its remaining functions were dispersed across several other federal institutions, including the Planning Commission, Federal Bureau of Statistics and newly established Inter-Provincial Ministry.Footnote 8 This decentralisation of the healthcare system created a plethora of issues, including national coordination of global health commitments, drugs licensing and the regulation of medical and nursing professionals.Footnote 9 To mitigate the challenges being faced at the federal level, the Ministry of National Health Services Regulation and Coordination (MoNHSRC) was created in 2012.Footnote 10 However, the MoNHSRC has struggled to establish legitimacy, as its creation has been contested by both provincial governments and the other federal entities to which its functions were originally assigned.Footnote 11 Further, not having a federal MoH means that there is no federal health minister. Pakistan is likely one of the few countries in the world to lack a permanent health minister at the federal level.Footnote 12 The devolution of healthcare to the provincial level has created a vacuum, as the lack of a federal health minister has resulted in the absence of coordination and advocacy on health-related issues in the federal cabinet or two upper houses: the National Assembly and Senate. The absence of a federal minister for health has created unsurmountable challenges for the healthcare system. Even though legislative and executive authority now lies with the provinces, the lack of a central authority leaves a significant gap in the development of overarching policy norms, provision of health information and management of interprovincial regulation and coordination, which are roles ascribed to the federal government.Footnote 13

15.2.2 Healthcare Structure

In addition to governance issues, Pakistan has a convoluted healthcare system. The system is multi-tiered and multifaceted, comprising a large network of government health facilities, private individual practitioners, philanthropic organisations and private medical entities.Footnote 14

Public sector healthcare service delivery is organised into three tiers: Basic Health Units and Rural Health Centres form the core of primary healthcare, whereas Tehsil Headquarters and District Headquarters are the spine of the secondary care structure.Footnote 15 Both primary and secondary healthcare are supported by tertiary care from teaching hospitals.Footnote 16 Although public sector hospitals are the lifeline of the underprivileged and provide critical and tertiary care, a large percentage of the population, approximately 78.08 per cent, depend on private healthcare facilities.Footnote 17 Healthcare delivery in the public sector, although free, is not the preferred choice of most, as it is basic and of mediocre quality.Footnote 18

Private sector healthcare facilities are generally favoured over those in the public sector owing to the latter’s poor performance.Footnote 19 Private facilities also offer a swifter service,Footnote 20 although the service provided can be placed on a continuum ranging from extremely low to very high quality.Footnote 21 Private healthcare fees are unregulated and depend on the physician, infrastructure and quality of care.Footnote 22 A number of private philanthropic organisations also offer reasonable quality treatment to the underprivileged segment of society.Footnote 23

15.2.3 Laws and Legislation

In light of the aforementioned issues with governance and the unsatisfactory healthcare system, it is perhaps unsurprising that there are currently no laws in Pakistan that deal with ADs.Footnote 24 The concept of respecting patient autonomy in a healthcare setting, however, can be seen in two pieces of legislation: the Mental Health Ordinance 2001 and the Transplantation of Human Organs and Tissues Act 2010. Both are noteworthy because they espouse to a certain extent the concept of individual autonomy in the healthcare context. They are briefly described here to provide a sense of what that concept means in Pakistan.

Mental Health Ordinance 2001 Prior to our discussion of this legislation, it should be noted that the Mental Health Ordinance 2001 is in fact a lapsed ordinance. Ordinances do not become valid laws in Pakistan if they fail to pass Parliament; they remain presidential orders and lapse after three months if left idle.Footnote 25 This was the case for the Mental Health Ordinance 2001, although, unlike in other jurisdictions where lapsed ordinances hold no value in the legal landscape, in Pakistan ordinances form a crucial part of the law, so much so that they carry the same weight as any Act passed by Parliament.Footnote 26 Accordingly, the Mental Health Ordinance 2001 can still be said to be of influence.

The purported purpose of the ordinance was to consolidate the laws pertaining to the care and treatment of mentally disordered persons and to make better provisions for their care and treatment and the management of their property and affairs and matters connected therewith or incidental thereto.Footnote 27 Although the Mental Health Ordinance 2001 was a step towards giving individuals autonomy by affording mentally disordered persons the right to make decisions about their care, specifically the course of their treatment, the mental health legislative framework remains fragmented and ineffective.Footnote 28 The ordinance assumes that such persons have the capacity to comprehend their diagnosis and prognosis.Footnote 29 It also fails to define capacity or specify how it should be measured, leaving it open to debate and discretion,Footnote 30 which may in turn raise concerns in relation to mentally disordered persons’ right to access healthcare. Nevertheless, the granting of the right to make their own decisions about healthcare constitutes an important step towards recognising the value of individual autonomy in the context of medical treatment decisions.

The Transplantation of Human Organs and Tissues Act 2010 – This Act is a major milestone for two reasons: firstly, it is a step towards recognising individual autonomy, and, secondly, it goes against long-standing Islamic ideology. The Act facilitates individual autonomy by granting the right to donate one’s organs after death.Footnote 31 Whilst this legal regulation is not directly relevant to ADs, as the decision takes effect only after a person dies, the Transplantation of Human Organs and Tissues Act 2010 affords individuals the autonomy to decide what is to happen to their body after death. Most people in Pakistan believe that performing any kind of medical procedure on a dead body constitutes mutilation of the body.Footnote 32 Some Muslim sects even discourage the performance of an autopsy or post-mortem, as the removal of organs is believed to be unIslamic.Footnote 33 This legislation thus demonstrates the significance of respecting individual autonomy in relation to one’s body even when doing so may conflict with established religious principles.

Thus, although AD legislation does not yet exist in Pakistan, respect for individual autonomy, upon which the concept of ADs is typically predicated, is gaining recognition. This suggests that despite the factors discussed in this chapter that may make AD implementation difficult, there may well be room for the development of ADs in Pakistan. Having considered the laws and healthcare structures in place in Pakistan, we now turn to its religious, socioeconomic, cultural and medical contexts.

15.3 Factors Influencing Legislation on ADs

The religious, socioeconomic and cultural environments in Pakistan exert a strong influence on both its legislative structure and healthcare delivery system. It is imperative that the factors related to these environments be charted in detail to understand the possible reasons for the absence of legislation on ADs. For example, as an Islamic country, religion features prominently in all spheres of life in Pakistan, including legislation, and religious beliefs intertwined with cultural influences, societal attitudes and socioeconomic structures have served to undermine both the importance and relevance of ADs.

15.3.1 Influence of Religion on Legislation

The Islamic Republic of Pakistan is a majority Muslim state that is guided by Islamic laws. In the Constitution of Pakistan 1973, Part IX: Islamic Provisions, Article 227 states that

All existing laws shall be brought in conformity with the Injunctions of Islam as laid down in the Holy Quran (the holy book of Muslims) and Sunnah (the ways of prophet Mohammad), in this Part referred to as the Injunctions of Islam, and no law shall be enacted which is repugnant to such Injunctions.Footnote 34

According to this provision, all laws enacted, or legislation promulgated, have to be in accordance with Islamic teachings. Although there are many sects in Islam, and each sect interprets the religion according to its own understanding, there is consistency of interpretation amongst most Islamic jurists in the belief that life is sacred. As interpreted by some and believed by many, refusing invasive treatment is tantamount to hastening death, which is contradictory to the teaching of the Quran.Footnote 35 Saving lives is a duty, and taking lives unjustifiable.Footnote 36 In addition, clerics, who exert a strong influence on society, believe that the withholding or withdrawal of treatment is contrary to religious ideology. In fact, according to the Council of Islamic Ideology in Pakistan, “life is sacrosanct and one should do everything possible to save it”.Footnote 37 This directive to sustain life at any cost can be understood to be in direct conflict with the concept of ADs, as ADs give individuals the right to refuse life-sustaining treatment. There are, however, interpretations consistent with the concept that do not run contrary to the sanctity of life. For example, some believe that life is given and taken by God and that the provision or withdrawal of treatment cannot prolong life or hasten death because the time of death is preordained; hence, death will occur irrespective of the treatment choice.Footnote 38 The religion may thus allow a person to make decisions on their course of treatment based on personal choice.Footnote 39 Given these differences in interpretation, families often rely on the advice of religious scholars before making decisions about end-of-life treatments for terminally ill patients because they lack confidence in their own knowledge of what is permissible in the Quran. In hopeless situations, religious scholars may allow families and patients to take decisions regarding the course of treatment, not with the intention to hasten death but to refuse treatment that is emotionally and financially exhausting and painful, in addition to being of no benefit.

Another aspect worth exploring is the assignment of responsibility for the elderly and women in the Quran. Some Quranic injunctions place such responsibility on the male members of the family. Islam encourages a sense of obligation towards caring for elderly parents and being responsible for women while also emphasising the inherent goodness of looking after the sick. Chapter 17 of the Quran, Al-Isra’, states: “Allah has ordered you to worship none except Him, and to be good to your parents. If either or both of them attain old age with you, do not say ‘fie on you’, nor rebuke them, but speak to them with words of respect”. Chapter 4, An-Nisa, discusses the husband’s role as “protector and maintainer”. Verse 34 of An-Nisa states: “Men are the caretakers of women, as men have been provisioned by Allah over women and tasked with supporting them financially”. A hadith (saying of the Prophet Mohammed) narrated by Muslim [2699] on caring for the sick reads as follows: “The one who stays with the one who is sick, and takes care of him and looks after him has done good by serving him and caring for him, and Allah, may He be glorified and exalted”.Footnote 40 These Quranic verses and hadith are indicative of the responsibilities of male family members.Footnote 41 Whether those responsibilities are limited to specific situations or extend to all matters is unclear.Footnote 42 However, prevailing religious values give male members of the family the right to make decisions on healthcare matters for the elderly (primarily parents) and women. This automatic assignment of rights suggests that ADs have little role to play, as the male members of the family are essentially substitute decision-makers in end-of-life situations.Footnote 43 Hence, issues related to patient autonomy, ADs, end-of-life medical treatment and other matters have perhaps not been addressed by the legislature based on the assumption that such decisions lie with male members of the family.

This section thus demonstrates that whilst religion generally has a guiding influence on legislation in Pakistan, different interpretations of Islamic teachings result in varying attitudes towards ADs. It is perhaps for this reason that no AD legislation has thus far been discussed. Legislators may well feel that they are in no position to make decisions on such a controversial subject rooted in religious ambiguity.Footnote 44

15.3.2 Economic, Social, Cultural and Medical Landscape

A medley of religious values, social and cultural norms, and economic stratification has resulted in a distinct economic, social, cultural and medical landscape in Pakistan. Both patriarchy and hierarchy feature heavily in Pakistani society, owing to which the family takes centre stage as opposed to the individual. The patriarchal system is supported by religious beliefs, traditions, and local social and cultural values, which in turn result in extended families that expand horizontally and vertically across generations. These beliefs and values further reinforce familial prioritisation and solidify the role of the family in undertaking decisions on terminal illness for competent and incompetent patients alike. Familial hierarchy, patriarchy and, as mentioned previously, religious teachings all select the oldest or most competent male family member as the pivotal decision-maker.Footnote 45 As a result, all healthcare decisions, including end-of-life care and treatment, are generally made by the selected male family member, leaving little space for individual autonomy and eroding the need for ADs. This power imbalance in itself reflects inadequate representation of the interests and perspectives of female family members, who, ironically, are often the primary caregivers in such situations. The patriarchal system is likely also rooted in socioeconomics, with limited resources often dictating that the survival of the family as a whole takes precedence over individual autonomy.Footnote 46

Furthermore, many patients themselves refuse to discuss death or terminal illness, and thus the responsibility falls on the family members who decide whether patients are to be informed of their diagnosis or prognosis.Footnote 47 Families channel their love and compassion by hiding painful realities or cloaking diagnoses in abstraction. Medical professionals accept this state of affairs as well, respecting family decisions and refraining from revealing the diagnosis to the patient.Footnote 48 Disease and death are viewed as happening to families rather than individuals, with the family of the individual in question playing a significant role in decision-making and responsibility.Footnote 49 For example, children are socialised to believe that caring for parents and grandparents is their duty, with sons often expected to live with their parents and take care of them in their old age.

This emphasis on the family in end-of-life decision-making may make it difficult for individual-oriented ADs to be accepted and used, as demonstrated by a study on advance care planning conducted amongst 57 South Asian individuals (including Pakistanis), which found that many of the participants considered planning ahead to be unnecessary because of close family ties and predefined familial roles and trust in the context of medical decision-making.Footnote 50 Most participants believed that one should focus on concrete activities, with advance care planning thought to be irrelevant, vague and unnecessarily worrying.Footnote 51

In addition to the role of the family, that of healthcare professionals is also relevant. A substantial number of people in Pakistan are uneducated and lack the ability to comprehend complex medical conditions, meaning that they depend on the advice of physicians. Physicians and nurses in Pakistan are often drawn towards taking on a decision-making role owing to a combination of factors. In line with the centrality of the family in Pakistan, healthcare providers are often symbolically “inducted” into the family in such a way that they end up directing rather than facilitating medical interventions and care.Footnote 52 In addition, physicians hold an esteemed position in Pakistani culture owing to their knowledge and expertise. Perhaps as a result of this status, as well as a lack of training in communication skills and ethics education, healthcare professionals assume responsibility for making decisions, often sharing limited information with family members and refraining from fully disclosing a diagnosis or prognosis to patients or doing so only in ambiguous terms, as they do not want to convey bad news to patients. Deeply entrenched in cultural values, medical professionals often ignore ethical values.Footnote 53 Undoubtedly, accepting cultural norms is easier and less exhausting than critiquing them or forging an alternative involving patients’ informed consent.Footnote 54 According to one study, nurses and physicians often adopt the role of care provider, counsellor and, most commonly, decision-maker.Footnote 55 Most physicians view themselves as independent decision-makers, particularly with regard to patients in a critical condition, assuming that they are best equipped to understand the needs of an incapacitated patient.

Recognising this practice as unethical, several healthcare organisations across the nation have formulated and implemented do-not-resuscitate, end-of-life care and withdrawal of life support policies and practices at an institutional level.Footnote 56 Palliative care services have been established in many of the leading tertiary care hospitals and comprehensive cancer care centres in the nation. Palliative care providers tend to have lengthy discussions with patients and their extended families to explore the goals of such care.Footnote 57 These discussions are often transcribed and documented in the patient’s medical record. Although such records serve to facilitate patient care, they hold no validity in the courts.Footnote 58 It is also unclear whether the goals transcribed in these informal records are met.

It can thus be seen that the economic, social, cultural and medical landscape of Pakistan erects numerous obstacles to the introduction of ADs. In addition to the role of the family in end-of-life decision-making, healthcare professionals in Pakistan have also taken on the role of decision-maker even in situations where doing so may not be ethical. We consider possible solutions to these issues in the following section. Whilst some steps are being taken to involve patients and their families in processes akin to advance care planning, their effectiveness cannot be ensured without a more formalised regime.

15.4 Discussion

The current scenario in Pakistan presents an image that points towards the non-acceptance of ADs. The governance structure, laws and legislation, and the healthcare system, along with the religious, social and cultural landscape, seem to be unprepared for the legislation and implementation of ADs. Although such legislation/implementation in Pakistan appears to constitute a daunting and time-consuming task, we believe there is a dire need to start a conversation about AD legislation given the importance of respect for autonomy. In the following, we lay out five key issues that require further examination and discussion in the Pakistani context.

15.4.1 Perceived Taboo versus Patients’ Actual Preferences

The belief that death is preordained and inevitable is prevalent in the Pakistani community, and yet talking about death remains a taboo and to-be-avoided subject. There is an overemphasis on optimism and a widespread belief that speaking negatively will give life to what is feared. Healthcare issues thus generally have a negative connotation and are considered bad news. Perhaps as a result, decision-making on and discussions of end-of-life care take place at a relatively late stage or do not take place at all.Footnote 59 As discussed previously, families generally want to ensure that their loved one maintains a positive outlook until the end, and the perceived taboo surrounding death often prompts families to collude with healthcare professionals to “protect” the patient from anxiety, stress and fear of losing hope by keeping a terminal illness diagnosis and prognosis from the patient, thereby avoiding any discussion of what course of treatment the patient would want in the event of incapacity. In certain circumstances where the patient has some knowledge of his or her diagnosis, the extent of the disease, its terminal or life-limiting nature, as well as the prognosis, may not be disclosed to the patient. Physicians also respect the wishes of the family and refrain from discussing end-of-life care and treatment in such situations.

There are limited data suggesting that this perceived taboo may not in fact be in line with patient preferences and that some patients would prefer to be informed of their prognosis and life expectancy.Footnote 60 In one study, 13 per cent of respondents reported feeling uninformed about their medical condition, and more than half expressed the importance of being informed about their medical condition, prognosis and management options. About two thirds wanted their families to be actively involved in decision-making on management options, and half wanted their families to make medical decisions if they themselves ever became incompetent, with 27 per cent preferring their physician to make decisions on their behalf. Whilst two thirds said they were comfortable discussing end-of-life care, 81 per cent said that they had never discussed life expectancy with their physician, and 42 per cent reported no discussions of choices concerning end-of-life care in the past year. Fifty-six per cent of the patients studied wanted to discuss end-of-life care only should the need arise. Many said they wanted to know their prognosis but only a few reported ever having had such a discussion.Footnote 61 This study thus seems to demonstrate a mismatch between patient preferences and actual practice in relation to end-of-life discussions, which may be a result of the taboo described previously. If the reluctance to discuss end-of-life matters is indeed merely perceived, then it would appear that engaging in larger conversations with the public about legislating ADs would be well worth the effort.

15.4.2 Unclear Legislative Responsibilities at the Federal and Provincial Level

That being said, beginning a conversation about ADs at the legislative level is likely to prove challenging. Between the constitutional role of the federal government and the devolution of power to the provinces following the 18th amendment, healthcare has sunk into great confusion, particularly with regard to who will legislate and regulate policies. The healthcare legislative process has suffered immensely from the unclear demarcation of federal and provincial roles and responsibilities.Footnote 62 Thus, as a consequence of the 18th amendment, it is not always clear whether it is the responsibility of the federal government or provincial governments to promulgate laws and legislation for the welfare of the people, and important issues are often left unlegislated by either. Some of the reasons attributed to such apathy are rooted in provincial governments’ lack of capacity.Footnote 63 The situation is further complicated by the influence of such factors as illiteracy, a lack of understanding and poor critical-thinking skills permeating all tiers and strata of society, including the legislative assemblies. Elected representatives are not required to have any educational attainments or qualifications.Footnote 64 Low literacy and education levels and a lack of exposure to the external world limit thinking capacity and logical reasoning ability, which is reflected in the absence of imperative legislation.Footnote 65 Building up the capacity of the provincial legislatures is thus key to promulgating laws on important healthcare issues.

15.4.3 Lack of Resources

Although legislating for ADs will inevitably be an uphill battle, ADs could well play an important role in the delivery of end-of-life care in Pakistan owing to the general lack of resources. Apart from a few cases of malicious intent and family disputes, the premature withdrawal of treatment is generally the result of insufficient financial resources. Much of Pakistan’s large population lives on very meagre resources, with many struggling to afford two meals a day. Although public sector hospitals are available, they are few in number and poor in quality, forcing people to turn to private sector hospitals,Footnote 66 which offer better facilities but are expensive. Seventy-eight per cent of the underprivileged resort to costly private healthcare, placing families in a precarious position.Footnote 67 Many struggle between expending all of their finances on treating and sustaining the life of a loved one and making ends meet. The lack of an option to formally specify in advance that one wishes to have life-sustaining treatment withdrawn at a particular stage of the end-of-life process unnecessarily prolongs the agony of patients and places families in a dire financial situation, with many burdened with a large amount of debt to pay back.Footnote 68 In these circumstances, the ability to make an AD would be beneficial for both patients and their families.

15.4.4 Physicians and the Implementation of ADs

If and when the legislative bridge is crossed and legislation on ADs is promulgated, the task of making that legislation implementable and acceptable will come into play. The implementation of ADs will not be easy, but training healthcare professionals in effective communication skills and medical ethics would pave the way for wider societal acceptance. Such training needs to occur in at least two key areas. The first is in relation to the AD concept itself. Although there is a scarcity of research data, a few studies have explored medical practitioners’ understanding of ADs. For example, one study revealed medical professionals to have a limited understanding of ADs, to be unaware of proxy decision-making and to believe that ADs are prepared only for the terminally ill.Footnote 69 After being given an explanation of what ADs are, however, they recognised them as an important component of end-of-life quality of care, and almost all of those surveyed said they favoured ADs for themselves. One physician stated that more palliative care services need to be established before ADs can be followed.Footnote 70 The medical professionals in the study as a whole emphasised that legal mechanisms, infrastructure, mass education and renowned hospitals taking the lead are all crucial to pave the way for ADs in Pakistan.Footnote 71 The barriers that they identified with respect to ADs included ineffective communication, inadequate and inappropriate information and a delay in information being given to patients and families, the paternalistic culture, the possibility of document forgeries, and inequitable resource availability.Footnote 72

The second area in which training is required is how to break news to patients and families and discuss diagnoses and prognoses, as well as end-of-life treatment and palliative care, which are important prerequisites to the development of ADs. Unless patients feel confident in their ability to make decisions, they will be unable to document their preferences with regard to end-of-life treatment and care. Formal ethics education would assist medical practitioners in dealing with ethical dilemmas and difficult end-of-life decisions.Footnote 73 Whilst issues such as end-of-life care, palliative care and ADs are recognised and taught in many undergraduate and postgraduate medical and nursing schools nationally, such courses are often optional or elective.Footnote 74 The regulatory bodies do not require them to be a mandatory part of the core teaching curriculum.Footnote 75

Training in these two areas would be particularly helpful in relation to the issue of healthcare practitioners, at times problematically, taking on a decision-maker role, as discussed previously. As some healthcare professionals working with terminally ill patients have expressed, appropriate training would be highly beneficial to themselves and the patients they treat.Footnote 76 In the absence of formal training, medical care practitioners often do not know how to define their role; they either become overly involved and assume the role of a family member or prime decision-maker or distance themselves to the point that the patient and family feel abandoned.Footnote 77 Healthcare professionals’ understanding of their role in relation to decision-making is highly important because whilst the superior medical knowledge of physicians vis-à-vis patients and families is beyond question, the risk of physicians misinterpreting patients’ wishes and infringing upon autonomous decision-making cannot be ignored.Footnote 78 Owing to the unchallenged power and authority that physicians possess against the backdrop of a population that is largely illiterate, financially insecure, unaware of individual rights and without access to judicial redress, a physician’s decision to continue life-sustaining treatment without any clear benefit may not be disputed. The absence of a comprehensive framework for ADs may therefore exacerbate the exploitation of unchallenged clinical discretion, which can be cloaked in references to divine predestination.Footnote 79

15.4.5 Religious Interpretation

With an array of interpretations on the meaning of Islamic teachings, as discussed previously, whether ADs will be viewed as permissible remains an open question. A healthy debate involving people from all walks of life is needed, including religious scholars who could review relevant clauses in the Quran and put forward a comprehensive proposal on AD legislation. In light of technological advancement, interpretations of Quranic texts may need to be reviewed to determine what exactly is meant when it comes to using technology for end-of-life treatment and how laws on ADs fit into the religious context. An updated interpretation of the Quran and a major shift in mindset are imperative if ADs are to be placed on the legislative agenda in Pakistan.

15.5 Conclusion

The complex governance structure and healthcare system in Pakistan, together with various religious, cultural, social and medical factors, have contributed to a distinct local context that makes the adoption and implementation of ADs extremely difficult. Given the growing importance of individual autonomy, as demonstrated by the Mental Health Ordinance 2001 and the Transplantation of Human Organs and Tissues Act 2010, and interpretations of Islamic teachings that are consistent with the use of ADs, however, we believe there is room for the development of ADs. There remain a number of hurdles to be overcome, and in this chapter, we have put forward suggestions for how we believe this can be accomplished. Despite the many challenges that lie ahead, we feel that ADs are an important goal to work towards. Not only would ADs educate healthcare practitioners about patient choices concerning end-of-life care and treatment, but they would also empower individuals, safeguard patient autonomy and ensure compliance with individual choices. In light of the patriarchal and hierarchical nature of the Pakistani family structure, ADs would also empower women to make decisions related to their healthcare. Accordingly, we believe it is worth deliberating on the viability and effectiveness of ADs, as well as advocating for them, within the context of Pakistan.

16 Advance Directives in Saudi Arabia: An Islamic Approach and Practical Implications

Ghaiath Hussein & Abdullah Adlan
16.1 Introduction

Saudi Arabia (SA) is an Islamic country in the southwestern part of Asia. It leads the Sunni Islamic world in many aspects, the most important of which is its responsibility for custody of the two holiest mosques in Islam. Making sense of advance directives (ADs) in SA, and the regulatory frameworks governing healthcare more generally, requires a careful understanding of the traditional Islamic religious legal framework of Shariʾah.

The main objective of this chapter is to offer clarity on how well-established principles, and Islamic statements of permissible and impermissible behaviour, should be reasoned through to provide an underpinning governance framework for healthcare practices at the end of life. We also review published evidence on the practical application of ADs in SA, and go on to examine the social and cultural factors that may explain the limited uptake of ADs. We then conclude with two arguments about how an appropriate role for ADs might be realised in the future – one concerning the need for legal clarity and the other concerning how to bring about improvements in professional knowledge and understanding.

16.2 Basic Legal Framework and the Role of Religion

The foundation of the Saudi legal system is Shariʾah law, or traditional Islamic law, which is supplemented by royal decrees, statutes, regulations and other legislative and policy documents in specific areas of law. As the Basic Law, or the Saudi equivalent of a constitution, states in Article 7: “Government in the Kingdom of Saudi Arabia derives its authority from the Book of God and the Sunnah of the Prophet (PBUH), which are the ultimate sources of reference for this Law and the other laws of the State”.Footnote 1

Because there are no specific laws or other legislative and policy documents derived from Shariʾah on ADs or end-of-life care and decision-making more generally, general Shariʾah principles apply. Shariʾah law is derived from two primary sources, the Quran and the Sunnah, or the practices and sayings of the Prophet Muhammad, as well as a number of secondary sources, including Ijma, or the consensus of Muslim scholars on particular issues, and Qiyas, or reasoning by analogy. To understand the permissibility of ADs under Islamic law, which is further discussed here, scholarly interpretations of the relevant parts of the Quran and Sunnah must be studied.

Actions in Islamic law are generally categorised within a scale of permissibility rather than the dichotomy of “do” and “do not”. That scale includes the following categories:

  1. 1. Must do (Wajib)

  2. 2. Permitted (Halal/Mubah)

  3. 3. Favoured (Mustahab)

  4. 4. Detestable (Makrouh)

  5. 5. Forbidden (Haram)

Any given act is judged within one of these categories based on a ruling by a scholar, usually based on one of the Islamic jurisprudential (Fiqhi) schools of thought known as Madhahib. The four main schools in the Sunni Muslim tradition are Hanafi, Shafiite, Maliki and Hanbali, named after the main Imam who developed that madhab. The main Fiqhi school followed in SA is the Hanbali, named after Imam Ahmed ibn Hanbal (who died in ad 857).

The categorisation of an act under any of the five foregoing categories is based primarily on the presence of a text (in the Quran and/or Sunnah) that discourages or forbids that act. In the absence of such a text, the act is considered permissible (mubah) based on the Fiqhi principles of “the original status of things is permissibility” and “nothing is forbidden except with a proof”. Such proof can be an Ayah (or verse) from the QuranFootnote 2 or a hadith, a record of the sayings or teachings of the Prophet Muhammad. Lower levels of proof include reasoning by analogy (Qiyas), whereby scholars reach a judgement that something is not permissible because it shares the same reasons as those of a known forbidden thing. For example, recreational drugs (e.g. heroin, cocaine, cannabis, etc.) are unanimously forbiddenFootnote 3 using Qiyas despite the absence of any text that forbids them, given that they share the effect of “covering the mind” caused by alcohol.

One of the most common forms of Islamic legal guidance is the “fatwa” (plural: “fatawa/fatwas”), which is a religious/legal non-binding opinion issued by an authentic scholar or group of scholars usually through the so-called Fatwa Complexes. In SA, the highest – and only – authority is the Authority of the Grand Scholars (aka Council of Senior Scholars), led by the Mufti of the kingdom. Members of this authority are allowed to issue personal fatwas on individual affairs if asked to do so.

It is important to emphasise here that fatawa are the intellectual outcome of a meticulous process known as Ijtihad, which ensures that these rulings are aligned to Islamic scripture and the purposes of Shariʾah Law (Maqasid), as we have discussed elsewhere.Footnote 4 The five higher goals of Shariʾah can be summarised as preserving the faith, body/soul, mind/intellect, lineage/progeny and wealth/property. The morality and legality of any act is measured against these goals; the more the goals are achieved by the act, the more legal and moral it becomes and vice versa (see previous discussion of the scale of permissibility). In the event that two or more of the goals contradict one another, for example, if someone were dying of thirst and the only drink he or she could find was alcohol, then the priority would be placed on saving the person’s life within the limitations detailed in the sub-principles of the major Fiqhi maxims, as described in the next section. The preservation of any one of the goals is attained both by the provision of its maintaining factors, such as the importance of staying healthy and abstaining from anything that could endanger one’s life. Saving a life, according to the Quran, is rewarded as if all human lives were saved: “and whoever saves a life, it will be as if they saved all of humanity” (Quran, 5:32).

16.2.1 Healthcare Context: Lessons for the End of Life

Emphasis on the sanctity of life, as demonstrated by the importance the Quran places on the saving of a life, is particularly significant in the healthcare context. As with all other religions, life is sacred in Islam and Muslims are obliged to safeguard it, and the preservation of life is amongst the highest purposes of Shariʾah. Moreover, life is believed to be given and owned by Allah, and hence only He can take it. In other words, no Muslim is allowed to take his or her own life, or to help anyone else, Muslim or not, to take his or her life, although, as we shall see, there are instances in which the withdrawal or withholding of futile treatment is permitted or even required.

Illness is generally believed to be a test from Allah, a test of His servants’ patience and a means of helping them to erase some of their sins. Whilst all suffering and death is determined by the will of Allah,Footnote 5 however, that does not mean that suffering and death should be sought or tolerated unnecessarily, with many hadith encouraging Muslims to seek remedies for their illnesses. Examples include the following:

Narrated by Abu Huraira: The Prophet (ﷺ) said, “There is no disease that Allah has created, except that He also has created its treatment”.

(Sahih al-Bukhari: 5678)

Narrated by Usamah ibn Sharik: The Prophet (ﷺ) said, “Make use of medical treatment, for Allah has not made a disease without appointing a remedy for it, except for one disease, namely old age (aging)”.

(Sunan Abi Dawud: 3855)

Scholars have proposed differing views in relation to the treatment that should be sought. For example, a very prominent scholar, Imam Ahmed ibn Taimiya (who died in ad 1328), stated that seeking treatment can itself fall anywhere on the aforementioned scale of permissibility based on the weighing of its benefits and harms, as follows:Footnote 6

  1. 1. If the treatment is more harmful than the disease or the person believes that he will be cured by the medicine (not by the will of Allah), then it is forbidden (haram);

  2. 2. If the treatment has equal value to no-treatment, then it is permissible (mubah);

  3. 3. If the treatment is likely to be beneficial, then it is favoured (mustahab); and

  4. 4. If the treatment is necessary to stop the harm to oneself or others, then it should be done (wajib).

Other scholars have divided the seeking of treatment into three categories: obligatory (where the disease is treatable or is a communicable disease that could be harmful to others), optional (where the treatment is experimental or the overall benefit is unclear) and abstinence (where the treatment would be futile or even harmful).Footnote 7 It thus appears that in situations in which a treatment could be futile or harmful, Islamic law principles would generally dictate that the individual not seek treatment, which is consistent with the withholding or withdrawal of futile or burdensome life-sustaining treatment at the end of life. This view is also in line with the concept of death in Islam. Muslims believe that death is like crossing a bridge between this temporary life (of action) and the eternal hereafter life (of judgement and rewards).Footnote 8 In other words, Muslim patients should not expect to be immortal or believe that they can delay death, which further supports the idea that the artificial and futile prolonging of life is not consistent with Islamic principles.

In addition to such principles and interpretations, fatwas are also a source of guidance in the healthcare context. Most of the leading fatwas related to organ donation, blood transfusion, cardiopulmonary resuscitation (CPR)Footnote 9 and many others were the result of doctors or patients submitting questions in pursuit of religious fatwas from the Council of Senior Scholars.Footnote 10 Arguably, this is a unique feature of the Saudi context in that clinical/medical decisions are not made solely within the confines of the doctor–patient relationship, as the scholars who are expected to rule by way of fatwas are mainly non-medical by profession. It is important to acknowledge the challenges associated with this feature of the Saudi context: because it is essential in Islamic jurisprudence for Islamic scholars to fully comprehend an issue in order to judge its suitability, they require a healthcare expert to explain the issue to them in lay terms and to answer their questions. That expert is usually a medical doctor. Whilst this is entirely understandable, the problem is that those providing the requested explanations are usually physicians, who may have their own preferences in the matter, which could result in experts advocating for what they think is right. The end result could be an indirect form of medical paternalism, aggravated by the religious cover it may have if the decision-making authority seems to have moved from a physician to a religious scholar.

The most relevant fatwa in the end-of-life context is likely the famous Fatwa No. 12086 issued on 28/3/1409 (H) (i.e. ad 1989) by the Presidency of the Administration of Islamic Research and Ifta’, Riyadh, KSA. This fatwa relates to do-not-resuscitate (DNR) orders and states that “if three knowledgeable and trustworthy physicians agreed that the patient condition is hopeless; the life-supporting machines can be withheld or withdrawn. The family members’ opinion is not included in decision-making as they are unqualified to make such decisions”.Footnote 11 This fatwa is a good example of the unique role that fatawa play in the Saudi legal system: although they are not laws per se, they can be used as legal evidence in the absence of law. This is demonstrated by the fact that, despite there being no mention of DNR orders in any Saudi law, the practice of DNR in Saudi hospitals has been reported for more than 20 yearsFootnote 12 and the only reference “legalising” this practice over the years is the aforementioned fatwa. Fortunately, there has not been a single case of the family of a patient who died while under a DNR order suing the patient’s doctor and/or the hospital at which he or she was admitted. It would be interesting to see how the Saudi courts would handle such a case and whether the fatwa alone would be sufficient to clear the doctor/hospital of liability.

16.2.2 Advance Directives

The foregoing discussion of the end-of-life care context in SA demonstrates the general permissibility of withholding or withdrawing futile or harmful life-sustaining treatment, as well as the very specific fatwa guidance in relation to DNR orders. Given that there are no laws or fatwas directly addressing the issue of ADs, however, how should we understand the permissibility of preparing and implementing ADs under Islamic law?

At least two sources of religious guidance can be drawn upon in understanding ADs under Islamic law. The first, which aids understanding of the individual’s own role in end-of-life decision-making, is a well-known hadith about the Prophet Muhammad’s illness and death:

This Hadith Narrated by Ibn ʿAbbas and ʿAisha (R.A): Abu Bakr kissed (the forehead of) the Prophet when he was dead. ʿAisha added: We put medicine in one side of his mouth but he started waving us not to insert the medicine into his mouth. We said, “He dislikes the medicine as a patient usually does”. But when he came to his senses he said, “Did I not forbid you to put medicine (by force) in the side of my mouth?” We said, “We thought it was just because a patient usually dislikes medicine”. He said, “All of those who are in the house will be forced to take medicine in the side of their mouth while I am watching, except for Al-ʾAb-bas, for he had not witnessed your deed”.

(Translation of Sahih Bukhari. Book of Medicine, Hadith number 2012)Footnote 13

This hadith demonstrates both a patient’s right to refuse treatment and the fact that this right cannot be overridden by the wishes of others, even his or her closest relatives. Al-Jahdali et al. further interpret the hadith as conveying three principles: (i) Muslims are permitted not to receive treatment, especially if they have an incurable disease; (ii) those taking care of patients are not permitted to force a patient to accept a certain treatment, especially when they know that the patient does not want it; and (iii) those persons will be held accountable for their actions if they do force the patient to do so,Footnote 14 or, in other words, a patient whose right has been unlawfully overridden has the right to seek retaliation for the (ab)use of his or her state of unconsciousness.

In the context of ADs, these principles can be understood as providing patients with the right to specify beforehand what they do not want to be done to them at the end of life, including choosing whether or not medication or other treatment options will be administered to them. In addition, they demonstrate that ADs should not be overridden and that those who attempt to do so can be held accountable for that attempt, even if made in good faith.

The second source of religious guidance comes from Fiqhi principles, which represent a practical framework for legal and moral decision-making through the categorisation of general rules under which there are sub-principles that are derived primarily from the text of the Quran and Sunnah.Footnote 15 Next, we discuss the five main Fiqhi principles agreed upon by most Sunni scholars, as well as some of their main sub-principles, and our interpretation of how they might be applied in the AD context.

  1. I. The Principle of Intention (Qaidat Al Niyyah)

This principle states that actions are judged by (or based upon) their intentions. Any act of a human being must come from and is based on his or her will and intention. Under this principle, there is a sub-principle which states that “the means are judged as the ends”, or, in other words, the means are judged using the same criteria as those used to judge the intention. Thus, if the intention is wrong, the means will also be considered wrong. In the AD context, this sub-principle can be understood to mean that when a person writes an AD, he or she cannot request illegitimate interventions to achieve a legitimate purpose or legitimate interventions to achieve an illegitimate purpose. For example, even if further treatment would be futile, burdensome or harmful, and the patient would die from the legitimate withdrawal of life-sustaining treatment, he or she cannot in his or her AD request extensive doses of analgesics that could lead to death.

  1. II. The Principle of Certainty (Qaidat Al Yaqeen)

This principle states that certainty cannot be removed by doubt; that is, what is known to be a fact cannot be overridden by what is doubtful. Under this principle, there is a sub-principle which states that what is proven by evidence is valid unless denied by contrary evidence of equal or better strength. In the AD context, this can be understood to mean that where an AD is considered to have been validly made (e.g. the patient was considered competent to make the AD at the time of its drafting) or is considered to apply (e.g. the patient has lost capacity), doctors should implement the AD unless they have contrary evidence of equal or better strength, such as strong evidence that the patient was not competent at the time he or she made the AD.

  1. III. The Principle of Injury (Qaidat Al Dharar)

This principle states that harm may be neither inflicted nor reciprocated in Islam. Harm must be eliminated but not by means of another harm. Under this principle, there is a sub-principle stating that harm is to be prevented to the greatest extent possible. In the end-of-life context, where continuing treatment would be futile in terms of recovery and would be burdensome or even harmful in terms of pain and suffering, an AD can be seen as a way to prevent and limit the harm caused to the patient. That view would, of course, be based on the view that the infliction of such prolonged pain and suffering would bring greater harm than bringing about death more quickly by following a patient request in an AD to withhold or withdraw life-sustaining treatment. This is the case because another sub-principle states that an injury cannot be relieved by inflicting or causing a harm of the same degree, which suggests that any option that could inflict some kind of harm, such as the withdrawal or withholding of life-sustaining treatment that would ultimately result in death, would need to be assessed as to whether it might cause equal or greater harm to the patient than what he or she is currently suffering, as well as what the projected outcomes might be.

  1. IV. Principle of Hardship (Qaidat Al Mashaqaat)

The basic principle here is that difficulty calls forth ease, and is the basis for allowing an exception to the rules where adherence to the rules would result in great hardship.Footnote 16 Whilst this principle deals primarily with what exceptions are permissible in situations of necessity, a sub-principle which states that “what is allowed for a cause (justification) goes with the cause” may be relevant in the AD context: if the AD’s validity and applicability are justified by the patient’s loss of capacity, they should become void as soon as he or she regains capacity.

  1. V. The Principle of Custom or Precedent (Qaidat Al Urf)

This principle states that custom or precedent has legal force. What is considered customary is what is uniform, widespread, predominant and not rare. Customary practices are those that are acceptable to people of a sound nature and enjoy universal or general acceptance by a given country or generation. Custom in a given society can take the form of words, actions, abstinence or a mixture thereof. Under this principle, there is a sub-principle stating that only known customs, not rare ones, are recognised; in other words, transient customs are not recognised. In the wider healthcare context, this sub-principle could be understood as a form of norm-setting by clinical professionals, which in turn renders the customary practice legitimate. Thus, in so far as a practice is customary, it sets a precedent that should be followed. In the more specific AD context, it would mean that if healthcare professionals used ADs customarily, that usage would constitute a bottom-up approach to the legitimisation of the use and implementation of ADs as professionally acceptable, or even required, behaviour.

Another sub-principle states that things are defined by customs, not only by language, and that the way in which people use words can be used as evidence. In the context of ADs, this sub-principle can be understood as follows: where patients use terms in their ADs that are ambiguous or capable of being interpreted in more than one way, the most common, or public, interpretation should be used. For example, if a patient expresses a desire to have all care withdrawn in the face of a life-limiting diagnosis, it would be appropriate for the phrase “all care” to be interpreted in terms of medical treatment interventions rather than basic palliative care support that mitigates pain or suffering in the last moments of life. This is the case because despite the fact that “all care” could reasonably incorporate all healthcare interventions, laypersons would be unlikely to interpret the phrase in those terms.

With respect to the specific content of an AD under Islamic principles, Albar and Chamsi-Pasha have identified four elements that can be included: (i) a request to discontinue treatment; (ii) an instruction to switch off life-support equipment; (iii) the inclusion of organ donation; and (iv) power of attorney (wakalah).Footnote 17 In relation to the discontinuation of treatment, these authors argue that treatment can be discontinued if continuing it would not improve the patient’s condition or quality of life and the intention is not to hasten death but rather to refuse “overzealous treatment”. This argument is in line with the principles and interpretations discussed previously, which consider the withdrawal or withholding of treatment to be permissible where treatment is futile. Albar and Chamsi-Pasha also argue that palliative care aimed at maintaining personal hygiene and basic nutrition should not be discontinued, which is in line with the idea that only futile or harmful interventions can and should be stopped. Care that is beneficial, at least in terms of quality of life, should remain as a treatment or “remedy” that should be sought when ill.

The instruction to switch off life-support equipment pertains primarily to the case of brain death, for which several fatwas provide guidance,Footnote 18 and organ donation, which is beyond the scope of this chapter. In terms of power of attorney, or wakalah, Albar and Chamsi-Pasha contend that it would be prudent for Muslims to entrust someone (their wakil, or authorised representative) with the power of attorney in their living will. Should the person in question subsequently become incompetent, the wakil would be responsible for conveying the wishes stated in his or her living will. Accordingly, it can be seen that the term “power of attorney” as used here goes beyond the conventional sense of an individual being granted the power to make decisions on behalf of another, extending it to the role of the wakil as a conveyor or even interpreter of the content of an AD. It should be noted that the content of a living will should not include any clauses that contrast with or contradict the rulings of Shariʾah; as long as that is the case, there would arguably be no justification for ignoring the directive.Footnote 19 Moreover, the wakil is committed to following the instructions in an AD without any alteration or hiding.Footnote 20 The wakil is considered a witness to the wishes of the person making the AD and is legally and morally bound to express and convey those wishes to others, including healthcare providers.Footnote 21

16.3 Practice and Sociocultural Context of Advance Directives in Saudi Arabia

In the previous section, we have considered how ADs would likely be regulated under Islamic law, although we should again emphasise that there are no specific laws, regulations or fatwas on this issue as yet. Moreover, there are no guidelines produced by healthcare professional bodies that mention an explicit role for ADs. We now turn to consideration of the situation relating to ADs on the ground. In particular, this section considers (i) knowledge of and attitudes towards ADs and (ii) the sociocultural factors that affect their acceptance in SA.

In terms of knowledge of ADs, whilst there appear to be no clear data on patient awareness, Baharoon et al. found in 2019 that there was a general lack of understanding on the part of patients about their illness and their options. Of their sample of 300 patients, only 25.3 per cent understood that their disease was incurable, and 54.7 per cent inaccurately thought that their disease was curable. Twenty per cent of the sample reported that their doctors had not discussed their prognosis with them directly. Less than 8 per cent understood the meaning or potential outcome of CPR, intubation or mechanical ventilation or how these interventions were relevant to their condition.Footnote 22 This general lack of understanding on patients’ part about their illnesses and options is likely to affect their ability and desire to engage in advance care planning.

With respect to healthcare practitioners, a 2019 study on the knowledge and attitudes of physicians and nurses towards ADs for cancer patients found that 64.9 per cent of the participating physicians provided correct definitions of ADs, whereas the figure for the nurses was significantly higher, at 82.4 per cent.Footnote 23 The nurses in the study thus had a much better understanding of ADs, interestingly, with the independent predictors of AD knowledge being female sex and level of education. In terms of attitudes, a 2018 study on the knowledge and attitudes of emergency department and intensive care physicians towards DNR orders found that even though only 13.4 per cent of the sample of 112 mostly Muslim physicians had made ADs themselves, 86 per cent believed that every patient should have an AD. In an earlier study in 2010,Footnote 24 Tayeb et al. found that although some medical staff, including physicians, were unaware of what an AD is, most of their participants (who included a range of persons involved in end-of-life care) agreed with the concept of ADs after it had been explained to them. In discussing these findings, the authors argued that ADs were underused in their hospital and that their adoption should be encouraged given that the practice was widely accepted by their sample of 284 Muslim participants.

The data thus far seem to suggest that the concept of ADs is not unknown or unwelcome to physicians. Nevertheless, the few data we have regarding the use of ADs in SA suggest that they are not commonly used in practice. Beyond the likely lower levels of awareness amongst patients, which can be deduced from the aforementioned study conducted by Baharoon et al., do sociocultural and religious factors also play a role?

16.3.1 Role of the Family

Available empirical data suggest that the family plays a significant role in medical decision-making in SA. In a 2012 study on end-of-life practices in a tertiary intensive care unit in Saudi Arabia, it was found that in 88 per cent of their sample of 135 patients who had died after an end-of-life decision, the family or surrogates had been informed and were involved in these decisions.Footnote 25 This finding is consistent with the description in Tayeb et al. of the distinct nature of the Saudi family and its composite interrelations and strong ties, whereby the patient and family are seen as one unit,Footnote 26 as well as the view of Al-Jahdali et al. that illness is considered a “whole-family affair” in Muslim culture.Footnote 27 Al-Jahdali et al. further argue that family members may even prefer that a patient not be directly informed of a life-threatening diagnosis or prognosis,Footnote 28 and may demand to make end-of-life medical decisions for the patient, decisions that often involve heroic interventions that the patient may not have wanted.Footnote 29

This is perhaps the reason why, despite the cultural significance of the family, studies have shown that a considerable percentage of patients prefer not to consult their family members on end-of-life decision-making. For example, in the previously described study by Baharoon et al., 25 per cent of the sample wanted to be the sole decision-maker, with 55 per cent wanting their family to participate in decision-making.Footnote 30 In a 2009 study by Al-Jahdali et al. of advance care planning preferences amongst dialysis patients,Footnote 31 one survey question asked participants what they would wish to do if they were transferred to hospital and told by a doctor that their chances of survival were hopeless/dismal. One of the response options queried whether the participant would, in such a scenario, wish to consult their family members before making a decision, and 28 per cent of the sample stated that they would not.

Whilst it is interesting that a significant percentage of patients appear not to want to involve their families in end-of-life decision-making, the importance of the family in Muslim cultures such as that of SA and family participation in (or in some cases, takeover of) decision-making in the majority of cases may create difficulties for the use of ADs in SA, at least in a format that emphasises the role of the individual as the sole or primary decision-maker.

16.3.2 Difficulties Concerning Discussions about Death and Dying

Another relevant factor emerging from the limited empirical research available is the perception that death is not a favoured topic, with discussion of it sometimes avoided, which affects the willingness of doctors and patients to engage in advance care planning more broadly. For example, in the aforementioned study by Tayeb et al., the following was reported: “Some focus group members were concerned about our society’s tendency to consider death as taboo, something that human beings cannot interfere with. Participants informed us of cases in which healthcare providers avoided end-of-life discussions because they believed that it is beyond our control as humans”.Footnote 32

This view aligns with the perception, mentioned by Baharoon et al., that Arab patients prefer not to discuss ADs owing to a fear of discussion of death and all news related to it,Footnote 33 as well as with the problems of palliative care in SA discussed by Alshammaray et al., which include a general unwillingness to discuss issues of death and dying.Footnote 34

There is, however, preliminary evidence from Baharoon et al. suggesting that Arab patients may be more willing to discuss end-of-life decisions, as well as ADs, than previously thought.Footnote 35 Although the authors found the majority of their sample to lack knowledge and understanding of their illness and options, as discussed previously, they also found that their patients were generally willing to engage in end-of-life care planning with their doctors and to make decisions about end-of-life care.Footnote 36 Despite their participants’ limited knowledge of CPR or mechanical ventilation, the majority were capable of making sensible judgements about end-of-life matters, and, when asked directly about their end-of-life preferences, 90 per cent of the sample had formulated opinions on whether resuscitative care would be desirable.Footnote 37 Given the limited scope of the study, however, more research is required to substantiate the authors’ observation. Nevertheless, avoidance of discussions of death and dying may well contribute to the general lack of discussion surrounding end-of-life care and decision-making, which in turn renders the use of ADs in SA more difficult.

16.4 The Way Forward

In considering the way forward, there are two key points to highlight. The first is that the lack of specific legislation or guidance on ADs is problematic and that, in this area, reliance on “on-call” fatwas may not be the best way forward. We argue that what is needed is the empirically guided development of clear policies related to ADs that are supported by a clear legal framework clarifying the roles and responsibilities of the patient, the family and caregivers through enacted laws. To achieve such development, we believe that relevant issues pertaining to ADs (amongst other end-of-life care issues) need to be identified, analysed and explained to the scholarly authorities to allow them to provide caregivers with an outline of how to approach the concept of ADs within the limits of Islamic guidance. Further, previous works within and beyond the fatwas need to be gathered, studied and summarised to develop guidelines for this practice. As stated earlier, not all fatwas are articulated as laws, although they can be used as supporting defence, if needed, as in the aforementioned example of DNR orders. We do not think that this is an ideal situation. The role of fatwas, and more broadly of the fatwa-issuing bodies, should be clarified, and these should be incorporated into mainstream guidance, as with the example of the National Guidelines for Informed Consent.Footnote 38

The second point to highlight relates to the training of healthcare professionals on the concept and application of ADs, as well as on end-of-life issues more generally. The studies discussed here suggest that healthcare professionals in SA do not often initiate or engage in discussions of poor prognoses or end-of-life issues with their patients, possibly owing to misconceptions about patients’ willingness to discuss such issues. This leads to a lack of understanding on the part of patients about their illnesses and their options, which includes the possibility of indicating a preference beforehand via an AD. Comprehensive and uniform training on ADs and end-of-life issues, including training on how discussions of such issues should be conducted, would be helpful in increasing both patient awareness and the use and implementation of ADs in SA.Footnote 39

16.5 Conclusion

Owing to the absence of a specific legislative framework, policy or religious guidance on the topic of ADs (despite the presence of guidance on other end-of-life care-related issues), uncertainty remains over the acceptability and role of ADs in SA. In this chapter, we have considered how Islamic Fiqhi principles might apply. Although there is a general emphasis on the sanctity of life in Islam, Islamic principles concerning the seeking of treatment and the Muslim concept of death provide the basis for an interpretation that could permit ADs in situations where treatment would be futile or even harmful. Fatwa No. 12086, although specifically addressing the issue of DNR orders, supports this interpretation.

However, although there appears to be a general acceptance of ADs in Islamic law, and although empirical data suggest that the concept of ADs is not unknown or unwelcome to healthcare practitioners in SA, clear evidence of AD practice on the ground is lacking. Whilst the absence of specific laws or policies pertaining to ADs is likely a contributing factor, the paucity of ADs in practice may also be the result of such sociocultural factors as the significant role of the family in decision-making or the observed difficulties of engaging in discussions of death and dying. We concluded the chapter with some specific recommendations for how SA might approach ADs moving forward, including the formulation of clearer laws, policy and/or guidance, as well as comprehensive and uniform AD training for healthcare professionals.

17 Advance Directives in Asia: Towards “Generative Accommodation”

Daisy Cheung & Michael Dunn
17.1 Introduction

This edited collection has surveyed the law and practice of advance directives (AD) in 16 Asian jurisdictions. In this final chapter, we offer some comparative analysis and tentative concluding comments. We begin with an examination of different aspects of the law and practice of ADs in these jurisdictions, identifying similarities and trends. With this summary of the various connections between these jurisdictions, we then offer some broader reflections on two key features common to Asian jurisdictions, the role of religion and the role of the family. We conclude with a critical examination of this emerging picture of ADs in Asia, arguing that these insights suggest that distinctive patterns of “generative accommodation” are observable as a way of aligning international consensus with localised traditions and expectations in a more nuanced account of the meeting ground between the East and the West.

17.2 Overall Observations

In order to provide an overarching thematic structure to the book, we categorised the 16 jurisdictions into “well-regulated”, “semi-regulated” and “non-regulated”, according to the extent to which ADs are formally legally regulated in that jurisdiction. The following table picks out the key relevant legislative frameworks and/or guidelines in each jurisdiction.

JurisdictionKey relevant laws/guidelines
Well-regulatedIsraelDying Patient Law (2005)
SingaporeAdvance Medical Directive Act (1996)
Mental Capacity Act (2008)
South KoreaAct on Hospice and Palliative Care and Decisions on Life-sustaining Treatment for Patients at the End of Life (2016)
TaiwanHospice Palliative Care Act (2000)
Patient Right to Autonomy Act (2019)
ThailandNational Health Act (2007)
IndiaGuidelines from Common Cause decision (2018)
Mental Healthcare Act (2017)Footnote 1
Semi-regulatedHong KongLegislative Proposal (2019 consultation paper: End-of-Life Care: Legislative Proposals on Advance Directives and Dying in Place)
Guidance for Hospital Authority Clinicians on Advance Directives in Adults (2020)
IranIran Charter of Patient Rights (2009)
General Guidelines of Professional Ethics (2020)
MalaysiaGuidelines on Consent for Treatment of Patients by Registered Medical Practitioners (2017)
Code of Professional Conduct (2019)
Guidelines for Resuscitation Training for Ministry of Health, National Committee on Resuscitation Training (2016)
PhilippinesVarious hospital guidelines
Ethics Guidelines on COVID-19 (2020)
National Mental Health Act (2018)Footnote 2
TurkeyPatient Rights Regulation (1998)
Turkish Medical Association’s Declaration on End-of-Life Decisions (2020)
Non-regulatedChinaChinese Medical Doctors’ Code of Ethics (2014)
JapanThe Decision-Making Process for Final Stage of Life Treatment and Care (Process Guidelines) (2018)
MacaoArticle 150/2 of the Criminal Code (1995)
Pakistan[n/a]
Saudi Arabia[n/a]

We begin with some general observations about each category, and then proceed to hone in on patterns that can be observed across all the jurisdictions.

17.2.1 Well-regulated Jurisdictions

The well-regulated jurisdictions are those jurisdictions with a clear set of legal rules focused on, or encompassing, ADs. These jurisdictions are described as “well regulated” simply because the legal regulation of ADs in these jurisdictions is relatively formal, and not on the basis of any normative assessment of the quality of this legal regulation.

All of the jurisdictions in this category have detailed legal rules regulating ADs, but each jurisdiction faces its own problems in terms of implementing its framework. The over-specificity of Israel’s law, for example, has led to a paradoxical limiting of its application. The scope of the law in Singapore is arguably too restrictive, and replete with too many formalities, whereas Thailand’s legal framework lands on the opposite extreme. Despite South Korea’s principled attempts to endorse patient preferences, it is comparatively difficult to execute a patient’s wishes due to the need for verification of such wishes prior to implementation, and the relative ease with which they can be overridden by family. India’s framework, which is the only one in this category that takes the form of judicial guidelines, is overly complex and administratively burdensome.

Except for Taiwan and Thailand,Footnote 3 jurisdictions in this category have frameworks that are restrictively limited to patients with terminal illness and the withdrawal/withholding of futile treatment, a feature that, as will be discussed, appears to be common among the Asian jurisdictions in this book. In addition, despite the detailed frameworks in these jurisdictions, there generally appears to be a low level of awareness and take-up of ADs.

17.2.2 Semi-regulated Jurisdictions

The semi-regulated jurisdictions are jurisdictions with other forms of regulation on ADs. Iran falls between the well-regulated and semi-regulated jurisdictions given the legally binding nature of its Charter of Patient Rights and General Guideline of Professional Ethics, but was nonetheless placed in this category because these documents fall under the lowest, or tertiary, level of legal regulation in Iran. Turkey is also anomalous in that the guidance it has on ADs is significantly less than any of the other jurisdictions in this category, but it was nonetheless included due to the specific reference that the Turkish Medical Association’s Declaration on End-of-Life Decisions makes to ADs.

The jurisdictions in this category employ different approaches to the regulation of ADs, including the use of (i) professional guidelines in the Philippines, Hong Kong, Malaysia and Turkey and (ii) official regulations in Iran. Two additional points are worthy of note here. The first is that, interestingly, two of these jurisdictions, the Philippines and India, have a formal legislative framework for psychiatric ADs despite not having an equivalent framework for ADs governing treatment for physical illnesses, and end-of-life care in particular.

The second point is that, for some of these jurisdictions, in particular the Philippines and Malaysia, there is what can be called a “bottom-up” approach to regulation via guidelines issued by professional societies. In such jurisdictions, there are generally sociocultural and/or religious reasons why the state has not pushed to regulate ADs, or why AD legislation has failed to pass, but there is nonetheless taken to be a need for such regulation in practice. In the Philippines, for example, religious and sociocultural influences have resulted in failed attempts to pass AD legislation, but mounting pressure on healthcare resources, and the corresponding need for healthcare professionals to have the confidence to withdraw or withhold life-sustaining treatment in certain cases, have created a practical need for ADs – a need which has been further exacerbated by the onset of the COVID-19 pandemic. In response to this, hospitals have stepped in and drawn up their own institutional guidelines to regulate the making and implementation of ADs, in what can be considered a pragmatic and decentralised “bottom-up” regulatory strategy.

Similarly to the well-regulated jurisdictions, both awareness and utilisation of ADs appear to be low in these semi-regulated jurisdictions, where data are available. This is despite guidelines about ADs being in place. The authors often make the claim that sociocultural and religious influences have a sizeable effect on the acceptance and use of ADs, which indeed is a common feature across all jurisdictions, although there is a significant lack of empirical evidence about practice on the ground in the semi-regulated jurisdictions.

17.2.3 Non-regulated Jurisdictions

The non-regulated jurisdictions are jurisdictions with no AD-specific guidance, although broad principles generally exist within other regulatory spaces that pay regard to the importance of patient preferences at the end of life. The format and formality of such principles vary among the jurisdictions, although Japan is anomalous in the level of detailed official governmental guidance it has in the area of end-of-life decision-making.

Like the semi-regulated jurisdictions, there is a dearth of empirical evidence about the practice of ADs (if any) on the ground in these jurisdictions, and in some cases, evidence about attitudes towards ADs as well. In Pakistan and Saudi Arabia, the lack of sufficient empirical data on attitudes may have a particularly significant impact, given preliminary data suggesting that the perception that patients are unwilling to discuss death and end-of-life preferences may not in fact always be true, and that patients in these countries may be more willing to have end-of-life discussions and be informed of their prognosis and life-expectancy than previously thought. This, in turn, suggests that further research may support the goal of increased efforts in promoting end-of-life discussions with patients.

Once again, sociocultural and religious influences are similarly thought to have a significant effect on the acceptance and use of ADs in these jurisdictions, and, for some of them, this has resulted in a need for more training for healthcare professionals concerning ADs and end-of-life discussions with patients and family members. The latter observation is particularly important where there may be the aforementioned possibility of a misperception in patients’ willingness to discuss death and end-of-life decision-making.

17.3 Key Comparisons: Patterns and Observations across the Jurisdictions

We now turn to discuss some of the broader patterns observed across all 16 jurisdictions in more detail. We show similarities are present across Asian jurisdictions, frequently in ways that transcend the degree of regulation in place. We also consider two significant points of variation among the jurisdictions, in terms of the level of specificity of AD regulation and the formalities involved. These patterns are of course to be expected; we would be surprised not to see significant variations amongst the jurisdictions of such a vast continent. Indeed, intra-regional variations around the norms, values and practice of ADs are a feature of other international settings as well.Footnote 4

17.3.1 Conservative Features

A clear trend across these jurisdictions is the conservative approach that has been adopted in relation to the governance and use of ADs. This approach is characterised by various overlapping features common to many jurisdictions. For example, while different forms of legal and/or professional regulation exist, the acceptability of ADs seems generally limited to patients with terminal illness, with the notable exceptions of Taiwan, Thailand and the proposed legislation for Hong Kong.Footnote 5 In some cases, such as Singapore, South Korea and India, this is further limited to instances of determined medical futility, which, as Chan suggests, “adds little deliberative value to the decision to withdraw life sustaining treatment”.Footnote 6

A conservative approach is also demonstrated by the requirements for further confirmation that exist in some of these jurisdictions prior to the implementation of the AD, and more generally, what appears to be a lack of concern for the implementation of the patient’s wishes in emergency situations. Thailand, South Korea and India, for example, all have procedures for further confirmation prior to implementation. Thailand and South Korea both require further verification of the patient’s wishes with the patient prior to implementation where the patient is conscious and retains capacity, and where the patient lacks capacity, South Korea requires the doctor to obtain the agreement of a second doctor, and the confirmation process typically involves a discussion with the family about the authenticity of the AD. In India, the procedures for confirming the AD are exceedingly lengthy and complicated, involving a Judicial Magistrate First Class (JMFC), the formation of a hospital medical board comprising multiple experts from various fields of medicine and the formation of a further medical board with the Chief District Medical Officer and other medical experts. While Malaysia does not have formal procedures in place, a similar lack of concern for emergency situations is demonstrated by the fact that the Malaysian Medical Council guidelines give physicians a wide scope of discretion to continue treating the patient in their best interests until they can obtain legal advice regarding the validity of the AD. This can be a lengthy procedure due to the lack of clarity surrounding how an AD can be demonstrated to be valid in Malaysia.

A further feature is the relative lack of duties and/or punishment imposed where there is a failure to implement an AD, in particular as compared to the presence of protections against liability where ADs are carried out.Footnote 7 Taiwan is the only jurisdiction with strict penalties for the violation of a patient’s AD, but only under its Hospice Palliative Care Act 2000. Under the more recent Patient Right to Autonomy Act 2019 (PRAA), there are notably no penalties for physicians, and a very wide scope to opt out of implementing ADs without a duty to refer the patient to someone else who will implement it instead.Footnote 8 Singapore also imposes a duty to implement an AD, but without mention of penalties if this is not complied with. India only imposes a duty on a physician to implement a psychiatric AD, with no similar duty in the case of end-of-life ADs. Not only is there no duty to implement, there are jurisdictions in which physicians are given significant discretion in deciding whether to implement at all. In Malaysia, for example, the Malaysian Medical Council guidelines only state that physicians “should” refrain from providing treatment contrary to an AD, and there is a flexibility not to comply with the AD if this decision is taken in consultation with the family. In Macao, physicians are required only to consider any patient wishes under Article 150/2 of the Criminal Code, and not necessarily to implement such wishes.

17.3.2 Lack of Awareness, Understanding and/or Utilisation

Another clear trend across the jurisdictions of this book is the general lack of awareness and understanding of ADs, even in jurisdictions where there is a clear, detailed and comprehensive legislative framework for ADs. All jurisdictions for which there were relevant empirical data indicated that there was a lack of awareness and understanding of ADs among the general public, and in several jurisdictions, such as Israel, Thailand, India, China and Turkey, there was evidence to suggest that there was an inadequate level of awareness and/or understanding of ADs among healthcare professionals as well. In some jurisdictions, there were statistics demonstrating that this had translated into low utilisation of ADs.Footnote 9

Two observations are worth making here. The first is that, while a lack of awareness and understanding of ADs is, in itself, a likely barrier to the use and acceptance of ADs, this may be a particular concern in jurisdictions where there are data showing that increased awareness may lead to a higher uptake of ADs. For example, there were studies from some jurisdictions in which a number of participants who did not previously know about ADs responded positively after being informed about them, and in some cases stated they would want to make one.Footnote 10 In Macao, there were data showing that the lack of information was a main reason deterring individuals from making ADs.

The second observation is that this lack of awareness and understanding is in some cases related to, or even a result of, the lack of communication about ADs by healthcare professionals to patients. In some jurisdictions like Pakistan, Saudi Arabia and Iran, this appears to be because of a more general reluctance to discuss issues of death and dying, or end-of-life decisions, with patients due to sociocultural factors or traditions in healthcare culture. In contrast, in Hong Kong the problem seems to be more of an institutional one, with a lack of effective and coordinated communication on the part of healthcare professionals regarding ADs, and in Malaysia, the professional guidance in relation to ADs is mostly reactive, without any encouraging of physicians or other healthcare professionals to initiate such discussions with their patients. The notable exception to this is the Philippines, where healthcare professionals are “instructed to carefully explain to patients how immensely useful an AD can be” as a necessary step in the delivery of healthcare.Footnote 11

There is one final point to make here, connected to the point about the lack of understanding of ADs. Namely that, even at the state level, the way that AD regulation has been incorporated into existing legal and regulatory frameworks reflects that the procedural requirements to implement and enact ADs frequently do not appear to have been well thought out or understood. In jurisdictions like Singapore and Israel, there remains uncertainty about parallel regimes and how they apply.Footnote 12 While the Philippines does not have end-of-life AD legislation, its psychiatric AD legislation has potential conflicts with existing next-of-kin laws, suggesting the practicalities of how the law is to be implemented have not been well considered. In Hong Kong, the introduction of the proposed legislation would further exacerbate the already very piecemeal approach that is employed in this area of the law.Footnote 13

In particular, many jurisdictions do not appear to have attended carefully to the mental capacity requirements for an AD, and how a person’s decision-making capacity is to be assessed. In some jurisdictions, there are mental capacity requirements and assessment criteria, but these are problematic. In Singapore, for example, there is inconsistency between two different legislative regimes, and therefore uncertainty regarding the mental capacity threshold to be applied in the Advance Medical Directive Act. The lack of an overarching mental capacity test in Hong Kong, together with the existence of various different tests in the common law, Mental Health Ordinance and Hospital Authority guidelines, similarly results in ambiguity as to what the test for mental capacity should be in relation to the making of ADs. In India, the court in Common Cause does not elaborate on how soundness of mind is to be assessed, even though a specific definition and assessment process exists for psychiatric ADs. Various jurisdictions, such as Malaysia, South Korea and Thailand, do not have guidance regarding how capacity in relation to ADs should be assessed. The assessment procedures in South Korea and Thailand raise particular concern. In South Korea, the lack of requirements on how capacity should be assessed has meant that it is not uncommon for this exercise to be left to nurses or even volunteers at the registering institution, who may not have any experience in this area. In Thailand, there is no requirement for the assessment of capacity at the time of making the AD at all, and physicians are only required to examine the patient at the time of receipt of the AD to see whether they were capacitous at the time the AD was made, something which is inherently difficult to do without an examination of the patient at that time.

17.3.3 Sociocultural and Religious Influences

The impact of sociocultural and religious factors on the regulation and practice of ADs is observable across all jurisdictions. The two most significant factors, the role of the family and the role of religion, permeated across some jurisdictions in complex ways, and so will be subjected to further analysis in Section 17.4.

Beyond these two factors, a cultural emphasis on deference to physicians was noted across many of the jurisdictions. For example, Tengaumnuay describes a paternalistic culture in Thailand where Thai people commonly allow physicians to make decisions for them, and are therefore less likely to make ADs. Similarly, there is a general deference to physician expertise in Malaysia, arguably also due in part to Islamic religious influence.Footnote 14 In Pakistani culture, Beg et al. describe physicians as holding an “esteemed” position. Physicians and nurses often take on a decision-making role due to various factors, including what is often a symbolic “induction” into families as directors rather than facilitators of care. There is a similarly greater role for doctors and medical paternalism in Indian culture as a result of the influence of Ayurvedic systems, although, interestingly, this has not resulted in a greater reluctance to make use of ADs. Instead, Dhru and Ghooi argue that this “preference for the role of the physician” has resulted in physicians being accorded a key role in overseeing and applying the AD regime.

17.3.4 Variations in Specificity of Regulation

In addition to the similarities observed previously, there were also important differences among the jurisdictions worthy of note. One such difference concerns the degree of specificity provided by AD regulations, where concerns were expressed regarding both over-specificity and under-specificity.

In relation to concerns about “over-specificity”, South Korea and Israel both define the terminal stage chronologically, and further make a distinction between two stages of dying. Israel distinguishes between a “dying patient” (who has no more than six months to live) and a “dying patient in the final stage” (who has no more than two weeks to live), whereas South Korea differentiates a “terminal patient” (who is expected to die within a few months) from a “dying patient” (who is going to die imminently). This distinction is important in both countries because the specific definitions shape permitted actions in different ways. In South Korea, for example, an Advance Statement for Life-sustaining Treatment (ASLST) cannot be implemented until the patient is a “dying patient”, and in Israel, while certain types of treatment can be withheld from a “dying patient”,Footnote 15 ventilator support, nourishment, palliative care and secondary/accompanying treatment can only be withdrawn or withheld from a “dying patient in the final stage”.

As the authors recognise, this level of specificity can be problematic. In the Israeli context, for example, Bentwich argues that the specificity of the timeline associated with these two stages of dying causes difficulty because of the ambiguity it paradoxically creates for physicians. This can be, for example, because prognoses often do not neatly fall into the categories of “less than six months” and “more than six months”, or because it is unclear whether an acute disease (like pneumonia) that can cause death within two weeks can be successfully treated, and therefore whether the designation of “dying patient in the final stage” is warranted.

On the opposing side of under-specificity (or over-flexibility), Ozeki-Hayashi et al. argue that the lack of a clear definition of when a patient would be considered to be in the “terminal stage” of illness in Japan’s process guidelines causes problems because it creates a reliance on the discretional judgement of the healthcare professionals assessing the patient’s condition, and because of the inconsistency in application which is likely to result. It is interesting to note that while the definition of “imminent death” in Singapore is similarly left to medical discretion,Footnote 16 there is a rigorous process of certification involving three medical practitioners, two of whom are specialists, and a separate panel of three other specialists if the initial three do not agree. While this complex process is likely to result in problems of its own,Footnote 17 it may safeguard against some of the concerns relating to inconsistency of application.

The possibility of variation in physician interpretation due to the flexibility in AD regulation is also problematised more widely. Kaur et al. argue in the Malaysian context that the wording of the Malaysian Medical Council guidance provides physicians with the flexibility to disregard explicit patient wishes. In Macao, even though there is no specific regulation on ADs, the fact that physicians are only required to take patient wishes into consideration means that physicians are given wide discretion to disregard such wishes and proceed as they see fit. In cases where life-sustaining treatment is to be rejected, Raposo and Iong hypothesise that physicians in Macao are likely to disregard such wishes due to the fear of potential litigation by family members.

17.3.5 Variations in Specificity/Complexity of Formalities

A further important but distinctive variation was observed relating to the specificity and/or complexity of the formalities placed upon the person making an AD. Here, there were jurisdictions on both ends of the spectrum of specificity and/or complexity, and the problems documented demonstrate how difficult it can be to obtain an appropriate and pragmatic balance between the two.

On one end of the spectrum, we have, for example, the jurisdictions of Singapore, India and Israel, which have very specific procedures and/or requirements in relation to making an AD, such as those relating to prescribed forms, safeguards or registration. The Singapore regime contains a number of formalities and safeguards, including a prescribed form, witnessing requirements, registration requirements, and a number of safeguards aimed at protecting the integrity and voluntariness of executing the AD. India’s judicial guidelines require an AD to be signed by two independent witnesses and to be countersigned by a JMFC, following which the JMFC must preserve the AD in both paper and digital form, send a copy to the Municipal Corporate or local village council for appointment of a custodian of the AD, inform the executor’s family of the AD, maintain a copy of the AD in their office and forward another copy of it to the relevant district court. This involvement of the JMFC renders the process particularly difficult, because, as Dhru and Ghooi argue, there are only a very small number of JMFCs in any given city, and these JMFCs will already be dealing with a significant backlog of cases. In Israel, it has been argued that the lengthy and complex prescribed form for ADs may be too difficult for laypersons to understand and use, in particular due to the inclusion of legal and medical jargon. Interestingly and also somewhat confusingly, it appears that this form also contains built-in options that allow individuals to include conditions (amounting to “unbearable suffering”) that do not comply with definitions under the law, and it is unclear what effect the specification of these conditions might have.

On the other hand, however, a regime which is flexible in terms of the formalities it requires presents difficulties of its own. A good example of this is in Thailand. Tengaumnuay claims that the regulatory procedures of this regime are so flexible that a number of specific practical problems arise, despite this approach being more supportive of patient autonomy in general terms. As there is no specific format for the AD, no requirement for medical or other witnesses and no registration system for ADs specified in the law, Tengaumnuay argues that physicians are less likely to be aware of the existence of an AD without a registry, and they are likely to be uncertain about the validity of the AD, especially whether the AD was made when the individual had capacity.

17.4 Broader Considerations: The Distinctive Role of Religion and the Family in the Asian Context

Two distinctive and common features impacting on ADs were shared by many, if not most, of the Asian jurisdictions examined in this volume: the role of religion and the role of the family. As these were thought to have a significant but complex impact on the law and practice of ADs in local contexts, we offer some detailed reflections on these two broader trends. With regard to religion, the jurisdictions in this volume were defined by a range of religious traditions, which included those from Christianity, Islam, Judaism, Buddhism, Hinduism and Jainism. One feature of several of these religions is the principle of the “sanctity of life”,Footnote 18 which is particularly noteworthy in its influence in this context. However, the impact of this principle, as we shall demonstrate, is not straightforward, and religion more generally has influenced the acceptance and regulation of ADs in these jurisdictions in different ways.

17.4.1 The Role of Religion: Sanctity of Life

The sanctity of life operates as a key principle governing jurisdictions with Christian, Jewish and Islamic influence. While in some cases, like Israel and the Philippines, this principle is given utmost importance, it does not appear to have precluded the development of ADs. In Israel, for example, ADs were formally included as part of the Dying Patient Law 2005, despite this legislation being primarily grounded in ultra-orthodox Jewish values, which include a “commitment to preserving and saving human life, regardless of the individual’s desires”.Footnote 19 The influence of such values does, however, appear to have resulted in a more restrictive scope for ADs. For example, Bentwich contends that the term “dying patient” has been defined very narrowly in the legislation, to the exclusion of patients with chronic illnesses such as dementia or amyotrophic lateral sclerosis (ALS) that do not have a clear prognosis, which appears to conform to the more orthodox view that the sanctity of life is a fundamental principle, and a key foundation of the Dying Patient Law. Similarly, Bentwich explains that the withdrawing and withholding of treatment and care is permitted in the Dying Patient Law in cases where the patients have reached the “final stage”, or where their bodies are undergoing acute systems failure, which corresponds to a Halakhic religious exception where refraining from treatments is allowed where “three or more systems in the human body have failed, and it is clear from a medical perspective that death is inevitable sooner or later”.Footnote 20 Similarly, in the Philippines, de Castro et al. argue that there will likely need to be a finding of medical futility before an AD could apply.Footnote 21

Despite the heavy influence of the sanctity of life in these jurisdictions, however, there appears to be a tension between such overarching religious principles and the needs of practice on the ground, which has resulted, in some cases, in a bottom-up approach to ADs, as discussed earlier in this chapter. This is true of both the Philippines and, to a lesser extent, Israel. In Israel, Bentwich argues that there remains a tension between the Dying Patient Law, a law grounded in strict religious values, and the practice of the law on the ground, which is shaped extensively by medical professionals and the more secular perspectives of patients and their families. We might view this in terms of there being a recognised, pragmatic need for more “practical” solutions to work around the rigidity of the law. The 2014 case of Ploni [John Doe] v The Attorney General, where a patient with ALS requested to be disconnected from a ventilator, for example, appears to be a case where a practical “workaround” was devised by the Attorney General of Israel to try and resolve this tension.

In other jurisdictions where the sanctity of life is not necessarily of utmost importance but still a fundamental principle, such as the Islamic countries of Iran, Pakistan and Saudi Arabia, this principle (i) is subject to varying interpretations with different outcomes and (ii) is not the only major religious principle that is relevant in this area. In relation to (i), Syed et al.’s analysis demonstrates that the rule requiring the preservation of life can be interpreted using a three paradigm conception of death that views the last stage of life as part of a “dying” (al-ihtiḍār) phase, where the obligation to preserve life no longer exists because the individual “is now approaching (destined) death and therefore is not the intended subject of the obligation to preserve life”.Footnote 22 Beg et al. similarly argue in the Pakistani context that while life is considered sacred in Islam, there are interpretations of this principle that are not inconsistent with ADs, such as the idea that the time of death is determined by God and thus preordained, which means that death will occur as decided by God irrespective of the patient’s treatment decision. In relation to (ii), Syed et al. and Hussein and Adlan both describe a number of key Islamic principles in addition to the sanctity of life that are relevant in the discussion of ADs and end-of-life decision-making, such as the Rule of No Harm and the Principle of Hardship. Finally, while neither of these three countries have a clear legislative framework on ADs,Footnote 23 it should be noted that the analyses of the relevant religious principles in these countries would suggest that if ADs were permissible, they would likely only be permitted where the treatment in question was an artificial and futile prolonging of death.

Thus, while the sanctity of life is recognisably a fundamental religious principle shared among many of these Asian jurisdictions, the principle does not appear to have a uniform effect on how ADs are regulated or implemented in these countries. It should also be noted that, in jurisdictions where religious traditions do not necessarily emphasise the need to preserve life, the influence of these traditions on ADs has also not been straightforward. On the one hand, Tengaumnuay has argued that the Buddhist contemplation and acceptance of death as part of the impermanence of life has led to the acceptance of the view in Thailand that individuals should be able to plan ahead to achieve a “good death”. On the other, Dhru and Ghooi argue that while death is seen in Indian religious tradition and philosophy as “a union with the Divine, the greater Self”,Footnote 24 the desire to avoid pain and suffering is not celebrated, and the use of an AD to reject life-sustaining treatment in order to alleviate pain and suffering would thus likely not be in line with Hindu and Buddhist religious beliefs.

17.4.2 The Role of Religion: Variation in Interpretation

Beyond the principle of the sanctity of life, the authors reveal how the influence of religion on ADs more generally is not necessarily straightforward in their jurisdictions. In our view, one reason for this might lie in variations in the interpretation of relevant religious principles in the process of end-of-life decision-making itself. Bentwich demonstrates, for example, using Justice Elon’s judgment in the 1993 Yael Shefer case, that Halakhic law is capable of supporting different approaches to the withdrawal of life-sustaining treatment, and in particular the withdrawal of ventilators. Contrary to the ultra-orthodox view as represented in the Dying Patient Law, which does not permit the withdrawal of ventilators until the final stage, Justice Elon offered in that case an interpretation of Halakhic law that would support ventilator withdrawal if the patient was suffering.

Similarly, our sense is that there appears to be some room for interpretation in the application of key Islamic religious principles. As Syed et al. demonstrate by examining a number of rules that may either negate or favour the respect of an AD to limit life-sustaining treatments, such rules can often be subject to varying interpretations, and in some cases even used to support opposing contentions.Footnote 25 Beg et al. argue that the study of relevant Islamic teachings has resulted in varying attitudes towards ADs amongst the interpreters of these teachings, which they hypothesise may be a reason why AD legislation has not been discussed. As they argue, “[l]egislators may well feel that they are in no position to make decisions on such a controversial subject rooted in religious ambiguity”.Footnote 26

Related to the issue of interpretation is an interesting point concerning the role and significance of religious legal guidance, specifically fatwa, in Islamic countries. While the legal force of a fatwa may vary between countries,Footnote 27 there is little question that fatwa are given primary importance in Islamic countries, in particular where there is no legislation on the topic. There appear to be, however, various institutional concerns with the obtaining of “reliable and accurate” fatwa on healthcare issues such as end-of-life decision-making. Syed et al. argue, for example, that the unreliability of fatwa may be due to several reasons, including the lack of stakeholder consultation or multi-disciplinary input that goes into the making of a fatwa and the fact that the derivative reasoning for medical fatwa are rarely published and therefore difficult to analyse. Hussein and Adlan raise another concern in the Saudi Arabian context, which is the fact that the Islamic scholars who issue fatwa are not generally medical professionals, and as a result, a healthcare expert will be relied upon to explain the relevant issues to them. Because this healthcare expert will usually be a physician, Hussein and Adlan argue that there is a risk that the physician may advocate for their own preferences in the matter, which may lead to an “indirect form of medical paternalism”, one with religious cover.Footnote 28

Our examination of the role of the family in these jurisdictions, to which we now turn, gives rise to similar observations. It should first be noted that the literature on the role of the family in medical decision-making in Asia tends to focus on the fact that, as alluded to in the Introduction, individual autonomy is not accorded the same primacy in Asian jurisdictions,Footnote 29 and that communitarian, familial models of decision-making are more common,Footnote 30 which seem to be contrary to the idea of the individually based AD. The chapters in this volume, however, have demonstrated that the significance of the family, as well as its relationship with ADs, challenges this essentialist, one-dimensional picture in ways that are not often expressed. Although the role of the family is recognised as being highly influential in almost all of the chapters, the nature of, and justification for, this influence is much more nuanced and complex than is typically recognised. What we can see from the patterns of influence in these jurisdictions is that the family can play different roles in medical decision-making for different reasons, which in turn has varying effects on whether or not ADs are likely to be accepted and adopted.

17.4.3 Family-focused Decision-Making: The Authority to Decide

The most commonly described role, and the one referred to most in the literature, is a family-based model of decision-making in which the family is seen as the authority in, and unit of, decision-making. The family model of decision-making takes two main forms in this context: (i) an approach in which the patient does not possess sole decision-making authority, with the family making shared decisions with the patient as a communal unitFootnote 31 and (ii) decision-making directly by the family in ways that can exclude the patient entirely.Footnote 32 For example, the application of a family-based model means that, in some jurisdictions, physicians feel comfortable notifying only the family members (and not the patient) of the patient’s condition and prognosis.Footnote 33 A more explicit example of direct family decision-making is found in Macao, where a family member, and not the patient, is responsible for signing the consent form required by the Hospice & Palliative Care Centre at the Kiang Wu hospital, which is the closest formally recognised mechanism to an AD in Macao. And, while not in relation to the making of the AD itself, Malaysian professional guidance permits a patient’s wishes to be overridden by a physician in consultation with family.

17.4.4 Family-focused Decision-Making: The Supportive Role

A very different family-focused approach to decision-making is one where family members are accorded specific supportive roles. In particular, one supportive role is where family members are relied upon to clarify the wishes and intentions of the individual in question. In the Philippines, for example, the details of a patient’s AD are verified by checking with their family members, and in South Korea, the family both assist with the verification process of an ASLST and bear witness to the patient’s preferences regarding life-sustaining treatment if no ASLST exists. In Macao, the physician has conversations with the family and takes these into account when determining whether the content of the AD reflects the patient’s current and authentic desires, and it is the family’s reaction that Raposo and Iong argue is most formative in shaping the doctor’s views on this. In Thailand, individuals can specify an individual, usually a close family member, who can clarify their intentions as laid out in the AD if there is any ambiguity or confusion. While the family plays an important role in all of these jurisdictions in assisting with the interpretation of the individual’s preferences at the end of life, the potential for abuse here must not be overlooked. Apart from the Thai context, where the individual selects their representative, there is potential, in particular where the individual does not have an amicable relationship with their family, for the individual’s wishes to be misrepresented or entirely overridden in these verification or clarificatory exercises.

17.4.5 Family-focused Decision-Making: The Carer Role

A third distinctive approach to family-focused decision-making is one in which family members adopt the role of a carer of the patient, with various implications for decision-making authority. For example, in some jurisdictions, this approach offers a justification for according an overarching decision-making responsibility to family members on the basis of a paternalistic rationale, or because doing so equates with the intrinsic expression of care within the relationship. De Castro et al. argue that, in the Philippines, it can be considered irresponsible for a family taking care of a vulnerable patient to let them make acute treatment decisions, and in jurisdictions like Pakistan and South Korea, families demonstrate their love and care by hiding the truth about poor prognoses from the patient. The family’s role as carer can also lead to a corresponding reliance on the family by the individual. In the Japanese context, for example, Ozeki-Hayashi et al. argue that the psychological factor of amae and the character trait of omakase in Japan can result in the individual preferring to leave the responsibility of making difficult decisions to their loved ones and/or physicians. Finally, related to this carer role is the importance of filial piety in jurisdictions influenced by Confucianism. This can mean that the children of the individual are less willing to initiate difficult end-of-life conversations with their parents,Footnote 34 or that they feel the need to do everything to save their parents.Footnote 35

17.4.6 Accommodating ADs in Family-Centric Societies: Some Potential Solutions

Given the significance of the place that the family takes with regard to ADs in these jurisdictions, how have different jurisdictions come up with solutions to accommodate the AD, in particular in light of these different roles that the family plays?

One solution that has been adopted is to incorporate family members officially into the decision-making process. This can be in terms of receipt of information,Footnote 36 or in the decision-making process itself, or the wider advance care planning (ACP) process.Footnote 37 A second solution gives family members an official supportive or clarificatory role. The Thai regime provides a good example of this, with the option to designate an individual, often a member of the family, to clarify any ambiguities in the AD, as mentioned previously. A third solution has been to go in the opposite direction, drafting legislation that constrains the heavy influence of the family. Article 4 of Taiwan’s PRAA, for example, specifically provides that the patient’s family are not to prevent the physician from acting on their treatment decisions, a measure which Tsai argues provides the patient with “a rights-based form of resistance against the common phenomenon of family-based decision-making in Chinese culture”.Footnote 38 In Hong Kong, the government’s legislative proposal has stated explicitly that patient autonomy must prevail in case of conflict with family, and in India, a concern about potential abuse by family members has resulted in a judicial regime that relegates family to a secondary level of importance.

17.4.7 Reflecting on the Distinctive Role of Family

In light of the preceding discussion, what are the insights that can be gained in relation to the significance of the family in the AD context? Two related points can be made. First, as mentioned at the beginning of this section, the influence of the family, much like religion, is not unidimensional, and there are various ways in which the family can have a significant role to play in every aspect of the AD or its implementation. The second point is that, among these different roles, it is important to recognise an often neglected, supportive role that families play. This is in addition to, but separate from, the authoritative, decision-making role that is often taken as the norm in the literature on medical decision-making in the Asian context.

By the term “supportive role” as adopted as a family-focused approach to decision-making in this context, we envisage something much more complex than the general forms of emotional and other social and relational supports typically associated with the family in the healthcare context. Instead, this support, a kind of “support plus” as it were, is broad in scope. It might involve professionals taking steps to actively involve the family in order to bring about the best outcomes for the individual, or it could involve an individual-led approach where the person is encouraged to involve their family members in various kinds of ways. Such approaches typically involve a co-opting of family members into the decision-making process in a mediating role, as facilitators, to allow both the family and the individual to reflect on the kind of support the individual needs, and then also to identify what is best for the individual. Co-opting family members in this way takes different forms across different jurisdictions. For example, like with the Taiwanese regime, the family could be brought into the decision to make the AD as a part of the wider ACP process. As argued in the Hong Kong chapter, the AD itself might also be used as a crux upon which to engender family support for personal preferences. In this way, the making of the AD could be used to initiate family conversations about end-of-life wishes, in particular in jurisdictions where the topic of death and dying is considered difficult to broach, providing an important basis upon which meaningful and well-supported decisions about an individual’s end-of-life care can be achieved.

In this way, the construct of the “family”, as it features across these Asian jurisdictions in relation to ADs, does not need to be placed in direct contradistinction with the “individual”, as is typical in the Asian bioethics literature. The conception of the family as “support plus” renders a focus on the individual (rather than the family) as the decision-maker entirely compatible with a cultural emphasis on the family. In particular, this supportive account of the family’s role does not threaten the individual’s best interests as the goal of the decision-making process, though the identification and realisation of these interests will of course be heavily dependent on the family’s input and participation.

17.5 Making Sense of ADs in Asia: “Generative Accommodation” in Local Context

In the foregoing sections, we described some of the patterns, trends and important variations in the regulation of ADs across the jurisdictions in this volume, followed by an in-depth examination of the distinctive nature of the influence of religion and family. In light of the international backdrop to changing law and practice in relation to ADs that we presented to introduce the book, how should we make sense of the law and practice of ADs in the Asian context?

As the principled foundations and regulatory strategies of ADs have become increasingly codified and implemented internationally in recent years, an emerging pattern of response can be observed across the majority of the jurisdictions included in this volume. Whether explicit or implicit, these responses have functioned to enable ADs to gain a foothold within Asia – in its case law, in its legislative frameworks, in its professional guidelines, or in the ground-level practice of healthcare.

In our view, we might helpfully understand this pattern as one of “generative accommodation”. We take these terms in turn, beginning with the idea of “accommodation”. The concept here is that, in light of an emerging international consensus in healthcare practice and regulation regarding the value of an AD and its underlying ethical principle of respect for patient autonomy, most of the jurisdictions in this volume have responded in a way that suggests these key concepts and principles are similarly being viewed as important and worthy of incorporation into their own local contexts, whether it be in the form of legislative frameworks, case law, guidelines or practice requirements. A reasonable query at this stage might be why and how we have determined that this is a form of accommodation, rather than something that is more indigenous to the jurisdiction in question. Our view that this adoption can generally be seen as a form of accommodation results from three key reasons.Footnote 39 The first is that, while the increase in emphasis on patient autonomy internationally began around the 1950s, the various forms of regulation of ADs and end-of-life care in the jurisdictions of this volume have been put in place or decided upon relatively recently, from the 1990s at the earliest. The second reason is what is, in most cases, an apparent lack of congruence or alignment of the concept of ADs and patient autonomy with local value commitments or beliefs, such as a heavy emphasis on familial involvement in medical decision-making or religious beliefs that prioritise the preservation of life over other values such as autonomy or individual rights. The final reason is that, apart from a general cultural acceptance in some jurisdictions of death and the importance of a good death, we have not observed strong evidence of any indigenous evolution of the concept of an AD, for example, on the basis of bioethical principles that have also developed importance locally. Indeed, what we do see across the chapters is a broad pattern of internationally agreed-upon ethical principles that are visible across the jurisdictions.

Having said that, however, the qualifier “generative” is equally, if not more, crucial to our understanding of ADs in Asia. We use the term “generative” to refer to the distinctive, locally specific approaches that have arisen, been set in motion, or been proactively produced in ways that are unique to these jurisdictions as they marshal their own commitments and expectations alongside this emerging international consensus. That is, in dealing with the sorts of ways in which the concept of ADs and patient autonomy may be incongruent or even in conflict with local values and/or beliefs, different types of solutions have been created to allow such concepts to exist and develop in these local contexts.

We view the extent to which an approach is generative as falling along a spectrum, with some more generative than others. Moreover, different modes of a generative approach are identifiable in ways that cut across this spectrum in quite complex ways. Taiwan presents a good example of a jurisdiction with a more generative approach, with its PRAA containing provisions that marshal the local cultural emphasis on the role of the family. Interestingly, as mentioned previously, the PRAA both recognises and affirms this role (through the requirement of the presence of a family member in the ACP process) and places constraints on it (through the provision that forbids family members from preventing a physician from acting on the patient’s treatment decisions). This, we argue, suggests that a significant amount of careful consideration was involved in the attempt to adopt these principles and concepts into the Taiwanese context in ways that retain their essence, but also align with local cultural values.

Also on the side of more generative approaches, Israel presents an interesting example, where we can observe two different modes of generative accommodation within the same country. The Dying Patient Law, espousing the ultra-orthodox Jewish perspective, and the judicial approach to end-of-life decision-making, exemplified by the more liberal religious interpretations of Justice Elon, demonstrate two ways in which generative accommodation has taken place. As Bentwich points out, however, the ultra-orthodox Jewish view is not shared by the majority of Israelis, and this view fails to align with the more secular perspectives of healthcare professionals and patients. This suggests that, while both approaches are generative to some degree, the judicial approach can be said to be more so, in that these court decisions are generating comparatively liberal interpretations of Jewish principles that accommodate the idea of ADs (in the form of prior wishes) and patient autonomy, in ways that allow them to be accepted by the majority of Israelis (especially Israeli Jewish citizens), and in particular the relevant stakeholders in the end-of-life process.

The Philippines provides another example of a more generative approach, but one that manifests itself in the practical spaces of decision-making itself, in the form of grassroots change driven from within networks of healthcare professionals working in specific hospitals. This approach does not focus on aligning the idea of ADs and respect for patient autonomy with local religious and cultural values, such as the Christian commitment to upholding the value of life and cultural attitudes towards disease causation and family. Instead, healthcare professionals and the medical community have brought such concepts directly into the local practice context by way of institutional guidelines, in a way that can meet practical needs and develop good professional practice.

On the end of less generative approaches, Thailand’s National Health Act recognises the principle of respect for individual autonomy and preserves the right to make an AD solely for the individual, but the over-flexibility in the rules for making an AD suggest that these concepts have not been introduced into the local context in a way that considers whether ADs can actually be successfully implemented (and respect for patient autonomy thereby upheld). Additionally, apart from the ability to designate an individual, often a family member, to clarify one’s wishes as contained in an AD, the Thai regime does little to reconcile their very individually focused AD with the cultural emphasis on family, leading to what is often non-compliance with the patient’s AD where family members disagree. India’s complex and administratively burdensome judicial regime similarly does not adopt ADs in a way that considers the likelihood of success of implementation, although the courts do appear to have taken the role of the family into consideration, and accordingly relegated family members to a secondary role in the process due to concerns of potential abuse.

Turkey further presents an example of a less generative accommodation process, one that can be said to involve only the painting of a veneer of common purpose and shared agreement, without substantially more. Although Turkey has ratified the Oviedo Convention, Article 9 of which requires a patient’s previously expressed wishes relating to medical interventions be taken into account, there remains no legislation or formal legal regulation of ADs in Turkey. This is despite the fact that the Oviedo Convention requires signatories to make their domestic law compatible with it. Suggestions have been made, by Ulman and others, as to how domestic law might be interpreted and/or amended to provide a basis for ADs, but, thus far, the Turkish approach appears to be only a superficial endorsement of the international consensus, without any further attempt to bring this in line with its own local context. It should be noted, however, that some generative accommodation appears to be beginning to occur in ground-level practice: in recent years, professional societies have issued guidelines affirming the importance of patient autonomy, the right to refuse futile treatment and ADs, and have called for public engagement and multilateral dialogue on these issues, so as to remove cultural factors that may hinder acceptance of these ideas.Footnote 40 This suggests that, while the state has commenced the process by ratifying the Oviedo Convention, it may be networks of healthcare professionals, like in the Philippines, who are the actual drivers of change – engaging with the values and characteristics of local culture and negotiating the acceptance of autonomy and ADs within this context. In a slightly different way, other modes of generative accommodation can be formulated “on the ground” through grassroots non-governmental organisations (NGO) which are promoting change. This looks to be the case in China. Though the power possessed by NGOs is inevitably limited, and thus the degree of generative accommodation that can be achieved in this way may correspondingly be limited, Chen speculates that the advocacy work of the Beijing Living Will Promotion Association has directly or indirectly led to the Chinese Government’s introduction of a pilot palliative care project in 2019.

In this way, different modes of generative accommodation encapsulate attempts to shape the “meeting ground” between international consensus and localised traditions and expectations – a much more nuanced picture than pitching Eastern healthcare practices against Western healthcare practices and identifying essential differences between them. Ways to accommodate, whether occurring explicitly or implicitly, involve picking up some elements of both components: a commitment to a certain kind of way of decision-making that is increasingly recognised and endorsed internationally but in ways that embrace local manifestations.

Different ways of generatively accommodating ADs in different jurisdictions can, we think, go a long way to help to explain the complex, multiple and different laws, guidelines and practices that are documented across this volume. Just as importantly, the Asian AD journey is likely in fact to be one of a series of unique journeys, regardless of the similarities documented. These journeys are likely to continue to evolve and take shape in ways both that reflect localised commitments, norms and expectations, and that track broader sociopolitical and sociocultural trends and phenomena within and between countries – all subject to ongoing negotiation.

We conclude with some brief reflections in relation to the implications of generative accommodation, and what might be required in the longer term of such an approach. While there may be various forms of generative accommodation, and while some forms may be more generative than others, the key goal underlying all generative accommodations should be to ensure that the adopted principles and concepts relating to ADs are worked through properly, both at the level of legislation and regulation and in ground-level practice, so that they are harmonised and coherent in the local context. It is not enough, for example, to introduce legislation or guidelines promoting patient autonomy and ADs without considering the extent to which they fit in with existing laws and principles, or to design procedures that are too complex or burdensome to realistically carry out. It is also not enough to introduce legislation or guidelines without taking steps to ensure proper operation in practice. As many authors of this volume have argued, AD legislation needs to be implemented consistently, good practice guidelines need to be developed, training needs to be provided to healthcare professionals working in the field, and awareness among both healthcare professionals and the public must be promoted, among others. In short, a failure to follow through in concrete ways with attempts at generative accommodation would be at odds with, and counterproductive to, its goals.

Footnotes

12 Advance Directives in China’s Mainland: An Emerging Framework?

1 World Health Organization, China Country Assessment Report on Ageing and Health (Geneva: WHO, 2015), apps.who.int/iris/bitstream/handle/10665/194271/9789241509312_eng.pdf?sequence=1, p. 15. “China’s mainland” or “Mainland China” is referred to as “China” in the chapter for better clarity.

2 D. Cheung, M. Dunn and R. Huxtable, Introduction, in this volume.

4 Civil Code of the People’s Republic of China (adopted at the Third Session of the Thirteenth National People’s Congress on 28 May 2020; entered into force on 1 January 2021).

5 Chinese Medical Doctor Association, Chinese Medical Doctors’ Code of Ethics (25 June 2014).

6 The General Provisions of Civil Law of the People’s Republic of China (adopted at the Fifth Session of the Twelfth National People’s Congress 15 March 2017; entered into force on 1 October 2017; repealed on 1 January 2021).

7 United Nations Convention on the Rights of Persons with Disabilities (adopted on 13 December 2006; entered into force on 3 May 2008) 2515 UNTS 3.

8 CRPD Committee, “General Comment No 1: Article 12: Equal Recognition before the Law” (11 April 2014) UN Doc CRPD/C/GC/1.

9 B. Chen, “Controversy and consensus: does the UN Convention on the Rights of Persons with Disabilities prohibit mental health detention and involuntary treatment?” (2020) 1 Foundation for Law and International Affairs Review 39.

10 Civil Code, art. 34.

11 Footnote Ibid., art. 1189.

12 Footnote Ibid., art. 21.

14 Civil Code, art. 28.

16 Civil Code, art. 30.

17 Footnote Ibid., art. 33.

18 Footnote Ibid., art. 31.

19 Footnote Ibid., art. 32.

20 Footnote Ibid., art. 35.

21 Footnote Ibid., art. 32.

23 The Civil Procedure Law of the People’s Republic of China (adopted at the Fourth Session of the Seventh National People’s Congress on 9 April 1991; amended on 8 October 2007, 31 August 2012, and 27 June 2017), chapter 14, section 4.

24 Shanghai Notary, “Enforcing my voluntary guardianship when I become confused” (China, 27 August 2018) www.shnotary.org.cn/info/db53f9b27389432fa77177e8242535c7.

25 Civil Code, art. 35.

26 The Leadership Unit for Implementing the Civil Code of the Supreme People’s Court, Understanding and Applying the General Provisions of the Civil Code of People’s Republic of China (Beijing: People’s Court Press, 2020), p. 213.

27 Civil Code, art. 35.

28 Chinese Medical Doctor Association, “Promote noble medical ethics and build a harmonious doctor-patient relationship: the Chinese Medical Doctors’ Code of Ethics officially released” (China, 25 June 2014) www.cmda.net/bmdt8/9666.jhtml [in Chinese].

29 CoE, art. 1.

30 Footnote Ibid., art. 9.

31 Footnote Ibid., art. 10.

32 Footnote Ibid., art. 12.

33 Footnote Ibid., art. 22.

34 Footnote Ibid., art. 23.

35 Footnote Ibid., art. 20.

36 Footnote Ibid. The chapter notes that substitute decision-making arrangements are not generally regarded as a process authorised to respect prior wishes alongside living wills.

37 CoE, art. 25.

38 In January 2021, the author conducted keyword searches in Chinese that referred to voluntary guardianship (意定监护), article 33 of the General Provisions of Civil Law (民法总则第三十三条) and article 32 of the Civil Code (民法典第三十二条). There are dozens of cases that mention these keywords but none of them are about medical decision-making. In one case, however, the court recognised the legality of a power-of-attorney form provided by the hospital and signed by the patient in which the patient appointed one of her children to decide on whether to withdraw or refuse life-sustaining treatment. The court ruled that this form served a similar function of voluntary guardianship but on different legal basis. At the very least, the case suggests the power-of-attorney practice exists and its legality could be accepted in court, though on an individual basis. See the case of Beijing Second Intermediate People’s Court No. 7645 Civil Case of 2020–Final Judgment (Case reference code is translated by author from 北京市第二中级人民法院(2020)京02民终7645号民事判决书). Further research is required to explore the extent to which this practice is widely adopted nationwide.

39 CoE, art. 20.

40 The Law on Practicing Doctors of the People’s Republic of China (adopted by the third session of the Standing Committee of the National People’s Congress on 26 June 1998; entered into force on 1 May 1998), art. 24.

41 LPD, art. 37.

42 The State Council of China, Administrative Regulations on Medical Institution (adopted on 26 February 1994; amended on 6 February 2016), art. 31, www.nhc.gov.cn/fzs/s3576/201808/f674e82257a2471a9a68f5c369403042.shtml.

43 The State Council of China, The Guiding Opinions on the Establishment of an Emergency Relief System for Diseases (1 March 2013) section 4(2), www.gov.cn/zwgk/2013-03/01/content_2342656.htm.

44 Y. Sun, Research on Advance Health Care Directives (Beijing: Legal Publishing House in China, 2019) pp. 89.

45 S. Zhang, “Predicament and solution in the implementation of intended guardianship system” (2020) 2 Oriental Law 121.

46 C. Ding, “Family members’ informed consent to medical treatment for competent patients in China” (2010) 8(1) China: An International Journal 139; V.L. Raposo, “Lost in ‘culturation’: medical informed consent in China (from a Western perspective)” (2019) 22(1) Medicine, Health Care and Philosophy 17.

47 B.Y. Huang et al., “The do-not-resuscitate order for terminal cancer patients in mainland China: A retrospective study” (2018) 97(18) Medicine e0588.

48 Y. An and M. Zou, “An assessment of advance directives in China: the ‘coming of age’ for legal regulation?” (2018) 20(1) Marquette Benefits & Social Welfare Law Review; Y. Zhou, “Care issues at the end-of-life in China” (2016) 45(2) Development and Society 231; M.C. Stuifbergen and J.J.M. Van Delden, “Filial obligations to elderly parents: a duty to care” (2011) 14(1) Medicine, Health Care and Philosophy 63; Y. Yang, “A family-oriented Confucian approach to advance directives in end-of-life decision making for incompetent elderly patients”, in R. Fan (ed.), Family-Oriented Informed Consent (Springer, 2015), pp. 257–70.

49 Z. Yang and H. Zhang, “Acceptance of advance directives and influencing factors among elderly patients with chronic diseases in the community” (2020) 23(31) Chinese General Practice 3949.

50 The authors suggest that patients who perceive death as an escape may be less willing to discuss ADs with their family because this may lead to conflicts in the process of decision-making, namely because the Chinese concept of filial piety is likely to cause family members to want to keep them alive at all costs. This does not appear to be a convincing explanation, however, given that this kind of conflict with family members is likely to be present regardless of the patient’s attitude towards death.

51 X. Wu et al., “Study on family members’ attitudes towards setting up advanced directives for stroke patients” (2020) 637 Medicine and Philosophy 18.

52 See, for example, X. Chen and R. Fan, “The family and harmonious medical decision-making: cherishing an appropriate Confucian moral balance” (2010) 35 Journal of Medicine and Philosophy 573; R. Fan and B. Li, “Truth-telling in medicine: the Confucian view” (2004) 29 Journal of Medicine and Philosophy 179; R. Fan, “Self-determination vs. family-determination: two incommensurable principles of autonomy” (1997) 11 Bioethics 309.

53 W. Ma and Q. Xue, “Factors associated with attitudes and behavioural intention concerning advance directives among physicians and nurses” (2020) 23(31) Chinese General Practice 3935.

55 National Health Commission of the People’s Republic of China, “The Notice of Second Pilot Projects of Palliative Care” (China: 2019) www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=efe3ed3d9dce4f519bc7bba7997b59d8 [in Chinese].

56 S. Zhang and G. Wu, “Exploring the legal application of voluntary guardianship to homosexual community” (2019) 2 Cross-strait Legal Science 70.

57 EqualRights.hku.hk, “Adult guardianship and autonomous decision-making” (Hong Kong: 2020), www.equalityrights.hku.hk/post/成人監護與自主決策-代表與被代表的那些事(上).

58 But the article was later deleted without explanation, see D. Wang, “I notarise voluntary guardianship for same-sex couples” (China: 2019), www.sohu.com/a/330829888_120146415 [in Chinese]. The deleted post could be found at Nanjing Public Notary Office, “Notarising voluntary guardianship (for LGBT community)” (China: 2019), mp.weixin.qq.com/s/nT9jmcf5jYe1PBlRSOsxsw?fbclid=IwAR2de0PFyxuWJ4vrihYZQxXqcCTgkXnWrRv8Jq7xMxvPR7sdZyXJRHHVKms.

13 Guideline-Based Approach to End-of-Life Care Decisions in Japan: Practice, Regulation and the Place of Advance Directives

1 Keiho [Penal Code], Act No 45 of 24 April 1907.

2 Minpo [Civil Code], Act No 89 of 27 April 1896.

3 In Victoria, Australia, the Public Advocate is an independent statutory officer who promotes and safeguards the rights and interests of people with disabilities and investigates allegations of abuse of vulnerable Victorians. See Office of the Public Advocate, “The Public Advocate”, www.publicadvocate.vic.gov.au/the-public-advocate. See also the Guardianship and Administration Act 1986 (Guardianship and Administration Act 2019) and Medical Treatment Planning and Decisions Act 2016.

4 Hanrei-Times No. 877, 148 [in Japanese]. The Tokai University Hospital case was the first case in which a doctor was convicted of homicide, and thus differs from previous cases in which family members were convicted of homicide.

5 Ministry of Health, Labour and Welfare, “The Decision-Making Process for Terminal Medical Treatment” (Process Guidelines) (May 2007). The title of the guidelines was changed to “The Decision-Making Process for Final Stage of Life” (Process Guidelines) (March 2015) and was changed again to “The Decision-Making Process for Final Stage of Life Treatment and Care” (Process Guidelines) (March 2018).

6 Our discussion is based on the idea that regulations and law are not limited to case law or administrative guidance with or without penalties. Rather, they include “soft laws”, such as guidance provided by medical colleges and professional medical societies. Soft laws can eventually be taken into consideration by the courts when it comes to judgments on the reasonableness of conduct or standard of care or justification (or excuse) in criminal law.

7 We understand that there are situations in which statutory protection would benefit patients in terms of respecting their wishes. Yet, given the developments in and limitations of living will (LW) and AD discussions in the United States and other countries over the past 40 years, the enactment of ADs may not be a panacea for improving end-of-life care. Even with such statutory protection, it is clear that many people do not have ADs. Moreover, because people cannot predict their future, greater weight is often placed on family agreement than on a patient’s AD. See, e.g., S.M. Wolf et al., “Forty Years of Work on End-of-Life Care – From Patients’ Rights to Systemic Reform” (2015) 372 New England Journal of Medicine 678.

8 Interestingly, not only medical professionals but also ordinary citizens are strongly opposed to the enactment of end-of-life legislation (discussed in Section 13.5). In 2012, a group of non-partisan Diet members proposed a draft Bill for Respecting the Patient’s Decision in End-of-Life Care Act (provisional name; hereafter, “draft AD Bill”) that would offer immunity to physicians if they withheld or withdrew life-sustaining treatment in accordance with a patient’s AD. As of 2020, however, the proposed draft AD Bill had yet to be submitted to the National Diet. See Footnote note 23. At present, it has no real prospect of being enacted, and, more importantly, there has been strong criticism of the efficacy of this type of enactment and the side effect of such a statute (namely, that physicians may try to strictly follow the literal meaning of the statute rather than considering its main purpose and spirit). Even in the United States, there is strong criticism of the effectiveness of this kind of legislation (e.g. Natural Death Act and ADs legislation) for improving the quality of end-of-life care. Wolf et al. (Footnote note 7) argued that the quality of end-of-life care has not improved in the 40 years since enactment of a patient’s right to refuse treatment (LWs) and AD legislation. Considering that the enactment of LW and AD legislation in other developed countries has not proved to be a panacea, it is at least debatable whether Japan needs to follow their path in legislating ADs (see Footnote note 7). Some researchers and advocacy groups for severely disabled patients are concerned that legislation on death with dignity would not ensure respect for the rights of severely disabled people, specifically their right to receive life-supporting treatment. See further E. Nakazawa et al., “Why Can’t Japanese People Decide? Withdrawal of Ventilatory Support in End-of-Life Scenarios and Their Indecisiveness” (2019) 11 Asian Bioethics Review 343, 344.

9 T. Irie [Former Judicial Research Officer of the Supreme Court of Japan], “Saikosai Tokino Hanrei: Keiji (Saikousai Heisei 21 12/7 Kettei) [Supreme Court Recent Case: Criminal]” (2012) 1446 Jurisuto 91, 93 [in Japanese].

10 This is relevant to our discussion of ADs because, like ADs, the process guidelines on end-of-life patient care are predicated on the central concept of patient autonomy.

11 Hanrei-Times No. 1185, p. 114; >Hanrei-Times No. 1237, p. 153; Hanrei-Times No. 1316, p. 147 [in Japanese].

12 K. Harada, “Shumatuki-iryo To Keiho [Terminal Stage and Criminal Law]” (15 April 2009) 1377 Jurisuto 86, 109 [in Japanese].

13 “The Suspicious Death: The Hospital in Toyama Prefecture ‘Seven Patients Euthanised’ 50-Year-Surgeon Switched off Artificial Ventilators from Patients” (25 March 2006) The Mainichi [in Japanese]; “The Hospital ‘the Physician Withdrew Treatments’ after Switching off Artificial Ventilators from Seven Patients; They Died ‘Ethically Problematic’” (26 March 2006) The Asahi Shimbun [in Japanese].

14 “Removing Artificial Ventilators in the Imizu Municipal Hospital: Two Physicians Not Prosecuted” (21 December 2009) The Yomiuri Shimbun [in Japanese].

16 The “2014 Guideline on End-of-Life Care in Acute Care and Intensive Care” (compiled collaboratively by the Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine and Japanese Circulation Society), the “2007 Guideline on End-of-Life Care” (Japan Medical Association) and the “2012 Guideline for Decision Making Process of Elderly Care: Focusing on the Use of Artificial Hydration and Nutrition” (Japan Geriatrics Society).

17 Although the conduct of healthcare professionals in breach of these guidelines is not directly punishable, whether or not they acted in accordance with them may matter if they are accused of having civil, criminal or administrative liability. In that sense, the process guidelines are loosely binding on healthcare professionals.

18 Process Guidelines, para. 1.1.

19 Whilst informed decision-making by the patient and family is a key aspect of the guidelines, the fact that consensus must be reached between the healthcare team and the patient suggests that patient wishes are perhaps not the most important consideration therein.

20 A law to promote comprehensive measures against cancer, the leading cause of death in Japan.

21 T. Morita and Y. Kizawa, “Palliative Care in Japan: A Review Focusing on Care Delivery System” (2013) 7 Current Opinion in Supportive and Palliative Care 207.

22 Ministry of Health, Labour and Welfare, “Press Release Regarding the Revised Guideline on Medical Decision-making Process at the Final Stage of Life: Commentaries on the Guidelines for the Decision-Making Process for End-of-Life Treatment and Care” (2018), www.mhlw.go.jp/file/04-Houdouhappyou-10802000-Iseikyoku-Shidouka/0000197702.pdf [in Japanese].

23 M. Tanaka et al., “Forgoing Life-sustaining Treatment – A Comparative Analysis of Regulations in Japan, Korea, Taiwan, and England” (2020) 21 BMC Medical Ethics.

24 Japanese Society of Neurology (eds.), Clinical Practice Guideline for Amyotrophic Lateral Sclerosis 2013 (Tokyo: Nanko-do, 2013), pp. 138–9 [in Japanese].

25 Social consensus is key here, as the correct formulation of a law that is fundamentally about ethical uncertainty about which people in Japan could reasonably disagree arguably requires a public consultation process as part of the development of overarching governance of the issue.

26 For example, the “2012 Guideline for Decision Making Process of Elderly Care: Focusing on the Use of Artificial Hydration and Nutrition” (Japan Geriatrics Society) has an appended list of lawyers and law professors, including four former and one current Supreme Court Justices and a former High Court Judge who was involved in the 2007 Kawasaki case decision, which supported the guideline, and the following statement: “It is practically unlikely to have any judicial intervention if medical teams withdraw AHN [artificial hydration and nutrition] and treatment based on the draft Guidelines. If there was any judicial intervention, it would be highly inappropriate”, www.jpn-geriat-soc.or.jp/proposal/pdf/jgs_ahn_gl_2012.pdf [in Japanese].

27 In Japan, there is no standard “AD form” that is provided by law or administrative guidelines. There is, however, a notarial system that can be used for such purposes, and there are also various AD documents prepared by healthcare systems, local governments, regional medical associations, the Japan Death with Dignity Association and other public institutions and private companies. Patients and their families can share these documents with healthcare professionals in the hope that they will inform treatment decisions. Although there is no law governing the handling of such written documents, they are usually included in patients’ medical record.

28 Y. Nakagawa et al., “Do Not Attempt Resuscitation Order in Japan” (2017) 4 Acute Medicine & Surgery 286.

29 The final report of the Ambulance Agency (Ambulance Service Planning Division of the Fire and Disaster Management Agency) working group on DNAR, of which Iwata was a member, was issued in 2018. The 2018 report includes the details of initiatives by a number of prefectural ambulance departments (e.g. Hiroshima City). According to the Hiroshima City Ambulance Service initiative, paramedics can transport patients with DNAR wishes without any aggressive treatment or leave the scene without any intervention if the patient’s doctor confirms that he or she is in fact at the end-of-life stage and wishes to receive no CPR. This is the service’s way of respecting patients’ wishes, as made clear by the patients’ own writing or a family statement. For further details, see N. Higuchi, “Kyukyugenba-to-DNA: Houteki-kenen [The Scene of Emergency and DNA: Legal Concern]’ (2021) 33 Pure-Hosupitaru Kea [Prehospital Care] 22 [in Japanese].

30 In 1975, Karen Ann Quinlan lost consciousness and stopped breathing after returning home from a party. She had no prospect of recovering consciousness. Her parents filed a lawsuit to stop the life-sustaining treatment, because Karen did not want to live on a ventilator. In March 1976, the New Jersey Supreme Court ruled 7–0 that the right to privacy guarantees the right to withdraw life-sustaining treatment, and in this case, the parents could make the decision for Karen. The Quinlan case shed light on the difficult question of what should and should not constitute life. The right-to-die movement is trying to help the courts better define the boundaries between life and death and fulfil their mission of preventing murder while respecting the desire to preserve human dignity. For further details, see I.M. Kennedy, “The Karen Quinlan Case: Problems and Proposals” (1976) 2(1) Journal of Medical Ethics 3.

31 These figures correspond to the results of a 2018 study by Tsuda et al., which found that only 1.9 per cent of patients had written ADs and that 32 per cent entrusted their decision-making to doctors or family members (see further S. Tsuda et al., “Impact of Patients’ Expressed Wishes on Their Surrogate Decision-Makers’ Preferred Decision-Making Roles in Japan” (2018) 21 Journal of Palliative Medicine 354).

32 K.N. Yadav et al., “Approximately One in Three US Adults Completes Any Type of Advance Directive for End-Of-Life Care” (2017) 36 Health Affairs 1244, 1247.

33 Ministry of Health, Labour and Welfare, Report of the Awareness Survey on End-of-Life Medical Treatment (2018), pp. 89–90, www.mhlw.go.jp/toukei/list/dl/saisyuiryo_a_h29.pdf [in Japanese].

34 M. Mori and T. Morita, The Evidence of Advance Care Planning (Tokyo: Igakushoin, 2020), p. 135 [in Japanese].

35 The term “living will” is used instead of AD in this section on empirical data about public attitudes where that term is employed in the study being discussed.

36 Y. Masuda et al., “Physicians’ Reports on the Impact of Living Wills at the End of Life in Japan” (2003) 29 Journal of Medical Ethics 248.

37 K. Nakazawa et al., “Palliative Care Physicians’ Practices and Attitudes regarding Advance Care Planning in Palliative Care Units in Japan: A Nationwide Survey” (2014) 31 American Journal of Hospice and Palliative Medicine 699.

38 The Japan Society for Dying with Dignity, “Goizoku Anketo [Bereaved family questionnaire 2019]”, https://songenshi-kyokai.or.jp/archives/2131, p. 9 [in Japanese].

39 J. Okochi, “End-of-Life Care at Nursing Homes” (2020) 2 Geriatrics 532 [in Japanese].

40 Y. Takezako et al., “Advance Directives in Japanese Nursing Homes” (2013) 45 Journal of Pain and Symptom Management 63, 65.

41 Footnote Ibid., p. 67.

42 E.g., Minna No Kaigo [Nursing for Everyone], “The Government to Consider Additional Funding for End-of-Life Care in Nursing Homes” (2021), www.minnanokaigo.com/news/kaigogaku/no975/ [in Japanese].

44 J. Kwak and W.E. Haley, “Current Research Findings on End-of-Life Decision Making among Racially or Ethnically Diverse Groups” (2005) 45 Gerontologist 634.

45 S. Tsuda et al., “Group-Based Educational Intervention for Advance Care Planning in Primary Care: A Quasi-experimental Study in Japan” (2019) 18 Journal of Asia Pacific Family Medicine.

46 See Nakazawa et al., Footnote note 8.

47 Y. Hirayama et al., “Japanese Citizens’ Attitude toward End-of-Life Care and Advance Directives: A Qualitative Study for Members of Medical Cooperatives” (2017) 18 Journal of General and Family Medicine 378, 381; Footnote note 45; and S. Bito et al., “Acculturation and End-of-Life Decision Making: Comparison of Japanese and Japanese-American Focus Groups” (2007) 21 Bioethics 251.

48 R. Voltz et al., “End-of-Life Decision Making and Advance Directives in Palliative Care: A Cross-Cultural Survey of Patients and Health-Care Professionals” (1998) 16 Journal of Pain and Symptom Management 153, 159; K. Hirai et al., “Good Death in Japanese Cancer Care: A Qualitative Study” (2006) 31 Journal of Pain and Symptom Management 140, 145; and Nakazawa et al., Footnote note 8, p. 381.

49 R. Ishiwata and A. Sakai, “The Physician–Patient Relationship and Medical Ethics in Japan” (1994) 3 Cambridge Quarterly of Healthcare Ethics 60.

50 C. Shimada et al., “Reconsidering Long-term Care in the End-of-Life Context in Japan” (2016) 16 (Suppl. 1) Geriatrics & Gerontology International 132, 136.

51 See Tsuda et al., Footnote note 31; and Hirai et al., Footnote note 48.

52 See Tsuda et al., Footnote note 31 and Hirai et al., Footnote note 48. This notion of the ideal dying process is also seen in other countries. See, for example, Wolf et al., Footnote note 7; A. Fagerlin and C.E. Schneider, “Enough: The Failure of the Living Will” (2004) 34(2) Hastings Center Report 30, etc. See also M. Sanjo et al., “Preferences regarding End-of-Life Cancer Care and Associations with Good-Death Concepts: A Population-based Survey in Japan” (2007) 18(9) Annals of Oncology 1539.

53 See Nakazawa et al., Footnote note 8.

14 Advance Directives in Macao: Not Legally Recognised, but…

1 Joint Declaration of the Government of the Portuguese Republic and the Government of the People’s Republic of China on the Question of Macau, Number 23/1988, 6 June 1988, Article 2(4), https://bo.io.gov.mo/bo/i/88/23/out01.asp#1.

2 For explanations of the legal and cultural particularities of Macao law, see V.L. Raposo, “Macao Report: Informed Consent in a Multilingual and Multicultural Region: A Bioethical Challenge” (2018) 27(3) Cambridge Quarterly of Healthcare Ethics 385.

3 Decree 58/95/M, 14 November 1995, which approved the Macao Criminal Code, https://bo.io.gov.mo/bo/i/95/46/codpenpt/codpen0001.asp#1.

5 Macao Health Bureau, “2nd Meeting of Ethics Committee for Life Sciences” (3 December 2019), www.gov.mo/pt/noticias/217173/.

6 For analyses of Articles 150/1 and 2 of the Criminal Code, see M.T. Iong, “Criminal Liability for Violation of Informed Consent in Macao” (2020) 22 UMagazine 62; M.O. Leal-Henriques, Anotação e Comentário ao Código Penal de Macau (Parte Especial). Vol. III (Macao: Centro de Formação Jurídica e Judiciária, 2014), pp. 262–6; V.L. Raposo, “Informed Consent in China and Macao” in T. Vansweevelt and N. Glover-Thomas (eds.), Informed Consent and Health – A Global Analysis (Cheltenham, UK: Edward Elgar Publishing, 2020), pp. 151–3; V.L. Raposo, “Quando o paciente diz não: sobre o artigo 150. do Código Penal de Macau (Intervenções e Tratamentos Médico-Cirúrgicos Arbitrários)” (2015) 36 Boletim da Faculdade de Direito da Universidade de Macau 59.

7 The expression “people mentioned in Article 144” refers to any “doctor or other legally authorized person”, and the expression “in view of the purposes referred to therein” refers to the “intention to prevent, diagnose, defuse or alleviate illness, suffering, injury or bodily fatigue, or mental disorder”, as clarified by Article 144 of the Criminal Code.

8 Raposo, “Informed Consent in China and Macao”, Footnote note 6, p. 152.

9 “There is presumed consent when the agent acts on the reasonable assumption that the holder of the legally protected interest would have effectively consented to the fact had he known the circumstances in which it is practiced”.

10 Moreover, not all medical acts are regulated by Article 150 of the CC; only those that meet the requirements of Article 144 of the CC. Cf. Raposo, “Quando o paciente diz não”, Footnote note 6, 64–6.

11 Cf. Raposo, “Quando o paciente diz não”, Footnote note 6, 70; though this legal mechanism is known as “presumed consent”, the concept is closer to the idea of “no presumed refusal”.

12 The same clarification in Raposo, “Quando o paciente diz não”, Footnote note 6, 68.

13 Nonetheless, some Macanese authors defend the implantation of legislation on ADs in the near future, including its binding nature in the Macanese jurisdiction. See, for instance, M.T. Iong, Directivas Antecipadas de Vontade: Um Regime Existente em Macau? (Brazil: Novas Edições Acadêmicas, 2017), pp. 13, 28, 71, 110–11; M.T. Iong, “Please Allow True Self-Decision under Macao Law” (2019) 38(2) Medicine and Law 183.

14 Portugal, as the original source of Macao’s doctrine and legal practices, has a different situation because Law 25/2012, 16 July 2012, imposes the binding power of ADs; thus, if doctors do not respect the content of ADs without proper justification, they may be criminally punished.

15 This same interpretation in light of existing law in Macao was advocated by Raposo, “Quando o paciente diz não”, Footnote note 6, pp. 71–2.

16 V.L. Raposo, Do Ato Médico ao Problema Jurídico (Breves Notas sobre o Acolhimento da Responsabilidade Médica Civil e Profissional na Jurisprudência Nacional) (Coimbra: Almedina, 2013), pp. 220–1.

17 See, for instance, Article 7/1 of Law 25/2012, which regulates ADs in Portugal, and that establishes a validity period of 5 years.

18 Interestingly, this is despite the fact that Macao generally adopts solutions from Portuguese legal doctrine, and Portugal has already legislated on ADs in 2012. See also J.P. Meneses, “Gentlemen, please think about this…”, Macau Business Media (24 February 2020), www.macaubusiness.com/gentlemen-please-think-about-this/.

19 Regarding the last example, see Iong, “Please Allow True Self-Decision”, Footnote note 13, p. 186. In this example, this author proposes the binding nature of prior will and the use of sychiatric ADs for the specific case of mentally ill patients in Macao (Iong, “Please Allow True Self-Decision”, Footnote note 13, pp. 186–90), but the reasoning can be transposed for other situations.

20 Raposo, “Informed Consent in China and Macao”, Footnote note 6, p. 151.

21 See Footnote note 2 and the references quoted in that study.

22 Footnote Ibid., pp. 391–2.

23 There are no specific guidelines in Macao on how to assess the patient’s presumed consent, so we used the existing guidelines in Portugal, see Entidade Reguladora da Saúde, Consentimento Informado-Relatório Final (May 2009), www.ers.pt/uploads/writer_file/document/73/Estudo-CI.pdf.

24 C.Y. Tse and J. Tao, “Strategic Ambiguities in the Process of Consent: Role of the Family in Decisions to Forgo Life-sustaining Treatment for Incompetent Elderly Patients” (2004) 29(2) Journal of Medicine and Philosophy 207.

25 The World Health Organization (WHO) defines palliative care as an approach that improves the quality of life of patients and family members who face life-threatening illness by preventing and relieving suffering by way of early identification and accurate assessment and treatment of pain and other problems, whether physical, psychosocial or spiritual. Cf. WHO, “Palliative Care” (5 August 2020), www.who.int/news-room/fact-sheets/detail/palliative-care.

26 Kiang Wu Hospital, Brochure Hospice & Palliative Care Centre – Introduction. Information also available at www.kwh.org.mo/medical%20center.php.

27 Detailed information regarding the centre’s operations was obtained from a conversation with a nurse who worked in the centre. There are no formal official documents in this regard.

28 In the past, patients who were admitted in the centre were required to sign a document called “Do-Not-Resuscitate Declaration”. Currently, the “Consent for the Hospice & Palliative Care Centre” document integrates the previous document.

29 This information was obtained from the “Consent in the Hospice & Palliative Care Centre” document.

30 Macao is, together with Hong Kong, a special administrative region of the People’s Republic of China. It has its own government and Chief of Government (the Chief Executive). As for Article 2 of the Macao Basic Law, “The National People’s Congress authorizes the Macao Special Administrative Region to exercise a high degree of autonomy and enjoy executive, legislative and independent judicial power, including that of final adjudication, in accordance with the provisions of this Law”. See António Katchi, As Fontes de Direito em Macau (Macau: Faculdade de Direito da Universidade de Macau, 2006), pp. 273408.

31 All about Macau Media, “The Claim that the Legislation Is Not Yet Due to ‘Low Public Awareness’ Health Bureau’s Reply and Public Response” (29 August 2020), www.cyberctm.com/zh_TW/news/mobile/detail/2620690#.YRko4y3R1QI.

32 Macao Health Bureau, “2nd Meeting of Ethic Committee for Life Sciences” (3 December 2019), www.gov.mo/pt/noticias/217173/.

33 All about Macau Media, “Before Existing ‘Advance Directives’ – Healthy and Undisturbed Centre that Allows End-of-Life Patients to Have a Choice (II)” [in Chinese] (13 July 2020), tinyurl.com/3f5wyu3m.

35 The only noticeable step is the promotion of ADs by some public and private entities. For example, the Macao Social Welfare Bureau promotes the use of ADs by the elderly when educating them on life-and-death matters (Macao Social Welfare Bureau, Macao Pension Status and Policy Research Report (2015), www.ageing.ias.gov.mo/uploads/file/a8387e568125adacb3c4d280d5354985.pdf), and the Geriatrics Society of Macao held an Academic Annual Meeting in 2019 with teaching on how ADs are put into practice in clinical work for the elderly (Cheng Pou Journal, “Geriatrics Society of Macao Held Its Inauguration Ceremony and Academic Annual Meeting” (26 November 2019), www.chengpou.com.mo/dailynews/183073.html).

36 S.M. Leong et al., “Prevalence and Predictors of Willingness to Make Advance Directives among Macao Chinese” (2021) 18(15) International Journal of Environmental Research and Public Health 7942.

37 All about Macau Media, “Claiming No Legislative Time Due to ‘The Public’s Low Awareness’ – Macao Health Bureau’s Response and the Public’s Response” [in Chinese] (29 August 2020), tinyurl.com/3756nz38. See also All about Macau Media, “Do Patients and Their Family Members Have the Right to Terminate ‘Invalid Medical Treatment?’ – The True Story of Miss Lam and her Family Members” [in Chinese] (1 May 2020), tinyurl.com/yckfdm3x.

38 It is not completely clear whether all forms of euthanasia are legally forbidden. Regarding the legality of euthanasia in Macao SAR, see Iong, Directivas Antecipadas de Vontade, Footnote note 13, pp. 54–67. For the same discussion in light of the Portuguese law, whose Criminal Code is the same as the one of Macao in this regard, see V.L. Raposo, “Doctor’s Criminal Liability and Medically Assisted Death – The Portuguese Case” (2019) 26(3) European Journal of Health Law 240.

39 For a distinction see Macao SAR, Iong, Directivas Antecipadas de Vontade, Footnote note 13; V.L. Raposo, “No Dia em que a Morte Chegar (Decifrando o Regime Jurídico das Diretivas Antecipadas de Vontade)” (2013) 22(24) Revista Portuguesa do Dano Corporal 79; V.L. Raposo, “Directivas Antecipadas de Vontade: Em Busca da Lei Perdida” (2011) 32(125) Revista do Ministério Público 169.

40 A detailed description of this disconformity is provided in Raposo, Footnote note 2.

41 K.Q. Wang et al., “On Legislative Protection of Living Will in China” (2017) 38(6A) Medicine and Philosophy 67; Q.S. Qi and J.Q. Xu, “Reflection upon the Legislation of Living Will in China” (2019) 35(8) Journal of Jilin Engineering Normal University 71; Y.P. Luo et al., “Promotion of Living Will: Practice and Suggestions” (2020) 41(22) Medicine and Philosophy 6; X. Bai and X. Liu, “On the Implementation of Living Wills in China” (2019) 11(1) Medicine and Jurisprudence 10; H.M. Zhang et al., “Evidence from Clinical Trials of the Changed Status in Living Will over the Past Twenty Years” (2020) 41(22) Medicine and Philosophy 13; S. Sui, “Discussion on the Issues of Living Will” (2014) 22(2) China Health Law 10.

15 Advance Directives in Pakistan: Religious, Cultural and Social Influences

1 “Pakistan Population (LIVE)”, Worldometer, 17 January 2022, www.worldometers.info/world-population/pakistan-population/.

4 M. Haider, “Human Development Index 2019: Pakistan Ranks Lower than All South Asian Countries”, The News, 12 December 2019, www.thenews.com.pk/print/582826-human-development-index-2019-pakistan-ranks-lower-than-all-south-asian-countries.

5 “Cabinet Approves Devolution of Seven Ministries”, Dawn, 28 June 2011, www.dawn.com/news/640139/cabinet-approves-devolution-of-seven-ministries.

6 S. Nishtar, Health and the 18th Amendment. Retaining National Functions in Devolution (Islamabad: Heart File, n.d.), www.heartfile.org/pdf/HEALTH_18AM_FINAL.pdf.

7 S.A. Khan, “Situation Analysis of Health Care System of Pakistan: Post 18 Amendments” (2019) 7 Health Care Current Reviews 1, 2.

8 S.A. Zaidi et al., “Health Systems Changes after Decentralisation: Progress, Challenges and Dynamics in Pakistan” (2019) 4 BMJ Global Health, e001013, 34.

11 Footnote Ibid., p. 3.

12 Khan, Footnote note 2, p. 2.

13 Footnote Ibid. Although the MoNHSRC is a federal entity, it is limited in its scope of work and is used to manage specific issues such as issues related to the COVID-19 pandemic. It is unable to take on a more holistic role owing to its contested legitimacy and opposition from the provincial assemblies.

14 Zaidi et al., Footnote note 8, pp. 1–8.

15 A. Hassan et al., “Healthcare System of Pakistan” (2017) 1 International Journal of Advanced Research and Publications 170.

17 S. Nishtar et al., “Pakistan’s Health System: Performance and Prospects after the 18th Constitutional Amendment” (2013) 381 The Lancet 2193, 2193.

19 M.T. Abdullah and J. Shaw, “A Review of the Experience of Hospital Autonomy in Pakistan” (2007) 22 International Journal of Health Planning and Management 45.

20 Zaidi et al., Footnote note 8, pp. 1–8.

21 Nishtar et al., Footnote note 17, p. 2193.

22 Footnote Ibid., 2201.

23 S. Kassim-Lakha and J. Bennett, “Philanthropic Funding for Health in Pakistan” (2013) 381 The Lancet 2236.

24 See also other factors discussed in Section 15.3.

25 A.I. Gilani et al, “Psychiatric Health Laws in Pakistan: From Lunacy to Mental Health” (2005) 2 PLoS Medicine e317, 1106.

26 Footnote Ibid., pp. 1106–7.

28 This ordinance is also sparingly implemented in practice (see Gilani et al., Footnote note 25). Despite the fact that health has shifted from a federal to a provincial matter since the 18th amendment of the Constitution, only three provinces have enacted mental health acts replacing the Mental Health Ordinance 2001, namely, Singh, Punjab and Khyber Pakhtunkhwa (see further S. Dey et al., “Comparing Legislation for Involuntary Admission and Treatment of Mental Illness in Four South Asian Countries” (2019) 13 International Journal of Mental Health Systems 1, 4).

29 Gilani et al., Footnote note 25, pp. 1105–9.

31 Transplantation of Human Organs and Tissues Act 2010.

32 M.A. Al-Bar and H. Chamsi-Pasha, Contemporary Bioethics: Islamic Perspective (Cham: Springer Open, 2015), pp. 250–7.

34 “Part IX: Islamic Provisions” (The Constitution of Pakistan), www.pakistani.org/pakistan/constitution/part9.html.

35 Al-Bar and Chamsi-Pasha, Footnote note 32, pp. 250–7.

37 “Herald Exclusive: When Life Meets Death”, Dawn, 26 April 2011, www.dawn.com/news/623972/herald-exclusive-when-life-meets-death.

38 Al-Bar and Chamsi-Pasha, Footnote note 32, pp. 250–7.

40 R.I. Khan, “Palliative Care in Pakistan” (2017) 2 Indian Journal of Medical Ethics 37.

43 F. Moazam, “Families, Patients, and Physicians in Medical Decisionmaking: A Pakistani Perspective” (2000) 30 The Hastings Center Report 28.

44 J. Akhtar, “Living Wills in Health Care: A Way of Empowering Individuals” (2010) 60 The Journal of the Pakistan Medical Association 240.

50 P.D. Biondo et al., “Understanding Advance Care Planning within the South Asian Community” (2017) 20 Health Expectations 911.

53 R.I. Khan, “End of Life Care in Pakistan; Some Ethical Issues” (2012) 22 Journal of the College of Physicians and Surgeons Pakistan 745.

57 W. Zafar et al., “Preferences regarding Disclosure of Prognosis and End-of-life Care” (2016) 30 Palliative Medicine 661.

61 F. Saeed et al., “Dialysis Decision Making and Preferences for End-of-Life Care: Perspectives of Pakistani Patients Receiving Maintenance Dialysis” (2020) 60 The Journal of Pain and Symptom Management 336.

62 Khan, Footnote note 7.

64 T. Ahmad, National Parliaments: Pakistan (Washington, DC: The Law Library of Congress, February 2017), https://tile.loc.gov/storage-services/service/ll/llglrd/2016478970/2016478970.pdf.

66 Nishtar et al., Footnote note 17.

68 N. Panjwani, “Advance Directives: A Policy Required in the Asian Countries” (2013) 3 I-manager’s Journal on Nursing 30.

69 N. Panjwani et al., “Physicians’ and Nurses’ Perspectives on the Importance of Advance Directives in Tertiary Care Hospitals” (2019) 1 Journal of Shifa Tameer-e-Millat University 3.

16 Advance Directives in Saudi Arabia: An Islamic Approach and Practical Implications

1 More on the legal system in SA and its religious basis can be found in A. Babgi, “Legal Issues in End-of-Life Care: Perspectives from Saudi Arabia and United States” (2009) 26 American Journal of Hospice & Palliative Medicine 119.

2 For example, “And do not kill your children for fear of poverty. We provide for them and you. Indeed, their killing is ever a great sin” (Quran, 17:31), which is used as proof that abortion is forbidden (unless there is a genuine cause).

3 Y.H.M. Safian, “An Analysis on Islamic Rules on Drugs” (2013) 1 International Journal of Education and Research 1.

4 N. Alsomali and G. Hussein, “CRISPR-Cas9 and He Jiankui’s Case: An Islamic Bioethics Review using Maqasid al-Shariʾa and Qawaid Fighiyyah” (2021) 13 Asian Bioethics Review 149.

5 See, for example, Quran, 57:22.

6 M.M. Malik, “Islamic Perceptions of Medication with Special Reference to Ordinary and Extraordinary Means of Medical Treatment” (2013) 4(2) Bangladesh Journal of Bioethics 22.

7 M.A. Albar, “Seeking Remedy, Abstaining from Therapy and Resuscitation: An Islamic Perspective” (2007) 18 Saudi Journal of Kidney Diseases and Transplantation 629 (as cited in H. Al-Jahdali et al., “Advance Medical Directives: A Proposed New Approach and Terminology from an Islamic Perspective” (2013) 16 Medicine, Health Care and Philosophy 163).

8 Death is described in the Quran as the “true life” or the “life indeed” (Quran, 26:64).

9 The Permanent Committee for Scholarly Research and Ifta’, “Fatwa no. 8926: Ruling on Cardiopulmonary Resuscitation”, in Fatwa Collections (Riyadh: General Presidency of Scholarly Research and Ifta’, 1988), Group 1, Vol. 25: Miscellaneous Fatwas 2, pp. 71–5, www.alifta.gov.sa/En/IftaContents/PermanentCommitee/Pages/FatawaChapters.aspx?cultStr=en&View=Page&PageID=9745&PageNo=1&BookID=7.

10 The Permanent Committee for Scholarly Research and Ifta’, “Fatwa no. 19165: Ruling on Using Euthanasia to End Suffering”, in Fatwa Collections (Riyadh: General Presidency of Scholarly Research and Ifta’, 1988), Group 1, Vol. 25: Miscellaneous Fatwas 2, pp. 8491, www.alifta.gov.sa/En/IftaContents/PermanentCommitee/Pages/FatawaChapters.aspx?cultStr=en&View=Page&PageID=9748&PageNo=1&BookID=7.

11 The Permanent Committee for Scholarly Research and Iftaʾ, “Fatwa no. 12086: Ruling on Cardiopulmonary Resuscitation”, in Fatwa Collections (Riyadh: 1988), Group 1, Vol. 25: Miscellaneous Fatwas 2, pp. 7982, www.alifta.gov.sa/En/IftaContents/PermanentCommitee/Pages/FatawaChapters.aspx?View=Page&PageID=9746&CultStr=&PageNo=1&NodeID=1&BookID=7.

12 A. Mobeireek, “The Do-Not-Resuscitate Order: Indications on the Current Practice in Riyadh” (1995) 15 Annals of Saudi Medicine 6.

13 Al-Jahdali et al., Footnote note 7.

16 J. Auda, Maqasid Al-Shariah: A Beginner’s Guide (Richmond, UK: International Institute of Islamic Thought, 2008), https://iiit.org/en/book/maqasid-al-shariah-a-beginners-guide/; A.H. Thahir, Ijtihād Maqāṣidi: The Interconnected Maṣlaḥah-Based of Islamic Laws, I. Haaz (ed.), (Geneva: Globethics.net, 2019), www.globethics.net/documents/10131/26882166/GE_Theses_30_isbn9782889312207.pdf/5b3a4fd5-b30f-b5d6-8c07-19251ccaacc4?t=1587732852812.

17 M.A. Al-Bar and H. Chamsi-Pasha, Contemporary Bioethics: Islamic Perspective (Springer, 2015).

18 See further chapter 14 of Al-Bar and Chamsi-Pasha, Footnote note 17.

19 See Footnote note 17, p. 256.

20 See “Then whoever alters the bequest after he has heard it – the sin is only upon those who have altered it. Indeed, Allah is Hearing and Knowing” (Quran, 2:181).

21 See Footnote note 17, p. 256.

22 S. Baharoon et al., “Advance Directive Preferences of Patients with Chronic and Terminal Illness towards End of Life Decisions: A Sample from Saudi Arabia” (2019) 25 Eastern Mediterranean Health Journal 791.

23 I.N. AlFayyad et al., “Physicians and Nurses’ Knowledge and Attitudes towards Advance Directives for Cancer Patients in Saudi Arabia” (2019) 14 PLoS ONE e0213938.

24 M.A. Tayeb et al., “A ‘Good Death’: Perspectives of Muslim Patients and Health Care Providers” (2010) 30 Annals of Saudi Medicine 215.

25 A.S. Aldawood et al., “End-of-Life Practices in a Tertiary Intensive Care Unit in Saudi Arabia” (2012) 40 Anaesthesia and Intensive Care 137.

27 Al-Jahdali et al., Footnote note 7.

28 This argument is also consistent with the view of Baharoon et al. that there is a strong belief amongst Saudi citizens that discussing serious illness openly with the patient will cause unnecessary depression or anxiety. As a result, relatives may require physicians to offer hope to the patient or at least request that the patient not be informed of the seriousness of his or her condition, corresponding with their data indicating that many patients are not aware of or informed about their terminal prognosis (see further Footnote note 22).

29 Al-Jahdali et al., Footnote note 7, p. 165.

30 See Footnote note 22, p. 794.

31 H.H. Al-Jahdali et al., “Advance Care Planning Preferences among Dialysis Patients and Factors Influencing their Decisions” (2009) 20 Saudi Journal of Kidney Diseases and Transplantation 232.

32 See Footnote note 24, p. 217.

33 See Footnote note 22, p. 794.

34 S. Alshammaray et al., “Development of Palliative and End of Life Care: The Current Situation in Saudi Arabia” (2019) 11 Cureus e4319.

35 See Footnote note 22, p. 794.

37 Footnote Ibid., p. 795.

39 See also AlFayyad et al., Footnote note 23, p. 9, which also recommends more uniform training on ADs for doctors and nurses, as well as access to AD registers.

17 Advance Directives in Asia: Towards “Generative Accommodation”

1 This legislation regulates psychiatric advance directives only, and not advance directives at the end of life.

3 Both Thailand and Taiwan permit ADs to be implemented for terminally ill patients, but also for patients with incurable disease for which medical treatment will merely prolong an inevitable death (Thailand) and patients with four specific clinical conditions that are unbearable, incurable and have no other appropriate treatment options (Taiwan).

4 See e.g. R. Horn, “‘Why Should I Question a Patient’s Wish?’ A Comparative Study on Physicians’ Perspectives on Their Duties to Respect Advance Directives” (2017) 24 European Journal of Health Law 523.

5 All three jurisdictions include some categories of patients without terminal illness. Hong Kong includes a general category of “other end-stage irreversible life-limiting condition[s]”. See Footnote note 3 regarding Thailand and Taiwan.

6 T.E. Chan, Singapore, in this volume, p. 52.

7 See e.g. Singapore, Thailand, Taiwan and Hong Kong’s proposed legislation.

8 This is in contrast to Israel and Singapore. In Israel, a physician can conscientiously object to implementing the AD, but is required to refer the patient to another physician who is able to do so. See further M. Bentwich, Israel, in this volume. Singapore similarly allows a physician to register an objection against implementing an AD, but requires the physician to “take all reasonable steps as soon as practicable” to transfer the patient to someone else who has not registered an objection (see further Advance Medical Directive Act 1996, s. 10(5)).

9 See e.g. Israel, Taiwan, Singapore, South Korea, Japan and Hong Kong.

10 See e.g. Hong Kong, Malaysia, Saudi Arabia and Turkey.

11 L.D. de Castro et al., Philippines, in this volume, p. 203.

12 Specifically, there remains uncertainty about how the legislative framework works in parallel with the common law (Singapore) or the judiciary (Israel). Furthermore, our reading of the Taiwan chapter is that there may also be some uncertainty about whether and how the two legislative regimes overlap in the case of terminally ill patients.

13 See e.g. the separate legislative frameworks proposed for ADs and continuing powers of attorney, in addition to the existing enduring powers of attorney legislation.

14 See further Malek’s argument that a contextualisation of patient autonomy according to Islamic values would include a prioritisation of the physician’s views, since physicians are generally seen to be the decision-making authority for the patient in Malaysian society in S. Kaur et al., Malaysia, in this volume, p. 188.

15 See in particular the distinction between “continuous” and “cyclical” treatments. The distinction between withholding and withdrawing treatment has also been made in the Japanese courts, and Ozeki-Hayashi et al. (Japan, in this volume) refer to the belief among doctors in Japan that ventilator support cannot be removed once the patient has been placed on it, due to the doctor’s duty to continue treatment once it has been started.

16 It had been suggested that the term “imminent” be defined chronologically, for example within 6–12 months, but it was decided by the Select Committee for the Advance Medical Directive Act that this was better left to medical judgement. See further T.E. Chan, Singapore, in this volume.

17 Such as the difficulties in implementation associated with a lengthy procedure and the need for unanimity among several professionals before the AD can be acted upon.

18 We use this phrase broadly to refer to the idea, shared by several of the religious traditions discussed in this volume, that life has intrinsic value and thus that preserving life must be prioritised.

19 M. Bentwich, Israel, in this volume, p. 23. It is interesting to note that this ultra-orthodox Jewish influence was not an inevitable consequence of the country’s religious traditions. See M. Bentwich, Israel, in this volume for a discussion of how ultra-orthodox Judaism is not in fact the religious tradition of the majority of citizens in Israel, but how ultra-orthodox Jewish values were adopted in the Dying Patient Law primarily due to political reasons.

20 M. Bentwich, Israel, in this volume, p. 28.

21 Although this remains unclear due to the lack of legislation on this issue. See further L.D. de Castro et al., Philippines, in this volume.

22 Z.A. Syed et al., Iran, in this volume, p. 166. This would, of course, only apply to those in the dying stage, as Syed et al. point out.

23 Although unlike Pakistan and Saudi Arabia, Iran’s Charter of Patient Rights does make specific mention of ADs.

24 K.A. Dhru and R. Ghooi, India, in this volume, p. 124.

25 See e.g. the Rule of No Harm and how it may be interpreted to either support or reject ADs in Z.A. Syed et al., Iran, in this volume.

26 M.A. Beg et al., Pakistan, in this volume, p. 284.

27 See e.g. the contrast between Saudi Arabia, where it is unclear what the legal role of fatwa might be, apart from supporting evidence in some cases (like do-not-resuscitate orders), and Iran, where the Constitution recognises the legally binding nature of fatwa in places where there are no statute or by-laws.

28 G. HUSSEIN and A. ADLAN, Saudi Arabia, in this volume, p. 298.

29 See e.g. R. Fan, “Self-determination vs. Family-determination: Two Incommensurable Principles of Autonomy” (1997) 11 Bioethics 309.

30 D. Martina et al., “Advance Care Planning in Asia: A Systematic Narrative Review of Healthcare Professionals’ Knowledge, Attitude, and Experience” (2021) 22(2) Journal of the American Medical Directors Association 349.e1.

31 In addition to East Asian jurisdictions where this is often said to be the case, see e.g. Iran’s concept of “family centric patient autonomous” where there is active involvement and inclusion of the family in decision-making; Turkey, where the family is frequently involved in decision-making; and Saudi Arabia, where the family and patient are seen as one unit and illness is a whole-family affair.

32 In Pakistan and the Philippines, the male members of the family are the ones who make decisions on behalf of the members of the family (in the case of the Philippines, this would be the eldest male).

33 See e.g. Singapore, where there is a not uncommon practice of collusion where families and physicians may work together to withhold a diagnosis and/or poor prognosis from a patient; and Taiwan, where the Hospice Palliative Care Act permits the physician to fulfil their obligation by merely informing the family. (The more recent PRAA requires the information to be shared with the patient, though permits physicians to share information with family unless the patient explicitly objects.)

34 D.F. Tsai, Taiwan, in this volume.

35 D. Cheung and R. Lee, Hong Kong, in this volume; Lee, South Korea, in this volume. See also Iran, where this is also the case, though not due to filial piety (see further Z.A. Syed et al., Iran, in this volume).

36 D.F. Tsai, Taiwan, in this volume; K.A. Dhru and R. Ghooi, India, in this volume.

37 See e.g. Taiwan where a family member must be involved in the ACP process. See also Japanese nursing homes, some of which require a family member’s signature on the AD form. In the psychiatric AD regime of the Philippines, the inclusion of the role of “supporters”, who can access information and attend medical appointments, can be seen as a way to keep family members involved.

38 D.F. Tsai, Taiwan, in this volume, p. 80. Note, however, that the PRAA also includes provisions that envisage a substantial amount of familial involvement. See e.g. Footnote note 33 for a discussion of how the PRAA permits the sharing of information with family as long as there is no explicit objection.

39 While none of these reasons on their own are determinative, together they point away from a conclusion of indigenous development.

40 See further Y.I. Ulman, Turkey, in this volume.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Non-regulated Jurisdictions
  • Edited by Daisy Cheung, The University of Hong Kong, Michael Dunn, National University of Singapore
  • Book: Advance Directives Across Asia
  • Online publication: 02 February 2023
  • Chapter DOI: https://doi.org/10.1017/9781009152631.015
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Non-regulated Jurisdictions
  • Edited by Daisy Cheung, The University of Hong Kong, Michael Dunn, National University of Singapore
  • Book: Advance Directives Across Asia
  • Online publication: 02 February 2023
  • Chapter DOI: https://doi.org/10.1017/9781009152631.015
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Non-regulated Jurisdictions
  • Edited by Daisy Cheung, The University of Hong Kong, Michael Dunn, National University of Singapore
  • Book: Advance Directives Across Asia
  • Online publication: 02 February 2023
  • Chapter DOI: https://doi.org/10.1017/9781009152631.015
Available formats
×